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My research has focused on the identification and characterization of the 
transcriptional enhancers required for the development and specification of neuronal 
populations that are impacted in human health and disease. The enhancer field has evolved 
quickly and as a result I have used multiple methods to identify cell-type restricted 
enhancers. I started by using sequence conservation to identify sequences flanking LMX1A 
and LMX1B that drive expression in the central nervous system. We identified 47/71 
constructs driving reporter expression in the CNS of mosaic zebrafish embryos. I then 
identified multiple founders driving consistent expression overlapping with endogenous 
expression patterns in 22/47 stable lines. This is a good method for locus specific analysis but 
is not easily scalable to genome-wide enhancer identification.  
In order to identify enhancers in a broader context we applied machine learning to 
create a classifier that identifies hindbrain enhancers genome-wide. Using a set of 
experimentally proven enhancers that drive expression in the hindbrain as a training set for a 
machine learning algorithm that searches for over representation of known transcription 
factor binding sites and de novo motifs, we predicted 40,000 hindbrain enhancers. The in vivo 
validation rate for tested elements reached 88% for expression in the hindbrain, displaying 
high sensitivity but low specificity. We attribute the lack of specificity to the heterogeneity of 
the training set and determined to employ a new approach to acquire a more homogenous cell 
population.  
Previous work has established that the joint analysis of transcriptional co-activator 
EP300 with histone modification H3K4me1 by ChIP-seq in cultured cells yields a highly 
accurate catalog of putative enhancers. However, my specific neuronal subtypes of interest 
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are not obtainable in the large numbers necessary for EP300 ChIP-seq. Instead, I examined 
public data from human substantia nigra and worked to optimize a small-cell number ChIP-
seq protocol for the analysis of ex vivo sorted neurons. I have completed histone ChIP-seq in 
sorted neurons from a transgenic mouse line driving EGFP in DA neurons. This work 
identifies a catalog of putative enhancers that may play important roles in the expression of 
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1.1 Enhancers and transcriptional regulation 
 In general, the DNA content within an organism of each cell is identical but this 
identical genetic content is also responsible for the vast diversity of cell types and expression 
patterns that we see in all eukaryotic life forms. This diversity is achieved by closely 
coordinated and dynamic control of gene expression that allows for responses to subtle 
environmental and developmental cues. The first step in this regulation occurs as DNA is 
transcribed to RNA. Transcriptional regulation requires the complex orchestration of 
interactions between numerous nucleotide and protein components. Transcription factors 
(TFs) and co-activators bind to DNA and other proteins in order to either induce or repress 
gene transcription. Many of the protein components involved in this regulation have been 
well studied and their functions are well understood (Buratowski et al., 1989; Thomas and 
Chiang, 2010). However, the regulatory instructions encrypted at the noncoding DNA 
sequence level have remained difficult to decipher. 
 The best characterized of the noncoding sequence encoded components is the 
promoter. The promoter is usually found within the 100 base pairs (bp) of sequence 
surrounding the transcriptional start site (TSS) and acts as the assembly point for the basal 
transcriptional machinery (Burke and Kadonaga, 1997; Juven-Gershon and Kadonaga, 2010). 
There is no universal sequence to identify promoters, instead they are made up of a 
combination of sequence elements including the TATA box, the initiator (Inr), TFIIB 
Recognition Element (BRE), Downstream core Promoter Element (DPE) and Motif Ten 
Element (MTE). The TATA box is located -30 bp from the TSS and acts to bind TBP (TATA 
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Binding Protein). It was the first identified promoter sequence (Goldberg, 1979) but it was 
later determined to be present in only 10-15% of mammalian promoters (Carnici et al., 2006; 
Kim et al., 2005; Cooper et al., 2006). The Inr is the located at the TSS and is the most 
commonly identified promoter element (Smale and Baltimore, 1989; Ohler et al., 2002; 
Fitzgerlad et al., 2006; Gershenzon et al., 2006). BRE motifs are in a subset of promoters 
with TATA boxes (10-30%; Lagrange et al., 1998), while DPE motifs are generally present 
only in promoters that do not contain TATA boxes (Burke and Kadonaga, 1996; Ohler et al., 
2002). Additionally the MTE motif can work independently or synergistically with any of the 
other core promoter sequences (Ohler et al., 2002; Lim et al., 2004). Despite the lack of 
precise sequence consensus of core promoter elements, promoters can still be readily 
identified by their position just 5’ of genes through cDNA sequencing and via their 
interaction with the transcriptional machinery using chromatin immunoprecipitation (ChIP; 
Trinklein et al., 2004; Cooper et al., 2006).  
A less well understood class of noncoding regulatory sequences includes enhancers 
and repressors and is characterized by the positive and negative modulation of gene 
expression. Enhancers are cis noncoding sequences that act to up-regulate gene expression, 
while repressors down-regulate expression in a cell-type-restricted manner. These sequences 
generally act independent of orientation and can be located upstream, or downstream of 
within the introns of their target gene. Some extreme examples have been shown to function 
from more than a megabase (Mb; Lettice et al., 2002, 2003) away from their target. 
Enhancers contain collections of transcription factor binding sites (TFBSs) that are predicted 
to function by binding TFs which in turn recruit EP300, CBP and mediator proteins (Figure 
1-1; Panne et al., 2007; Noonan and McCallion, 2010; He et al., 2011). This complex of TFs 
and co-factors can then interact with the basal transcriptional machinery at the promoter of a 
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target gene to initiate transcription (Ong and Corces, 2011; Chepelev et al., 2012). Since 
enhancers and repressors are not found in a specific location relative to their target gene and 
there is no overt sequence characteristic of them historically, as a class they have been very 
difficult to identify. Additional factors involved in transcriptional regulation include 
chromatin structure, histone modifications and proximity of cis regulatory features to a gene. 
The histone modifications H3K4me1 and H3K27ac have been associated with enhancer 
function for many years (Heintzman et al. 2007; Rada-Iglesias et al. 2007; Heintzman et al., 
2009; Creyghton et al., 2010).  
 
1.2 Phenotypic effects of variation in human enhancers 
The instructions encoded within regulatory elements, including enhancers, play 
important roles in directing cell fate determination, and allowing cells to respond to their 
environment by changing levels of gene expression. Variation in these elements is predicted 
to contribute significantly to normal human variation and disease risk. Mutations affecting 
enhancers have been known for many years to result in Mendelian inherited developmental 
defects in humans. However, our very limited understanding of the sequence basis of 
enhancers makes it difficult to identify relevant enhancer sequences from primary genomic 
sequence alone. As a result, our lab has an ongoing interest in identifying enhancer catalogs 
in a variety of cell types and determining the sequence vocabularies that make them up.  
One of the earliest examples of a Mendelian disorder resulting from disruption of an 
enhancer was found in a familial form of aniridia, a developmental defect characterized by 
hypoplasia of the iris first described in the late 1950s (Shaw et al., 1960). Aniridia had been 
found to be caused by loss of function mutations in the coding region of PAX6, a TF with a 
paired box DNA binding domain involved in nervous system and eye development. Families 
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with aniridia were soon identified that had no coding mutations but did have cytogenetic 
rearrangements near the PAX6 locus (Fantes et al., 1995). Breakpoint mapping using Yeast 
Artificial Chromosomes (YACs) implicated a region 125 kb downstream from PAX6 as an 
enhancer important for regulating expression of PAX6 in the eye. Around the same time 
another group identified a sequence downstream of the quail Pax-6 that drove expression 
specifically in neuro-retinal cells (Plaza et al., 1995). It was later shown that a single point 
mutation in this region causes loss of reporter expression in the retina of zebrafish and mice 
(Bhatia et al., 2013).  
As a result of our constantly improving understanding of noncoding DNA the 
literature is now full of examples of both Mendelian and complex human diseases arising 
from alterations in predicted enhancers. Other diseases included within this list are mutations 
affecting an enhancer of SHH located 1 Mb away leading to pre-axial polydactyly (Lettice et 
al., 2002, 2003); SOX9 enhancer mutations linked to Pierre Robin Sequence (Benko et al., 
2009); POU3F4 regulatory mutations associating with X-linked deafness type 3 (De Kok et 
al., 1995; Ahn et al., 2009; Naranjo et al., 2010); and sex-dependent mutations of an enhancer 
for RET causing forms of Hirschsprung disease (Emison et al., 2005). We hypothesize that as 
the tools to study enhancers continue to evolve we will identify many more phenotypic 
effects that are rooted in non-coding DNA. Evidence for this hypothesis is found in the 
hundreds of Genome-Wide Association Study (GWAS) results that implicate noncoding 
regions with a frequency of almost 95% (Maurano et al., 2012; Welter et al., 2014). We 
propose to leverage these GWAS results to identify functional putative enhancers with roles 




1.3 Sequenced based analysis for the identification of enhancers 
 In the years following the sequencing of the human and mouse genomes the most 
commonly used method of enhancer identification became the use of sequence conservation 
across species. The use of conservation as an indication of function is based on the 
hypothesis that functional sequences in the genome will be less tolerant of variation than 
regions that are non-functional. Accordingly, if one examines a speciation event at a 
hypothetical single locus it is observed that at first (time=0) sequence identity is 100 percent, 
but over extensive evolutionary time random mutations will arise across the genome during 
replication. Those that decrease the fitness of the organism are not tolerated and will be lost 
while those that have no effect on fitness will be allowed to accumulate. This results in 
varying amounts of sequence conservation across the genome from which one can predict 
functional elements. Support for this hypothesis is found in the fact that exons of genes show 
very high conservation while introns tend to show lower conservation (Miller et al., 2004). 
Therefore, noncoding regions with high interspecies conservation are predicted to be 
functional and can be selectively cloned from the genome for further functional analysis.  
Our lab has used screening regions of interest for conservation for more than 10 years 
and my discussion on the identification of enhancers at LMX1A and LMX1B applied this 
strategy directly (Grice et al., 2005; Fisher et al., 2006; Antonellis et al., 2008; Burzysnski 
and Reed et al., 2013). However, there are a few drawbacks, the most significant being that it 
is a locus-based analysis and extrapolation to the whole genome would be a monumental and 
likely prohibitive task. We have also previously shown that analysis of conserved regions 
alone misses a significant portion of functional noncoding sequences (McGaughey et al., 
2008; McGaughey et al., 2009). Additionally, the presence of conservation gives no 
information regarding the function of a region or the gene upon which it may act. For these 
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reasons, we are constantly investigating new technologies and molecular methods that will 
allow for genome-wide identification of enhancers within a specific cell type.  
 
1.4 Molecular methods to identify enhancers 
Chromatin immunoprecipitation (ChIP) for transcription factors, histone 
modifications and/or transcriptional co-activators has become a commonly used strategy to 
show that a particular DNA sequence interacts with known proteins (O’Neill and Turner, 
1995). ChIP is based on the physical interaction of proteins with specific DNA sequences. 
Cells are generally cross-linked to maintain the in vivo interactions and then cells are lysed, 
DNA fragmented, and antibodies are used to enrich for the protein of interest, and thus the 
DNA that it has bound (O’Neill and Turner, 1996). Initially these methods were limited to 
predefined loci, however as technology has improved, first with chips to employ microarray 
hybridization of immunoprecipitated DNA (ChIP-chip; Horak et al., 2002) then with high 
throughput next-generation sequencing (ChIP-seq; Robertson et al., 2007) they have become 
scalable to analysis of the whole-genome.  
It was first shown in 2007 by ChIP-chip that a specific histone modification, 
H3K4me1, is associated with enhancers that are characterized by binding of the 
transcriptional co-activator EP300 (Heintzman et al., 2007). ChIP-seq for EP300 as a marker 
of enhancers was first used in 2009 to identify enhancers genome-wide in the forebrain, 
midbrain and limb of embryonic mice (Visel et al., 2009). Further ChIP-seq experiments for 
histone modifications found enrichment for both H3K4me1 and H3K27ac at putative 
enhancers defined by the presence of EP300 (Rada-Iglesias et al., 2011). As the cost of high 
throughput sequencing has decreased in recent years its frequency of use has eclipsed that of 
sequence conservation alone.  
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DNase-seq is another genome-scalable method that allows for the broad capture of 
DNA in euchromatin, a prediction of functionality, and has also been used to create catalogs 
of putative enhancers (Song and Crawford, 2010; Mercer et al., 2013). Molecular methods 
for the discovery of enhancers, like ChIP-seq, are desirable because they are unbiased by the 
conservation status or location of a putative enhancer and therefore provide a broad look at 
the noncoding genomic regions predicted to be functional within a particular cell type. This 
makes them an ideal starting point for discovering catalogs of enhancers and characterizing 
the vocabularies associated with them in specific neuronal populations 
 
1.5 Dopaminergic neurons and human disease 
 Dopaminergic (DA) neurons are characterized by the use of dopamine as a signaling 
molecule. The most dense population of DA neurons is found in the substantia nigra (SN), in 
the ventral midbrain, where they play a key role in voluntary movement. Smaller, more 
sparse, populations of DA neurons exist throughout the CNS in the hypothalamus, olfactory 
bulb, retinal amacrine cells, striatum and the ventral tegmental area (VTA) where they are 
hypothesized to influence diverse processes such as satiety, scent, reward pathways, mood 
and other cognitive behaviors (Prakash and Wurst, 2006). The variety of functions makes DA 
neurons a very important contributor to many aspects of human health and disease.  
Degeneration of DA neurons of the SN leads to the akinesia, hypokinesia and/or 
bradykinesia that characterize Parkinson’s Disease (PD), while disruptions of the pathways 
encompassing DA neurons in the striatum and VTA have been implicated in addiction, 
depression, bipolar disorder (BP) and schizophrenia (SZ; Robinson et al., 1993; Tzschentke 
et al., 2000; Meyer-Lindberg et al., 2002). PD and SZ are among the world’s most common 
neurological disorders, each having a population incidence of !1% (Savitt et al., 2006). 
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Mutations in at least 8 genes have been shown to cause Mendelian forms of Parkinson’s and 
Genome Wide Association Studies (GWAS) have identified more than 19 other loci, some 
affecting the same genes that are mutated in Mendelian forms (Table 1-1; Singleton et al., 
2013). Our incomplete understanding of the molecular genetics controlling DA neuronal 
differentiation, survival and competence is a major obstacle to novel prophylactic and 
preventative strategies. The studies that follow aim to begin the process of identifying and 
characterizing the transcriptional networks underlying the development and function of this 
clinically relevant neuronal subtype.  
 
1.6 Functional assays in zebrafish 
 Upon identification of a putative neuronal enhancer we must investigate if, when and 
where the sequence drives expression. Zebrafish are a good model system for this analysis 
for a number of reasons. First, embryos are transparent, undergo external development and 
develop a fully functional nervous system after 4-5 days of development (Kuwada, 1995; 
Budick and O’Malley, 2000). Second, both the genome (Gates et al., 1999; Barbazuk et al., 
2000) and brain development and structure are largely conserved between zebrafish and 
mammals (Figure 1-2; Mueller and Wullimann, 2003; Guo, 2004; Mueller et al., 2006; 
Aizawa et al., 2011). Zebrafish contain all of the major cell types found in the CNS 
(Westerfield et al., 1986; Koulen et al., 2000; Kawai et al., 2001; Yoshida et al., 2005; Avila 
et al., 2007; Peri and Nusslein-Volhard, 2008), and share many of the same neuroanatomical 
(Rink and Wullimann 2002; Mueller and Wullimann 2009) and neurochemical pathways 
with humans (Holzschuh et al., 2003; Mueller et al., 2006; Filippi et al., 2010; Filippi et al., 
2014). Additionally, zebrafish have a relatively short time to sexual maturity (~ 3 months) 
and each female can produce hundreds of embryos each week, making it easier to obtain 
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large numbers for analysis than with transgenic mice. For these reasons, zebrafish reporter 
assays allow for a quick and cost effective analysis of putative neuronal enhancers. 
Reporter assays in zebrafish are very straightforward and are done by first designing 
PCR primers to the genomic region of interest. The sequence is then PCR amplified and 
cloned into a vector upstream of a minimal promoter linked to a fluorescent reporter. The 
minimal reporter alone does not drive reporter expression but in the presence of a sequence 
that acts as an enhancer it will drive expression in the embryo wherever that sequence is 
active. Our reporter construct is also flanked by tol2 sequences that allow it to randomly 
integrate into the zebrafish genome when co-injected with tol2 transposase into fertilized 
zebrafish embryos (Fisher et al., 2006a and b). Fluorescent readout can be visualized in the 
developing embryos to determine when and where the sequence drives expression. One 
limitation of these assays is the possibility of interaction between the minimal promoter and 
the genomic DNA flanking the site of integration, dubbed position effects (Fisher et al., 
2006b). These effects can be overcome by the analysis of many transgenic embryos to 
identify overlapping regions of expression as the true enhancer readout. In vivo reporter 
assays are especially useful when examining specific neuron populations that may not have 









1.7 Tables: Chapter 1 
Table 1-1. Genes with coding mutaions linked to familial parkinsonian phenotypes. 
Gene Location Heritability OMIM # 
SNCA 4q22.1 AD 168601, 605543 
LRRK2 12q12 AD 607060 
VPS35 16q11.2 AD 614203 
EIF4G1 3q27.1 AD 614251 
DNAJC13 1p31.3 AD 614334 
PARK2 6q26 AR 600116 
PINK1 1p36.12 AR 605090 
DJ-1 1p36.23 AR 606324 
DNAJC6 1p31.3 AR 615528 
ATP13A2 1p36.13 AR 606693 
FBXO7 22q12.3 AR 260300 
PLA2G6 22q13.1 AR 612953 
ATP6AP2 Xp11.4 X-linked recessive 300911 
















1.8 Figures: Chapter 1 
Figure 1-1. Model of enhancer function. 
 
Nucleosomes flanking enhancers are enriched for H3K4me1 (red circles). Transcription 
factors bind the enhancer and recruit co-factors such as EP300 and the mediator complex to 
interact with the promoter and in turn recruit RNA polymerase. Adapted from Noonan and 
McCallion, 2010 and Gorkin, 2013.  
Abbreviations: E – Enhancer; N – Nucleosome; P – Promoter; TF – Transcription factor. 
%&!
Figure 1-2. Zebrafish brain organization is largely conserved with mammals. 
Representation of saggital sections from A) rat brain and B) zebrafish brain. Although the 
structure and organization are slightly different, functional regions and cicuitry are retained 
in zebrafish. Red and blue lines show examples of conserved circuitry in the habenular 
pathways. Adapted from Aizawa et al. 2011.  
Abbreviations: SNc – Substantia nigra pars compacta, RMTg – rostromedial tegmental 
nucleus, VTA – Ventral tegmental area.  
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CHAPTER 2 
USE OF ESTABLISHED METHODS OF SEQUENCE CONSERVATION 
AND REPORTER ASSAYS FOR ENHANCER DISCOVERY 
 
2.1 Introduction 
In this chapter we examine sequences predicted to regulate the expression of the lim 
homeodomain containing transcription factors, LMX1A and LMX1B. These genes play critical 
roles in the development of the central nervous system, specifically in neural tube 
regionalization, hindbrain development, the development of axonal projections and 
differentiation into dopaminergic and serotonergic neuronal subtypes (Hobert and Westphal, 
2000; Shirasaki and Pfaff, 2002; Dai et al., 2009; Andersson et al., 2006). Lmx1b has been 
shown in mice to be required for normal mesencephalic dopaminergic neuron development, 
serotonergic neuron development, podocyte differentiation and numerous cases of 
inactivating LMX1B mutations have been found to be responsible for human nail patella 
syndrome (Smidt et al., 2000, Zhao et al., 2006, Miner et al., 2002, Vollrath et al., 1998). 
Similarly, Lmx1a mutations were initially described in mouse neurological mutant dreher, 
which displays defects in cerebellar, hippocampal, and cortical development, as well as 
hindbrain roof plate malformations, short tail and deafness consistent with the patterns of its 
embryonic expression (Millonig et al., 2000; Failli et al., 2002).  
Despite the developmental importance of these genes their regulation is not well 
understood. When examining specific loci evolutionary sequence conservation provides a 
powerful tool for the identification of functional sequences, and although conservation alone 
is unable to discern the biological roles of sequences, through functional analyses, one can 
discover regulatory elements. In order to begin to investigate the transcriptional regulation at 
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LMX1A and LMX1B we have identified 71 conserved noncoding regions flanking these loci.  
We first characterize the expression patterns of the homologous zebrafish genes (lmx1a, 
lmx1a-like, lmx1ba, and lmx1bb) in order to describe their overlap with the patterns driven by 
putative enhancers flanking their human counterparts. Next we test the ability of these 
noncoding sequences to drive expression in zebrafish reporter assays. This reporter analysis 
identifies 22 previously unknown enhancers, 17 flanking LMX1A and 5 flanking LMX1B, 
which drive expression in the CNS and may be important in regulating gene transcription 




2.2.1 Evolutionary conservation facilitates identification of zebrafish lmx1a and lmx1b 
genes 
 In order to effectively evaluate the expression patterns of putative enhancers flanking 
LMX1A and LMX1B in zebrafish one must first characterize the expression of the 
homologous zebrafish genes. Therefore, we first set out to identify homologs of LMX1A and 
LMX1B in zebrafish. Approximately 30% of the gene content of Danio rerio is duplicated as 
a result of an ancient genomic duplication event in the teleost fish lineage (Amores et al., 
1998). Due to this duplication, the zebrafish genome contains two identified LMX1B paralogs 
(lmx1ba and lmx1bb). However, only one LMX1A paralog (lmx1a) had been identified in the 
zebrafish genome at the time of these experiments. We performed a BLASTP query of the 
zebrafish peptide database in GenBank using the human LMX1A RNA sequence 
(NM_001174069.1) and identified another potential paralog previously annotated with 
‘predicted’ status (LIM homeobox transcription factor 1-alpha-like, XP_001922131.3). 
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LMX1A is 66% identical to LMX1B at the amino acid level, and is 58% and 59% identical to 
zebrafish Lmx1a and Lmx1a-like, respectively. The LMX1B homologs are more similar with 
Lmx1ba having 72% protein sequence identity and Lmx1bb being 82% identical to the 
human LMX1B protein sequence (NP_001167617.1). Figure 2-1 provides a phylogram 
illustrating the similarity among the amino acid sequences that encode LMX1A, LMX1B and 
their zebrafish paralogs. The paralogs of LMX1A cluster together, but in a distinct node from 
their human counterpart. By contrast, LMX1B shares a common node with its zebrafish 
paralogs. 
 
2.2.2  Zebrafish lmx1 genes are expressed throughout the central nervous system 
After identification of zebrafish lmx1 homologs we performed whole mount in situ 
hybridizations (ISH) to examine expression of the endogenous zebrafish lmx1 genes. ISH 
allows us to document the spatial and temporal expression patterns of the endogenous lmx1a, 
lmx1a-like, lmx1ba and lmx1bb mRNAs, and to determine the similarity to the published 
expression of their mammalian orthologs in mice. Aspects of the early developmental 
expression of lmx1ba and lmx1bb have been previously described, however we repeated their 
ISH analysis to ease comparisons with expression patterns of lmx1a and lmx1a-like (O’Hara 
et al., 2005; Cheng et al., 2007; Elsen et al., 2008; McMahon et al. 2009; Filippi et al., 
2010).. 
Transcript from lmx1a was seen diffusely throughout the brain, including the 
diencephalon and telencephalon, at both 48 hours post fertilization (hpf) and 72 hpf (Figure 
2-2 A-D). We detected a more distinct and localized signal in the ventral diencephalon, raphe 
nuclei and otic vesicles at both time points, and at 72 hpf saw specific labeling of the cranial 
ganglia (Figure 2-2 A-D). In contrast, lmx1a-like expression was regionally restricted, with 
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distinct labeling of the epiphysis, ventral diencephalon, rhombic lip, and raphe nuclei, closely 
resembling expression of LMX1B paralogs (Figure 2-2 E-L). We also detected expression of 
lmx1a-like in the anterio-dorso-lateral hindbrain and in the ventro-midline, corresponding 
with the cerebellar rhombic lip and serotonergic raphe nuclei, respectively (Figure 2-2 E-H). 
Both lmx1a and lmx1a-like appeared to be more highly expressed in the anterior raphe nuclei 
at 48 hpf (Figure 2-2 A, B, E, and F), while the lmx1b paralogs were seen approximately 
equally in both raphe nuclei populations (Figure 2-2 I, J, M, and L). These data are consistent 
with both Lmx1a and Lmx1b mammalian counterparts, which are expressed in the developing 
cerebellum and serotonergic neurons. lmx1a-like has very little dorsal hindbrain expression at 
48 hpf but by 72 hpf transcripts are detected strongly in the posterior dorsal hindbrain (Figure 
2-2 G and H). This pattern is unique to lmx1a-like while some expression domains overlap 
expression of lmx1ba and lmx1bb in the ventral diencephalon, rhombic lip, serotonergic 
raphe nuclei and faintly in the otic vesicles (Figure 2-2 I, J, M and N; Cheng et al., 2007; 
Filippi et al., 2010). 
The patterns of expression are very similar between lmx1ba and lmx1bb with shared 
domains in the ventral diencephalon, raphe nuclei, rhombic lip, and dorsal hindbrain, as well 
as the amacrine neurons of the retina at 72 hpf (Figure 2-2 I-P). lmx1bb and, to a lesser 
extent, lmx1ba show additional expression in the dorsal diencephalon that is not seen for the 
lmx1a transcripts (Figure 2-2 I-P). Overall lmx1bb shows broader domains of expression than 
lmx1ba throughout the CNS, however lmx1ba transcript is also unexpectedly detected in the 
heart (Figure 2-2 I-L). Notably, strong expression is seen for all transcripts in the ventral 
diencephalon, the area where main clusters of dopaminergic (DA) neurons are formed, 
through 72 hpf consistent with their roles in the induction and specification of midbrain DA 
neurons (Andersson et al., 2006; Mishima et al., 2009; Yan et al., 2011).   
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2.2.3  Selection of noncoding sequences at human LMX1A and LMX1B loci 
The human LMX1A gene is made up of seven exons, encompassing 154 kb on 
chromosome 1q24 and is flanked by PBX1 and RXRG (Figure 2-3 A). LMX1B includes 8 
exons that cover 112 kb of chromosome 9q33.3 and is flanked by FAM125B and ZBTB43 
(Figure 2-3 B). Candidate sequences for functional analysis were selected from the intervals 
between their respective flanking genes, therefore providing LMX1A and LMX1B regions of 
554 kb and 298 kb, respectively. Although this search space was not exhaustively explored, 
we prioritized conserved noncoding sequences for assay using Genomic Evolutionary Rate 
Profiling (GERP; Cooper et al., 2005). We successfully PCR amplified 71 noncoding DNA 
sequence intervals (see methods; 43 sequences at LMX1A and 28 at LMX1B). These putative 
enhancers were cloned into pGWcfos: EGFP and injected into fertilized zebrafish embryos 
(Fisher et al., 2006 a and b). All embryos showing mosaic EGFP expression in the CNS (33 
LMX1A (77%) and 14 LMX1B (50%)) were separated and raised for germline transmission 
analysis. 
 
2.2.4  Tested sequences display LMX1A and LMX1B-appropriate EGFP activities 
 Of the assayed sequences, 37 displayed reporter expression in the CNS upon passage 
through the germline. We identified two or more founders with concordant expression from 
22/37 (59%) conserved noncoding regions  (LMX1A, n=17 and LMX1B, n=5). In general, the 
lines for which we were unable to identify multiple founders suffered from poor survival and 
fecundity. Those elements were therefore most often excluded, not because of divergent 
expression patterns but due to the inability to obtain a sufficient number of fertilized embryos 
for screening.  
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All 22 sequences in which multiple founders were identified displayed spatial control 
in the CNS that overlapped, at least in part, with the endogenous expression patterns 
described above (Table 2-1; Failli et al. 2002). This includes directing reporter expression 
within discrete regions of the diencephalon, telencephalon and hindbrain. We also identified 
enhancers at LMX1A that display regulatory control of reporter expression resembling the 
more diffuse expression of lmx1a in the CNS (LMX1A_-1.59; Table 2-1). Consistent with 
their neuronal activity in our synthetic assay, the majority of endogenous sequence intervals 
corresponding to our assayed sequences also displayed enrichment for the enhancer 
associated H3K4me1 mark in two lines of cultured neurospheres derived from human 
neuronal cells Neurosphere Cultured Cells, Ganglionic Eminence Derived (NGED) and 
Neurosphere Cultured Cells, Cortex Derived (NCD) (Figure 2-3 A-C; Heintzman et al. 2007; 
Bernstein et al. 2010). Indeed, despite lacking a positive GERP alignment score, sequence 
LMX1A_36.74 displayed strong H3K4me1 binding in both NGED and NCD cells and was 
validated in our zebrafish assay (Figure 2-4 E). 
 
2.2.5 Identification of LMX1A enhancers with telencephalic and diencephalic regulatory 
control 
Consistent with the endogenous expression of the mouse Lmx1a mammalian ortholog 
(Faili et al., 2002), we identified many LMX1A enhancers displaying overlapping control in 
the telencephalon (Figure 2-4 A-C, D, E; and Table 2-1). Telencephalic expression displayed 
by these sequences is consistent with the function of LMX1 genes in cortical hem 
development (Figure 2-4 A-E; Chizhikov et al., 2010; Adams et al., 2000; Guo et al., 2007). 
Telencephalic expression is also evident for the zebrafish lmx1a, however it is diffuse and 
and not at significant levels (Figure 2-2 A-D). This observation may thus reflect mammalian 
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(LMX1A/Lmx1a) control alone in this structure. We identified multiple additional sequences 
at LMX1A that direct expression in the diencephalon (Figure 2-4 A, D-F; and Table 2-1 e.g. 
LMX1A_238.85, LMX1A_-36.74 and LMX1A_9.65). These populations may include 
portions of the catecholaminergic diencephalic cluster, consistent with the established role of 
Lmx1a in mouse catecholaminergic neurogenesis (Yan et al., 2011). 
 
2.2.6 Many identified LMX1A and LMX1B enhancers display regulatory control at the 
midbrain/hindbrain boundary and in the hindbrain 
 Multiple REs from both loci are able to drive expression in the midbrain-hindbrain 
boundary region that includes the IsO and anterior cerebellum (Figure 2-5 and Table 2-1; e.g. 
LMX1A_-36.74, LMX1A_41.10, LMX1A_479.86, LMX1A_135.15 and LMX1B_-79.84). 
These data corroborate with the role of mammalian LMX1 genes in IsO and cerebellum 
development and function (Adams et al., 2000; Guo et al., 2007). Additionally, many assayed 
sequences directed expression in the hindbrain (Figure 2-5 and Table 2-1; e.g. 
LMX1A_475.57, LMX1A_238.85, LMX1A_5.34, LMX1A_-1.59 and LMX1B_28.46), 
including the roof plate (LMX1A_102.3) and the spinal cord (Table 2-1; e.g. LMX1A_-1.59, 
LMX1A_238.85 and LMX1B_28.46) consistent with the endogenous expression of their 
corresponding zebrafish paralogous transcripts. 
 
2.2.7 LMX1 enhancers display regulatory control in peripheral neuronal as well as non-
neuronal cell populations 
We identified several LMX1A and LMX1B sequences that direct expression in the otic 
vesicle (Figure 2-4 B, and Table 2-1, e.g. LMX1A_-36.74, LMX1A_92.33 and 
LMX1A_117.21, LMX1B_-93.21), consistent with the expression of Lmx1a (Failli et al., 
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2002). Furthermore, mice deficient in Lmx1a display abnormal ear development and 
deafness (Millonig et al., 2000; Huang et al., 2008). Multiple lines display reporter 
expression in PNS structures, like motor neurons (Figure S2 and Table 2-1; LMX1A_238.85) 
or sympathetic chain (Figure S2 and Table 2-1; e.g. LMX1A_475.57). In contrast to the well-
characterized neuronal roles of LMX1A and LMX1B, many identified enhancers also drive 
reporter expression in non-neuronal tissues such as the branchial arches, (Table 2-1, Figure 2-
4 A-C, Figure S2) which are also documented sites of expression in the mouse (Chen et al., 
2003; Failli et al., 2002). We also identified a single LMX1B enhancer that displays 
expression in the heart (LMX1B_-93.21). Although unexpected, this is consistent with our 
ISH for endogenous expression of lmx1ba. The biological significance of lmx1ba has not yet 
been determined but may, in part, correspond to the aortic arch neurons where expression of 




In order to better understand the regulatory landscape of LMX1A and LMX1B we 
undertook a functional study of conserved, noncoding sequences (putative REs) at these loci, 
using zebrafish transgenesis. We first established the identity of two zebrafish paralogs for 
each human LMX1 gene. We then demonstrated that their endogenous expression closely 
resembles the previously characterized expression of their mammalian counterparts, 
including expression in the areas of presumptive catecholaminergic neurons, cerebellum, 
raphe nuclei and otic vesicles (Figure 2-2). Next, we used comparative sequence analyses to 
identify conserved, noncoding sequences at the human LMX1A and LMX1B loci, selecting 
71 putative REs for functional evaluation. Of these putative enhancers, 45 directed CNS 
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reporter expression in the CNS of mosaic zebrafish embryos. We further described the 
reporter expression of 22 sequences in stable transgenic lines (LMX1A, n=17; LMX1B, 
n=5). All 22 display consistent CNS enhancer function (n!2 independent founders) that 
overlaps, at least in part, with the endogenous transcripts. The majority of these sequences 
display enrichment for H3K4me1, a modification known to be enriched at enhancers, in 
cultured neurospheres (Figure 2-3; Heintzman et al., 2007; Bernstein et al. 2010), consistent 
with their neuronal activity in our synthetic assay, and providing evidence supporting their 
likely cis-regulatory role in their endogenous context. Instances where we do not detect 
reporter expression most often reflect failure to identify more than one founder transgenic 
line and not inconsistencies among multiple lines for a single construct. 
The diencephalon, telencephalon and midbrain-hindbrain boundary were among the 
most common structures marked by reporter expression for REs identified at both loci 
(Figure 2-4; Table 2-1; Appendix 1). Many enhancers similarly directed broad expression in 
the midbrain (Figure 2-4; Table 2-1; Appendix 1) and more discrete expression in the 
hindbrain e.g. in single rhombomeres, area postrema (Figure 2-5; Table 2-1; Appendix 1, 
LMX1B_-79.84) or hindbrain roof plate (Figure 2-4; Table 2-1; Appendix 1, 
LMX1A_102.3). These sites of expression overlap known domains of Lmx1a and Lmx1b 
expression in mammals and teleosts. The expression directed in the midbrain-hindbrain 
boundary, cerebellum and posterior rhombomeres is consistent with the important function of 
both LMX1A and LMX1B in the development of the cerebellum rhombic lip and hindbrain 
roof plate (Mishima et al., 2009; Chizhikov et al., 2010). Furthermore, LMX1B is known to 
be instrumental for proper functioning of the IsO [(Adams et al., 2000; Guo et al., 2007). We 
hypothesize that the forebrain expression patterns of some LMX1A enhancers reflect the 
gene’s role in early development of cortical hem in mammals.  
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Many sequences also direct expression in the PNS and some non-neuronal tissues, 
consistent with the endogenous expression of these TFs and their roles in the differentiation 
and maintenance of a range of populations. The most common non-neuronal site of reporter 
expression was found in the otic vesicles, which is consistent with previously published 
LMX1A/B biology (Millonig et al., 2000; Failli et al., 2002; Huang et al., 2008). Interestingly 
we also identified some enhancers that drive expression in the heart, which may correspond 
to peripheral neuronal populations (Wen et al., 2008). 
Transgenic assays provide an approximation of how a regulatory sequence can 
behave in a model system and may not capture every nuance that the corresponding sequence 
may display in context. Therefore, their correspondence to the spatial expression of lmx1 
genes does not definitively demonstrate their control (exclusive or shared with neighbors) of 
these genes. In particular, we recognize that aspects of the CNS regulatory control displayed 
by enhancers isolated near LMX1A and LMX1B may also be considered consistent with 
expression of the flanking genes. In particular, transcript from the zebrafish pbx1a paralog is 
seen in many domains that also show expression of lmx1a/lmx1a-like (Thisse et al., 2004), 
including discrete expression in the telencephalon. Thus firm conclusions regarding enhancer 
driven reporter expression and their direct relation to LMX1-expressing neuronal populations 
or those of their flanking genes will require additional experimental determination of possible 
physical interaction between enhancer and one or more cognate promoter. Despite these 
caveats, these assays can and do provide significant insight into the biological relevance of 
assayed sequences.  
We demonstrate how a range of available data types may be integrated in the 
exploration of the genomic information content of sequence encompassing two critical 
human genes. This work is the first to describe the endogenous expression patterns of all 
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zebrafish LMX1A paralogs; it identifies 22 previously unknown enhancers and sheds light on 
previously unknown transcriptional regulatory landscape at the LMX1A and LMX1B loci. If 
one accounts for the presence of additional conserved and/or histone-marked sequences in the 
genomic intervals under consideration, these enhancers may represent only a fraction of the 
conserved noncoding elements at these loci. We hypothesize that many enhancers may be 
required in combination to orchestrate regulatory control of these genes. The multitude of 
neuronal and non-neuronal populations marked by these conserved noncoding sequences may 
highlight additional complexity in this regulatory control or reflect position effects. These 
data reinforce the value of targeted screens in the analysis of human disease loci and 
integrating comparative sequence analysis, chromatin modifications and functional validation 
using zebrafish transgenesis in the identification of transcriptional regulatory sequences.  
 
2.4  Methods 
2.4.1 Fish maintenance  
Zebrafish were kept and bred under standard conditions at 28.5oC (Westerfield, 
2000). Embryos were staged and fixed at 48 and 72 hpf using 4% paraformaldehyde (PFA) in 
phosphate-buffered saline (PBS; pH 7.2) as described elsewhere (Kimmel et al., 1995). To 
better visualize in situ hybridization and EGFP reporter results, embryos were grown in 0.2 
mM 1-phenyl-2-thiourea (PTU; Sigma) to inhibit pigment formation (Westerfield, 2000). 
 
2.4.2  Whole mount in situ hybridization 
Digoxigenin labeled riboprobes complementary to lmx1a, lmx1a-like, lmx1ba or 
lmx1bb mRNAs were generated by linearization of pCR II TOPO TA vectors containing 
partial ORFs of the genes (for probe sequences see Table 2-1). Plasmids were linearized with 
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EcoRV (New England Biolabs) and subsequently labeled riboprobes were transcribed using 
SP6 polymerase and the DIG RNA Labeling Kit (T7/SP6) (Roche). Probes were synthesized 
for 2 hours at 37oC, followed by the addition of 1 µl of RNAse free DNAse I for DNA 
template digestion. Subsequently, probes were purified using SigmaSpin columns (Sigma-
Aldrich). Whole mount in situ hybridization reactions were performed using 1:4000 dilutions 
of rioboprobes at 70˚C as previously described (Thisse et al., 1993 and 2003). Probe 
sequences were selected to avoid cross-hybridization with lmx1 family members and 
unrelated transcripts by using pairwise alignment of lmx1 transcripts to find unique stretches 
of mRNA. Sequences were aligned using Clustal Omega 
(http://www.ebi.ac.uk/Tools/msa/clustalo/).  
 
2.4.3  Selection and amplification of human noncoding sequences  
To select regions to test for potential enhancer activity, genomic intervals 
encompassing LMX1A and LMX1B loci were considered up to the neighboring genes, set as 
boundaries, (LMX1A, chr1: 163,082,934 - 163,636,974 bp; LMX1B, chr9: 128,309,140 – 
128,607,182 bp). This study is not intended to be exhaustive and the genomic intervals 
encompassing these genes are very large. Therefore, sequences were prioritized for selection 
based upon proximity to the LMX1 loci and conservation.  
Using the Galaxy computational interface (Goecks et al., 2010) and UCSC genome 
browser, we chose conserved noncoding vertebrate elements with positive GERP alignment 
scores (Cooper et al., 2005). The GERP algorithm identifies constrained sequences in 
genomic alignments by determining whether a scarcity of substitutions exists at each point in 
an alignment relative to what is expected of the neutral rate of evolution. Selected intervals 
positioned less than 500 bp apart were merged into single amplicons. DNA region 
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coordinates and primer sequences used for amplification are listed in Appendix 2. Sequences 
were also selected to avoid clustering and are distributed across these loci (Figure 2-2 A). 
Amplicons were PCR amplified from human genomic DNA, TA cloned into pCR8 
(Invitrogen) and then cloned using the Gateway system (Invitrogen) into pGW_cfosEGFP as 
previously described (Fisher et al., 2006a and b). 
 
2.4.4  Embryo injection and analysis  
EGFP reporter constructs were injected into AB background G0 embryos (n!200) at 
the one to two cell stage with tol2 transposase as previously described (Fisher et al., 2006a 
and b). Injected embryos were evaluated for EGFP expression between 24 and 72 hpf. As 
negative controls EGFP reporter constructs containing only the cFos promoter were injected. 
Nonspecific expression from the cfos minimal promoter is occasionally observed in the 
myotome and no other nonspecific expression was detected. Embryos showing consistent 
EGFP expression were selected and raised for further analysis when signal was observed in 
!10% of injected embryos. Mosaic fish were subsequently crossed to identify those 
constructs that passed through the germline transmission, better facilitating spatial evaluation 
of corresponding EGFP expression. Embryos were imaged using a Carl Zeiss Lumar V12 
Stereo microscope with AxioVision software (version 4.5). 
 
2.4.5  Immunocytochemistry  
Embryos were anesthetized with tricaine (10 "g/ml) in embryo medium (Westerfield, 
2000) and fixed in 4% PFA in phosphate-buffered saline (PBS; pH 7.2) for 2 hours. They 
were then rinsed four times in PBST (PBS/0.1% Triton X-100), incubated in Proteinase K 
(Roche) for 1h at room temperature, washed 5 # 5 minutes in PBST, and incubated for 2 
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hours in blocking solution (10% goat serum, 1% bovine serum albumin (BSA), in PBST). 
Embryos were then incubated overnight at room temperature in primary antibody (anti-GFP, 
Invitrogen 1:2000), rinsed 6 # 45 minutes in PBST with 1% goat serum, and incubated 
overnight at room temperature in secondary antibody (Alexa-Fluor, 488, Invitrogen 1:1000). 





















2.5 Tables: Chapter 2 
Table 2-1. Primer sequences used for generation of RNA in situ probe fragments. 
Transcript 
name 
Primer sequence RefSeq alignment Length (bp) 
lmx1a-F ACTCTCTGGATAATGATGTGCCA NM_001025498 
4 - 204 
201 
lmx1a-R ATTGCGGAGAAAGCAGGTGT 
lmx1a-like-F AACACTGAAGTTTGGCTTTTGGA XM_001922096 
51 - 310 
260 
lmx1a-like-R GATGGGGGACTCGCAGC 
lmx1ba-F CTCTCGACAGATCCGGCTG NM_001025168 
104 - 334 
231 
lmx1ba-R TCAATTTTGATTCCGTCCAGCA 
lmx1bb-F GCCGAATGGCGCACTAATTT NM_001025167 




Primers designed against zebrafish LMX1 cDNA paralogs and the RefSeq database 














Table 2-2. Systematic annotation of LMX1A and LMX1B enhancer activity in zebrafish 
body structures. 
Enhancer Tel Dien Mesen Rhom SC Mb/Hb PNS Other 
LMX1A -36.74 + + + +   ++ +   
LMX1A -1.59 ++ ++ ++ ++ ++ + +   
LMX1A 5.34       + ++ +   NC 
LMX1A 9.65 + +   + +     OV 
LMX1A 11.50 +  + + +   + +   
LMX1A 32.09   + + + +     Pn, L 
LMX1A 67.70 ++ +     +   + NC 
LMX1A 71.89 + + + +     + C, F, H, OV, R 
LMX1A 92.33 +       +     C, F, OV 
 LMX1A 102.30 ++ + + ++ + +     
LMX1A 117.21 + + + + + + + C, H 
LMX1A 135.15 + + + + + ++ +   
LMX1A 187.31 + + + + +   ++   
LMX1A 238.85   + + ++ ++   ++   
LMX1A 296.85 ++ +   ++ +      
LMX1A 475.56 + + + + +   + OV  
LMX1A 479.56 +   + +   ++   C 
LMX1B -93.21       +      + C, H 
LMX1B -79.84     ++ + + ++ +   
LMX1B 12.07 + + + + + + + U 
LMX1B 28.46 + + + + + +   L 
LMX1B 59.40 + + + + +   +   
 
Abbreviations: C – Cartilage, Dien – Diencephalon, F – Fins, H – Heart, L – Lens, Mesen – 
Mesencephalon, Mb/Hb – Midbrain/Hindbrain, NC – Notochord, OV – Otic Vesicle, PNS – 
Peripheral Nervous System, Pn – Pronephros, R – Retina, Rhom – Rhombencephalon, SC – 
Spinal Cord, Tel – Telecephalon, U – Ubiquitous.   
+, Weak; ++, Moderate; +++, Strong expression (Relative). 
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2.6 Figures: Chapter 2 
Figure 2-1. Lmx1 phylogram. 
 




















Figure 2-2. In situ hybridization showing the expression patterns of endogenous zebrafish 
LMX1A and LMX1B orthologs. 
 
Expression of lmx1a (A-D), lmx1a-like (E-H), lmx1ba (I-L) and lmx1bb (M-P) are shown, 
assayed at 48 hpf and 72 hpf.  
Abbreviations: Am – Amacrine neurons, CG – Cranial Ganglia, DD – Dorsal Diencephalon, 
dHB – Dorsal Hindbrain, Ep – Epiphysis, H – Heart, Hb – Hindbrain, Mb-Hb – midbrain-
hindbrain boundary, OV – otic vesicle, RL – rhombic lip, RNa – anterior raphe nuclei, RNp – 




Figure 2-3. LMX1A and LMX1B loci and the noncoding conserved sequences selected for 
analysis. 
 
LMX1A (A) and LMX1B (B) genomic loci displaying the selected sequences and their 
corresponding GERP sequence conservation tracks. H3K4me1 ChIP-seq signal from two 
types of cultured neurospheres (cortex derived and ganglionic eminence derived) are 
included to highlight the substantial overlap observed between conservation and high 
H3K4me1 signal intensity. C) Enlarged example intervals show the local sequence 
conservation within amplicons. The names of REs indicate the approximate distance in kb 





Figure 2-4. LMX1 enhancers drive reporter expression in the zebrafish diencephalon and 
telencephalon. 
 
Representative images of LMX1 sequences that drive expression in the diencephalon and 
telencephalon. A-C, lateral images. D-F, dorsal images.   
Abbreviations: BA – branchial arches, Hb – hindbrain, Dien – diencephalon, Hb – hindbrain, 











Figure 2-5. Multiple LMX1 elements drive expression in the hindbrain and midbrain-
hindbrain boundary. 
 
Representative LMX1 transgenic zebrafish lines showing reporter expression in the hindbrain 
and midbrain-hindbrain boundary. Anterior is shown to the left in each panel. A, C, E, G are 
lateral images. B, D, F, H are dorsal images.  
Abbreviations Cb – cerebellum, Dien – diencephalon, Hb – hindbrain, Mb – midbrain, Mb-
Hb – midbrain-hindbrain boundary, OV – otic vesicle. 
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CHAPTER 3 




In this chapter I will discuss our work towards extending our ability to identify 
enhancers from a locus specific approach to a tissue-specific approach. We asked whether 
regulatory signatures (vocabularies) could be uncovered from a complex cellular substrate, 
the central nervous system. In particular, we set out to determine the sequence basis of 
regulatory control in the hindbrain (Hb). The Hb, or rhombencephalon, is the most primitive 
part of the human brain, and likely evolved from a homologous structure present in 
Urbilateria around 550 million years ago (Ghysen, 2003). It includes the cerebellum, pons, 
and medulla oblongata, which are structures that control functions as fundamental and 
diverse as respiration, heart rate, reflex and voluntary movements. Impaired Hb development 
and function are associated with many disorders such as autism, ADHD (Attention Deficit 
Hyperactivity Disorder), schizophrenia, cerebral palsy, and various sleep disorders (Berquin 
et al., 1998; Aston-Jones, 2005; Andreasen and Pierson, 2008)].  
As with other diseases and phenotypes, most variants identified by genome-wide 
association and sequencing population studies are found in non-coding regions of the 
genome, and therefore suspected to play a role in regulatory control (Cooper and Shendure, 
2011). Understanding the gene regulatory landscape of the human genome in Hb 
development and structure is an important step towards uncovering the non-coding substrate 
of the genomic component of brain disorders. 
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We introduce a machine learning approach, based on the enrichment of transcription 
factor binding sites (TFBSs) in sequences, which are capable of accurately identifying 
enhancers which drive expression in the developing Hb. Our classifier performs very well in 
de novo discovery of Hb enhancers, with 88% (30/34) of computational predictions validated 
in vivo using transgenic zebrafish reporter assays. We also analyze the impact of small 
collections TFBSs on the Hb function of the host enhancers, and present a catalog of 40,000 
putative Hb enhancers in the human genome. In summary, our data show how the application 
of effective computational methods for enhancer prediction can greatly improve our 
understanding of the gene regulatory networks controlling human development and disease. 
 
3.2 Results 
3.2.1 Building a training set of hindbrain enhancers 
 In order to construct a model for Hb enhancer activity, we first compiled a data set of 
211 enhancers for which Hb activity has been validated in vivo with reporter assay systems in 
transgenic mice and zebrafish (Appendix 3). Most of these sequences (n = 192) were 
obtained from the VISTA Enhancer Browser (Visel et al., 2007) and an additional 20 
enhancers were identified in our laboratory in the context of ongoing in vivo transgenic 
enhancer screens in zebrafish. This set of Hb experimentally proven enhancers bears genomic 
features consistent with other enhancer sets. The GC and repeat-content is close to the 
genome averages (Figure 3-1). Thirty-nine percent of the Hb enhancers in this catalog are 
intronic and 61% are intergenic, displaying a genomic distribution close to expected (for 
comparison, 44% of enhancers in the VISTA database are intronic). On the other hand, these 
Hb enhancers are especially well conserved among vertebrates – 99% of the Hb enhancers 
are conserved between human and mouse genomes, and 82% are also conserved between 
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human and chicken genomes. The average PhastCons evolutionary conservation score 
(Siepel et al., 2005) of Hb enhancers is 1.6, which is significantly higher than the 
corresponding scores of heart and limb enhancers (0.5 and 1.2, respectively; Wilcoxon rank-
sum test P-value << 0.001). Enhancers driving expression in the nervous system frequently 
direct expression in one or more additional tissues or developmental stages. Accordingly, 
eighty percent of Hb VISTA enhancers also direct transcription in other tissues, such as 
midbrain (49%), forebrain (33%), neural tube (43%), and limb (8%), suggesting that the 
same elements may play pleiotropic roles in expression, and thus that regulatory lexicons 
may not always be discrete. 
 
3.2.2 Designing an enhancer classifier 
There is broad interest in determining the extent to which computational power can 
be used to elucidate how transcriptional regulatory instructions are encrypted in primary 
DNA sequence. The increased volume of genomic sequence-based data sets far exceeds our 
present capacity to impute biological value to primary sequence and variation therein, 
particularly in noncoding sequence. We previously developed a linear regression approach 
that relies on sequence patterns to accurately predict sequences with similar regulatory 
activity in the human genome de novo beginning with a small catalog of known heart 
enhancers (Narlikar et al., 2010). Since then, a similar method based on support vector 
machines (SVMs) and primitive short sequence segments (k-mers) has also performed well in 
classifying enhancers from different expression domains, including forebrain- and midbrain-
derived ChIP-seq data sets (Lee et al., 2011). However, the SVM method was unable to 
accurately distinguish between different brain enhancer data sets. This was likely due in part 
to the cellular complexity of the tissues in which analyzed sequences chosen for the training 
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set drove expression. Therefore, although both the SVM and the linear regression method 
exhibited similar performances, we opted to combine the specificity of our original classifier 
with the advanced statistical model proposed by the latter approach (Lee et al., 2011). To this 
end, we constructed an SVM classifier which searches for overrepresented known TFBSs and 
de novo identified motifs, which we dubbed EnhSVM. We then used this strategy to 
determine if we could better discriminate among regulatory catalogs of CNS subdomains and 
extend this to define a classifier for the Hb, which currently has no ChIP-seq substrate 
available.  
When applied to the collection of 11 tissue-specific experimentally validated sets of 
VISTA enhancers (forebrain, midbrain, hindbrain, neural tube, limb, heart, dorsal root 
ganglia, branchial arch, nose, cranial nerve, eye) our classifier was able to discriminate all 
enhancer sets from background genomic regions with accuracies exceeding 60% according to 
the area under the Receiver Operating Characteristic (ROC) curve (AUC) measurements in 
all cases (Figure 3-2). The majority of predictions produced by these models only overlapped 
predictions from related tissues, indicating that our method identifies cell type-restricted 
enhancer signatures. CNS enhancer classifiers (forebrain, midbrain, hindbrain, neural tube) 
performed better than the rest (Figure 3-2), and the Hb classifier displayed the highest AUC 
accuracy at 91%. 
 
3.2.3 Refinement of a hindbrain classifier 
The embryonic Hb forms along the anterior–posterior axis and is initially segmented 
into a series units called rhombomeres. The identity of these rhombomeres is correlated with 
domains of Hox gene expression and function, which in turn are determined by a gradient of 
retinoic acid along the anterior–posterior axis of the Hb (Schneider-Maunoury et al., 1998). 
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The most anterior rhombomeres contribute to the metencephalon, which in humans develops 
into the pons and cerebellum, while the most posterior rhombomeres form the 
myelencephalon, leading to the medulla oblongata in humans. In order to determine if we 
could further refine our classifier’s predictive capacity, we separated the data set of Hb 
enhancers into 161 anterior and 153 posterior Hb enhancers based on expression patterns 
driven by the sequences in embryonic mice at developmental stage E11.5.  
Although these sets of enhancers are highly overlapping with 80% of the sequences 
driving reporter expression in both domains, we hypothesized that simple functional 
clustering should result in increasingly homogeneous data sets, more suitable for our method. 
Other groups have shown that combinations of multiple classifiers trained on different 
subsets of a larger dataset often outperform single classifiers (Kittler et al., 1998). We 
predicted that this sort of functional clustering would improve our classifier. We trained and 
tested three independent Hb classifiers using a standard 10-fold cross validation setup on five 
random partitions of the data, using three slightly different data sets: the complete Hb data 
set, the subset of Hb enhancers that are active in the anterior Hb, and the subset of enhancers 
which functions in the posterior Hb. We found that no single classifier significantly 
outperforms the others. Instead, all three Hb classifiers achieved average AUCs of about 
90%, with a true positive rate (TPR) of at least 47% at a false positive rate (FPR) of 5% 
(Figure 3-3 A). 
 
3.3.4 Hindbrain enhancers harbor putative binding sites for transcriptional regulators of 
cell identity 
Our Hb classifiers rely on sequence motifs representing TFBSs that facilitate 
distinction of Hb enhancers from random genomic sequences. We analyzed the 
! '-!
discriminatory power of individual motifs to reveal specific TFs likely to interact with Hb 
enhancers. All three Hb classifiers identified motifs that are known to bind the critical Hb 
TFs including MEIS1, NKX6-1, HOX family members, and POU protein family members 
among the 100 most relevant sequence features for identifying Hb enhancers (Waskiewicz et 
al., 2001; Nelson et al., 2005; Kiyota et al., 2008). Similarly, motifs known to bind SOX2, 
which is highly expressed in the Hb and has multiple roles in CNS development, were 
common to all three Hb classifiers (Appendix 4; Kelberman et al., 2008). Many of these 
motifs are specific to Hb development and function, and their relevance differs for analogous 
classifiers trained on data sets of enhancers specific to other tissues (compared, for example, 
with motifs relevant to limb and heart gene expression regulation, Appendix 4; Figure 3-3).  
As expected, the distinct sets of Hb sequences, even if largely overlapping, showed 
slight differences in the contribution of each motif to the decision function of the 
corresponding classifier. For example, we observed differences in the relevance of the 
estrogen receptor ESR1 motif, which is specifically enriched among enhancers active in the 
posterior Hb. Thus, the motif for ESR1 is among the 100 most relevant sequence features for 
the Hb classifier focusing on posterior Hb, but not among the 100 most relevant sequence 
features for the other two Hb classifiers. Estrogen receptor-related proteins, which can bind 
ESR1-like motifs (Vanacker et al., 1999; Giguere, 2002), have previously been implicated in 
anterior–posterior brain segmentation (Bardet et al., 2005). The ability of the Hb classifiers to 
recover motifs corresponding to TFs with known functions in the Hb provides additional 
validation of our model. However, we must caution that it is unlikely that all computationally 
predicted motifs are bound by a TF. Moreover, even if they are, establishing the identity of 
the TFs binding to these motifs is not straightforward, since the binding affinity catalog of 
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TFs is not complete and many motifs are recognized by multiple TFs (Vavouri and Elgar, 
2005).  
In order to determine the specificity of the motifs with high discriminatory power in 
the Hb classifiers, we compared them with additional EnhSVM classifiers trained on 
published EP300 ChIP-seq datasets in forebrain, midbrain, and limb tissues (Visel et al., 
2009). While a negligible fraction (<5%) of EP300 peaks is shared among all data sets, 
overlap among EP300 peaks for closely related tissues, such as forebrain and midbrain, was 
higher (15%–20%), consistent with a cell-type-restricted EP300 binding specificity. Less 
than 10% of the motifs are shared among the 50 most relevant sequence features between the 
ChIP-seq based classifiers. Additionally, less than 20% of these factors overlap with the 
motifs identified for Hb enhancers, highlighting the ability of our Hb classifier to specifically 
capture the Hb enhancer code. The fraction of TFBSs shared between the Hb and other brain 
classifiers included binding sites for MEIS1, NKX, SOX, and HOX homeobox domain 
factors, as well as ZHX2, a TF that is active in cortex development (Wu et al., 2009). 
 
3.2.5 Genome-wide predictions identify novel hindbrain enhancers 
Our training set is made up mainly of deeply conserved sequences (Visel et al., 
2009), so to obtain a genome-wide map of putative human enhancers active in the Hb, we 
restricted our genome scan to sequences which are at least conserved among mammals (n = 
337,000; Siepel et al., 2005). We completed independent searches using the anterior Hb 
(aHb), the posterior Hb (pHb), and the full Hb enhancer classifiers. Approximately 40% of 
the conserved sequences scored positively for at least one classifier (Figure 3-4), but only 
12% (40,000) scored positively for all three (we dubbed the overlap set HbEns, as it 
represents the most reliable prediction of Hb enhancers). Seventy-seven of the HbEns (0.2%) 
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are known hindbrain enhancers from the VISTA Enhancer Browser (Visel et al., 2007), and 
26,000 (60%) overlap ChIP-seq of known enhancer marks (H3K4me1 or H3K27ac). Likely a 
reflection of the similarity of the training data, we observed a large overlap among the 
highest scoring predictions obtained by each Hb classifier (Figure 3-5 B). Interestingly, the 
overlap correspondingly increases when raising the score cutoff, suggesting that sequence 
signatures for general Hb activity, rather than anterior or posterior Hb, dominate the decision 
function of all three classifiers.  
The genomic distribution of the HbEns is similar to that observed for the training set. 
Approximately half of the candidate enhancers are intronic and half are intergenic (Appendix 
2). HbEns are also fairly uniformly distributed with respect to the conserved sequences that 
served as the basis for the genome scans, with an average of four candidates per locus and a 
maximum of 102 in the case of PTPRD, a 2.3 Mb gene highly expressed in brain and recently 
associated with ADHD (Elia et al., 2010).  
Compared with all scanned conserved sequences, HbEns are enriched within the loci 
of genes that are known to play a role in Hb development (P-value = 2.8 3 109, 
hypergeometric test). Moreover, higher scoring predictions are located significantly closer to 
genes associated with Hb development (Figure 3-5 C), indicating that our method 
preferentially identifies enhancers that are active in the Hb. Although all HbEns are, as 
defined by our search space, conserved among mammals, their level of evolutionary 
conservation is notably elevated. HbEns are significantly more conserved with respect to the 
conserved sequences that served as the basis for the genome scans (based on average 
PhastCons scores (Siepel et al., 2005), P-value <2.2 x 10-16, Wilcoxon rank-sum test). 
Additionally, 21% of HbEns are shared with chicken, 8% with frog, and 3% with zebrafish. 
Also, relative to the conserved sequences that served as the basis for the genome scans, 
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conservation in vertebrates is slightly, but significantly, enriched among HbEns (P-value 2.3 
x 10-11 for the overlap with regions that are also conserved in chicken, Fisher’s exact test). 
We also found a statistical enrichment of DNase I hypersensitive sites (HSS) identified in 
genomic DNA isolated from human fetal brain among HbEns (1.2-fold enrichment as 
compared with low scoring sequences, P-value < 2.2 x 10-16, Fisher’s exact test), while we do 
not observe any enrichment for DNase I HSS in other fetal tissues, such as heart and lung. 
Although, the hindbrain is only a subset of the complex tissue analyzed in fetal brain, and 
may refer to a different developmental stage, the enrichment in brain DNase I HSS 
corroborates our predictions as tissue-specific enhancers.  
Finally, to evaluate the ability of our method to accurately define tissue-specific 
sequence patterns, we compared the distribution of predicted Hb enhancers with forebrain, 
midbrain, and limb enhancer predictions obtained in the same manner. In particular, we 
sought to verify that our predictions are not generally shared between different tissues, which 
would suggest a failed attempt to define a tissue-specific classifier. After we trained 
additional classifiers on the corresponding EP300 ChIP-seq enhancer sets, we found that 
there is <20% overlap between the top 5% of high scoring predictions (16% forebrain, 13% 
midbrain, 9% limb). This overlap is further reduced to 12% when comparing the top1% of 
high scoring predictions. This confirms our hypothesis that genome-wide predictions of 
classifiers trained on enhancers with different activities constitute largely disjoint sets, 
suggesting that the corresponding classifiers recognize sequence patterns involved in 




3.2.6 The hindbrain classifier is a highly accurate predictor of hindbrain activity in 
zebrafish 
In order to determine the accuracy of our method we set out to determine how 
frequently our predictions identify active Hb enhancers in vivo. We selected 55 sequences 
with a positive scaled summary Hb score for functional evaluation in a transgenic zebrafish 
reporter assay (Table 3-1). To avoid the introduction of biases based on genomic position, we 
included both intronic and intergenic sequences residing on 21 different human chromosomes 
(all except chr10 and Y). In addition, six low scoring sequences with a scaled summary Hb 
score less than zero were selected as likely ‘‘negative’’ predictions (Table 3-2). Predicted 
sequences may not identify all functional components within a complete enhancer, thus 
although our predictions were based on 100–200 bp sequence intervals, we designed primers 
to include ~200 bp flanking each side of the original sequence. The average size of all 
assayed amplicons was 485 bp (Appendix 2).  
All sequences were tested for enhancer activity in the Hb using our established 
zebrafish transgenesis pipeline (Fisher et al., 2006 a and b; McGaughey et al., 2008). We 
define hindbrain expression as any expression in the CNS region that is posterior to the 
midbrain extending through the myelencephalon and delimited by the anterior portion of the 
spinal cord. Since the training set sequences directed expression in a number of non-Hb 
tissues, we do not require that expression is restricted to this region, and are therefore testing 
the sensitivity of the classifiers to Hb patterns rather than the specificity. The vast majority of 
constructs (51/55 putative Hb enhancers) directed reporter expression in some portion of the 
CNS in mosaic zebrafish embryos. Similarly, 6/6 low likelihood predicted sequences 
displayed mosaic signals in some part of the embryo, including portions overlapping the 
CNS.  
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All embryos that displayed reporter expression in mosaics were raised to maturity 
and crossed with AB zebrafish to determine which sequences could direct EGFP expression 
in the Hb. In total we identified two or more founders for 34 putative Hb enhancers, of which 
30 (88%) founder sets displayed concordant expression in the Hb (Appendix 1), a predictive 
success rate that meets or exceeds prior rates of enhancer validation using both computational 
predictions as well as EP300 ChIP-seq-based predictions (Figure 3-6; Narlikar et al., 2010, 
62%; Blow et al., 2010, 84%). In contrast, none of the six low likelihood controls displayed 
consistent expression in the Hb when passed though the germline (Appendix 1).  
The patterns observed in stable lines displayed marked pleiotropy in their range of 
reporter expression both in Hb regions as well as in non-Hb regions, likely reflecting the 
heterogeneity of the training set. Figure 3-7 provides eight examples that illustrate the diverse 
patterns of expression observed in our validation set. Although the models trained on anterior 
and posterior sets of sequences did not appear to be particularly predictive of the relative 
position of Hb expression, we found that the resulting patterns could be grouped into 
categories displaying similar expression.  
HB41, HB34, and HB02 share an expression profile that includes the cerebellum, part 
of the anterior Hb, in addition to varying levels of expression along the length of the Hb 
(Figure 3-7, A–C). However, HB02 also directs non-neuronal expression in the lens of the 
eye and myotome (Figure 3-7, C), which may be a result of position effects based on the site 
of amplicon insertion in the zebrafish genome as it was not observed in all stable lines. Some 
sequences, like HB15 (Figure 3-7, D), show expression in the Hb and very little extraneous 
expression. In contrast, HB25 and HB51 share a different expression profile displaying 
strong expression in the dorsal Hb as well as the tegmentum, a structure in the midbrain that 
is continuous with the medulla oblongata (Figure 3-7, E,F; Thisse and Thisse, 2004; Thisse et 
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al., 2004). HB10 shows distinct expression in the Hb, spinal cord, and dorsal diencephalon, 
as well as faint expression in the tegmentum and non-neuronal expression in the myotome 
and fin buds (Figure 3-7, G). In contrast to the distinct Hb expression seen in HB10, many 
domains within the CNS are faintly marked by reporter expression directed by HB50, 
including Hb neurons, cerebellum, tegmentum, dorsal diencephalon, and telencephalon 
(Figure 3-7, H).  
The varied patterns of expression observed within the Hb validation set are consistent 
with the diverse nature of the motifs comprising the classifier. Addtionally, this result is 
expected given that the training set is comprised of sequences that displayed significant 
pleiotropy and included sequences that directed expression in an array of Hb subdomains, 
and non-Hb tissues. Consequently, we expected that TFBSs contained within these 
amplicons, and contributing to their prediction, would be diverse. However, we also 
anticipated that they would include sites for factors whose endogenous expression overlap 
with domains of reporter expression. In vivo validated Hb enhancer sequences are enriched 
for the 100 most relevant motifs for discriminating Hb enhancers compared with random 
sequences with similar GC content (Appendix 4). TFBSs for proteins in the POU, NKX, or 
PAX families, as well as LHX3 are especially common in our validation set (Table 3-2). 
Consistent with the in silico evaluations of TFBSs identified in HbEns collectively, factors in 
these families play critical roles in neuronal development. Furthermore, the observed reporter 
expression for each is largely consistent with previously published zebrafish expression 
patterns for one or more of the corresponding TFs.  
POU domains are found in a large family of TFs and bind the consensus sequence 
ATGCAAAT (Verrijzer and Van der Vliet, 1993). They are expressed mainly in the CNS, 
and act as regulators of neurogenesis in zebrafish (Spaniol et al., 1996). Consistent with these 
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data, POU family TFBSs were the most commonly identified sites in our validation set and 
showed an enrichment of 2.6 over 600 randomly selected GC matched control sequences (P-
value = 0.01, Fisher’s exact test; Table 3-2) and many of our elements share expression 
domains with POU factors.  
NKX proteins are necessary for the proper development of motor neurons in the 
hindbrain (Pattyn et al., 2003) and consistent with this role we see a significant enrichment 
(2.4; P-value = 0.005, Fisher’s exact test; Table 3-2) for NKX family TFBSs in our validated 
set of Hb enhancers. Similarly, the PAX gene family comprises a large group of highly 
conserved TFs required for neuronal development (Wang et al., 2010; Thompson and Ziman, 
2011), and 10/30 validated predictions contained at least one PAX family motif (enrichment 
of 1.8; P-value = 0.05, Fisher’s exact test; Table 3-2). Finally, a number of sequences contain 
an LHX3 motif that binds a LIM domain TF with a role in neuronal specification (Cepeda-
Nieto et al., 2005; Gadd et al., 2011), resulting in an enrichment of 4.6 (P-value = 0.0002, 
Fisher’s exact test; Table 3-2). HB25 and HB51 both contain an LHX3 TFBS and share many 
overlapping domains of reporter expression, including in the Hb and spinal column, which is 
consistent with endogenous lhx3 expression (Figure 3-6 E,F; Appendix 1; Thisse and Thisse, 
2004; Thisse et al., 2004). In contrast to our HbEns predictions, only one of the low 
likelihood controls contained any of these motifs, supporting their high predictive power in 
our model. Collectively, these data provide compelling evidence that the HbEns sequences 





3.2.7 Tissue-restricted enhancer activity is due to the presence of specific transcription 
factor motifs 
Our data suggest that TFBSs contributing to the Hb classifier might independently or 
collectively explain aspects of the observed regulatory control of the sequences within which 
they reside. We selected two sequences displaying Hb regulatory control (HB01 and HB16) 
to examine more closely, surveying the distribution of TFBSs within each predicted 
sequence. We then identified smaller sequence fragments for analysis in zebrafish based on 
the clustering of TFBSs therein. The full-length HB01 sequence directed distinct expression 
in the rhombomeres, as well as the midbrain Hb boundary, cranial ganglia, and dorsal 
diencephalon (Figure 3-8, B and E).  
We amplified two smaller fragments (HB01_I and HB01_II) from within the full-
length sequence based on the pattern of TFBSs clusters. HB01_I is a 56-bp sequence 
containing motifs for PITX2, CDX, CEBPG, NKX3-1, and BCL6 (Figure 3-8, A). Upon 
passage through the germline, HB01_I displayed broad reporter expression in the CNS 
(Figure 3-8, C and F). This pattern encompasses the expression domains also marked by the 
full-length HB01. The expanded expression domains of HB01_I could reflect the increased 
efficiency of TFBSs being placed closer to the minimal promoter (Nolis et al., 2009). It may 
also reflect the absence of other regulatory sequence motifs within or beyond the initial 
predicted interval which otherwise act in the full-length construct to mediate transcriptional 
activity (Gompel et al., 2005). Notably HB01_II, which is 93 bp and contains motifs for 
HNF3, POU2F1, NKX2-5, MYOG, SOX10, and HMGA1 (Figure 3-8, A) did not show any 
mosaic expression, and was determined to be insufficient for enhancer activity in the Hb in 
this assay (Figure 3-8, D and G).  
! (,!
Similarly, HB16 displays prominent expression in the dorsal Hb and fainter 
expression in the ventral Hb and lateral tegmentum (Figure 3-8, I and M). Once again we 
amplified three short fragments from within the initially predicted sequence based on TFBS 
clustering (Figure 3-8, H). HB16_I is a 29-bp fragment containing a GATA1 motif; HB16_II 
is 54 bp in length and contains MEOX2, NKX6-1, EN1, TAL1, NKX2 family, JUN, and 
PAX4 motifs; and HB16_III is a 23-bp fragment encompassing a HOXA4 motif (Figure 3-8, 
H). Upon passage through the germline, both HB16_I and HB16_II directed expression in the 
Hb (Figure 3-8, J,K,N,O). In contrast, HB16_III only drove expression in the myotome of 
stable lines (Figure 3-8, L and P). Notably, the reporter expression in the Hb neurons and the 
lateral tegmentum directed by HB16_I are similar to those of the endogenous gata3 (Figure 
3-8, J and N; Thisse and Thisse, 2004; Thisse et al., 2004). This pattern is consistent with 
expression directed by full-length HB16.  
Furthermore, HB16_II directs expression along the entire length of the ventral and 
medial Hb and spinal column (Figure 3-8, K and O). As such, it overlaps much of the Hb 
domain marked by HB16 and resembles the endogenous expression of nkx6 family, nkx2 
family, and tal1 RNA (Thisse and Thisse ,2004; Thisse et al., 2004; Binot et al., 2010). The 
observed reporter expression in the tegmentum is also consistent with endogenous tal1 RNA 
(Thisse and Thisse, 2004; Thisse et al., 2004). A potential role for the JUN TFBS identified 
in HB16 is not obvious but these factors display broad expression throughout the CNS and 
may account, at least in part, for expression domains extending dorsally. Although not 
conclusive, these data suggest that the expression of TFs corresponding to motifs 
contributing to our classifier are consistent with their predicted biological roles in modulating 
expression in the Hb and show that enhancers can be further broken down into their 
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component TFBS fragments while continuing to faithfully drive reporter expression in the 
predicted tissue. 
 
3.3  Conclusions 
As we have previously discussed, the exquisite orchestration of transcriptional 
control is essential for the normal development and homeostasis of multicellular organisms, 
however systematic identification of sequences responsible for these activities has proven a 
significant challenge. Although sequence constraint has been used with significant success, it 
can impute little regarding the likely biological activity of any identified sequence. Similarly 
ChIP-seq profiling of TFs, histone modifications, and transcriptional co-activators such as 
EP300 has recently emerged as a powerful tool for the identification of enhancers active in 
various tissues; however, not all enhancers are captured by affinity-based methods, and not 
all cell types are amenable to these assays. Recent efforts to identify overrepresented 
sequence motifs have proven increasingly powerful, allowing the elucidation of early 
language structure for regulatory control in specific tissues (Narlikar et al., 2010; Lee et al., 
2011).  
We have integrated these computational strategies, employing machine learning to 
train a sequence-based classifier on a set of largely published in vivo validated enhancers in 
the Hb. The result is a highly accurate predictor of enhancer activity in the Hb. When applied 
to the human genome, 88% (30/34) of sequences demonstrate Hb regulatory control when 
assayed in vivo. In contrast, in prior studies that identified sequences as being deeply 
conserved only ~8% were observed to drive expression in the Hb (Pennacchio et al., 2006). 
The motifs identified by our classifier frequently represent TFBSs for factors with known 
roles in regulating transcription in the Hb and with endogenous expression patterns 
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overlapping with that of reporter expression. Furthermore, we show that, consistent with our 
classifier, smaller sequences containing clusters of TFBSs (~30 – 100 bp) contributing to 
predicted Hb regulatory control can account for aspects of Hb regulatory expression observed 
in the original (~500 bp) sequence from which they were derived. 
Although the vocabulary described is an effective predictor of Hb activity, we 
observed pleiotropy among Hb domains marked by reporter expression as well as expression 
in domains outside the Hb, including non-neuronal tissues. These observations are consistent 
with the complexity of vertebrate enhancers known to display a broad expression pattern 
across multiple tissues (Visel et al., 2007). It is particularly important to keep in mind that the 
Hb enhancers in our training data set were not exclusively expressed in the Hb, but largely 
displayed multi-tissue expression patterns. From the sequence analysis perspective, our 
training set contained a large group of Hb enhancers and several smaller clusters of other 
expression subdomains. The non-Hb signatures in our training set likely created a plethora of 
misleading signals confusing the classifier. However, the high Hb validation rate of HbEns 
reflects the ability of the classifier to sensitively extract the Hb sequence encryption from the 
noisy input data set. Knowing that Hb sequence encryption often resides within enhancers 
with broad expression patterns and does not represent a code of exclusive Hb expression, we 
expected the observed pleotropic expression of experimentally assayed HbEns sequences.  
As additional support for the utility of our model, we find that our predicted Hb 
enhancers are enriched for a particularly large number of CNS TFBSs compared with TFs 
known to be active in other tissues. Our experimental data also suggest that Hb enhancers can 
be divided into independent functional subunits with similar activities but different sequence 
structures—an observation that highlights flexibility of the Hb sequence encryption with 
potential for adaptation to additional functions and the use of different activation 
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mechanisms. The observed biological behaviors of these TFBS clusters were consistent with 
the known patterns of expression of TF family members predicted to bind them. This raises 
the possibility that retraining algorithms using subsets of training or predicted sequence sets 
may define the sequence grammar that is specific to individual Hb sub-domains and cell 
types.  
Computational methods are becoming increasingly powerful tools for enhancer 
prediction. Here we have shown that experimental validation rates for computer-learning 
algorithms are comparable to those achieved by experimental ChIP-seq predictions. 
Computational predictions can be similarly independently correlated with the presence of 
features known to be present in active enhancers such as known TFBS motifs, specific 
histone marks, and increased conservation.  
This study demonstrates that, in addition to the sequence substrate provided by 
genome-wide ChIP-based strategies, the published literature may serve as a valuable entry 
point for such analyses of regulatory elements. We demonstrate that even a relatively small 
curated experimental data set can provide significant insight into the regulatory lexicon of a 
highly complex anatomical structure like the Hb, and that this vocabulary can likely be 
dissected and improved in subsequent cycles of investigation and/or by the refinement of the 
substrate on which it is trained. Therefore, this study adds to the ongoing project of genome 
annotation by identifying sequences that have a functional role in the Hb. The development 
of regulatory language is a pivotal step in the prediction of functional variation by inspection 
of the primary sequence and as such this study makes a significant first step in the 




3.4  Methods 
3.4.1 Tissue-specific enhancer models 
We extracted 771 human sequences from the VISTA Enhancer Browser (Visel et al., 
2007) with validated in vivo enhancer activity in 23 tissues. We were able to retrieve at least 
29 sequences each for 11 of these tissues. Each enhancer model was trained to distinguish 
between enhancers specific for a given tissue and other noncoding sequences, randomly 
drawn from the noncoding human sequence, with length, GC, and repeat-content 
distributions similar as those observed for the enhancers. The decision of the corresponding 
classifier was based on the presence or absence of two different types of motifs: 775 
corresponding to binding specificities of vertebrate TFs compiled in public databases 
(TRANSFAC and JASPAR; Matys et al., 2003; Bryne et al., 2008), and 20 short sequence 
patterns enriched among the set of enhancers, identified with PRIORITY (Narlikar et al., 
2007), which should account for the binding of unknown TFs or TFs with unknown binding 
specificities. Thus, each sequence was represented as a feature vector indicating the number 
of matches per base pair to each of these motifs, computed using MAST (Bailey and 
Gribskov, 1998). We built the classifier using linear SVMs (implemented in libsvm; Chang 
and Lin, 2011), assuming no prior knowledge of TFs active in the different tissues, with the 
goal being to discover them using the feature weights learned by the classifier.  
 
3.4.2 Hindbrain enhancer models for mouse, chicken, frog, and zebrafish 
Orthologous regions of the human Hb enhancer training set were identified using the 
liftOver utility from the UCSC Genome Browser (Karolchik et al., 2008). We discarded 
mapped sequences longer than 5 kb. We successfully mapped 100%, 86%, 74%, and 47% of 
the 211 Hb enhancers onto the mouse (mm9), chicken (galGal3), frog (xenTro2), and 
! )'!
zebrafish (danRer5) genomes respectively. For each enhancer in the training set, 10 controls 
with similar length, GC, and repeat-content were randomly drawn from the noncoding 
portion of the corresponding genome. 
 
3.4.3 Forebrain, midbrain, and limb enhancers identified using ChIP-seq 
Genomic regions enriched for EP300 binding in mouse forebrain, midbrain, and limb 
tissues were extracted from Supplemental Tables 2–4 of Blow et al. (2010). We identified 
orthologous regions of the mouse coordinates with the liftOver utility from the UCSC 
Genome Browser (Karolchik et al., 2008). Sequences longer than 1 kb were discarded, 
resulting in a total of 2199 forebrain sequences, 1909 midbrain sequences, and 3155 limb 
sequences.  
 
3.4.4 TFBS mapping, association and enrichment 
Putative TFBSs were identified de novo by searching the predicted enhancer 
sequences with MAST (Bailey and Elkan, 1994) for 775 motifs in the TRANSFAC Release 
2009.2 (Matys et al., 2006) and JASPAR (Bryne et al., 2008) databases. MAST was run 
independently on each individual sequence with default setup and parameters. The identity of 
the TFs binding to de novo motifs was queried using STAMP (Mahony and Benos, 2007) and 
JASPAR (Bryne et al., 2008). TF annotation for known TFBSs was obtained from 
TRANSFAC, JASPAR, and the Broad Institute MsigDB (Subramanian et al., 2005). 
Overrepresented TFBSs were determined by comparing the occurrence of the motifs among 
query sequences and background genomic sequence, and applying Fisher’s exact test using a 
P-value threshold of 0.05. When indicated, we adjusted the P-values for multiple testing 
using the procedure suggested by Benjamini and Hochberg (1995). 
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3.4.5 Extracting homogeneous Hb enhancer data sets  
Hb enhancers tend to drive expression in multiple tissues, and even show 
heterogeneous patterns of expression within the Hb. As a result it is unlikely that we would 
be able to identify a unique set of sequence features representing all Hb enhancers. Thus, 
similar to the approach taken in Narlikar et al. (2010), we selected a large subset of these 
sequences sharing homogeneous sequence features as an attempt to reduce the sequence 
heterogeneity among the 212 human Hb enhancers. For this purpose, we repeated the 10-fold 
cross-validation on five random partitions of the Hb enhancer data set as well as on that of 
the corresponding controls, and selected only those Hb enhancers that were classified as such 
in at least 50% of the times in which they were tested for the final training set. Therefore, the 
final human Hb enhancer data set contained 124 sequences. The performance of the 
classifiers was evaluated in a 10-fold cross validation, using the area under the ROC curve 
(AUC). AUC values range from 0.5 (random discrimination) to a theoretical maximum of 1. 
 
3.4.6 Creating linear SVMs 
Training a linear SVM classifier is equivalent to solving the following constrained 
optimization problem (Shawe-Taylor and Cristianini, 2002): 
Given the training samples ! ! !!! !! !!! ! !!! !! ! !!!! !!!
!
find the values of w, b and 
!! that minimize  
!
!
!! !! ! ! !!!!!!   
satisfying the constraints !! !! ! !! ! ! ! ! ! !!!!! ! !!! ! !  
and !! ! !!!! ! !!! ! ! 
The decision function of the classifier for an unknown sample x is given by 
! ! ! !"#$ !! ! ! ! !  
! ))!
The dual form of this problem is: Given the training samples  
! ! !!! !! !!! ! !!! !! ! !!!! !!!
!
 




satisfying the constraints ! ! !! ! !!!! ! !!! ! ! 
and !!!!!!!! ! !! 
Samples !! for which !! ! !!are called support vectors. 
The vector w can be computed in terms of !! as ! ! !!!!!!!!!!  
and, therefore, contains the weighted features of the support vectors. 
 
3.4.7 SVM parameter selection 
Linear SVMs have only one parameter, C, which controls the trade-off between 
errors on the training data and margin maximization. We found that the performance of the 
Hb enhancer classifier was relatively stable with respect to changes in C. We estimated C 




. Additionally, because the training data are 
unbalanced (there are 10 controls for each enhancer sequence), misclassifications are 
penalized differently depending on the class of sequences (controls and enhancers), 
proportionally to the total number of sequences in each class. 
 
3.4.8 Motif rankings 
After obtaining a linear SVM model, the weight vector ! can be used to decide the 
relevance of each feature (Guyon et al. 2002). The larger !! , the more important role of 
feature j in the decision function. We rank features, in our case, motifs, according to !! . We 
! )*!
exclude de novo motifs from these ranks unless stated otherwise. It is important to note that 
this interpretation for ! is only valid for linear SVMs. 
 
3.4.9 Hindbrain genes 
We identified a set of 787 human genes likely to be involved in Hb function by 
retrieving genes with relevant phenotypes from the Online Mendelian Inheritance in Man 
(OMIM) database (Amberger et al., 2009) and the corresponding orthologs of genes with 
pertinent annotation in the Mammalian Phenotype (MP) Browser at the Mouse Genome 
Informatics website, The Jackson Laboratory, Bar Harbor, Maine (http://www.informatics. 
jax.org). 
 
3.4.10 Genome scans 
We applied three human Hb enhancer models trained on (1) the complete Hb data set, 
(2) the subset of Hb enhancers that are active in the anterior Hb, and (3) the subset of 
enhancers which functions in the posterior Hb to scan sequences highly conserved across 
mammals using the Most Conserved Elements database from the UCSC Table Browser 
(Siepel et al., 2005). Noncoding conserved sequences were determined based on annotation 
in UCSC Known and RefSeq (Hsu et al., 2006; Pruitt et al., 2009). Sequences within 100 bp 
of each other were clustered together and clusters shorter than 100 bp were excluded from the 
analysis. Using classifiers trained on the orthologous sequences of the complete data set of 
human Hb enhancers, we utilized an analogous procedure to predict Hb-specific enhancers in 




3.4.11 Scaled summary Hb score 
Each scanned sequence is given three scores, anterior Hb score, posterior Hb score, 
and general Hb score; by the classifiers trained on the subset of Hb enhancers that are active 
in the anterior Hb, the subset of enhancers which functions in the posterior Hb, and the 
complete Hb data set, respectively. The scores are distributed in the range [-17,15], [-20,15], 
and [-22,15], respectively (Figure 3-4). Scores greater than zero correspond to putative 
enhancers active in the anterior Hb, in the posterior Hb, and in the (general) Hb, respectively. 
Approximately 130,000 sequences scored greater than zero for at least one of the classifiers, 
while 40,000 sequences scored greater than zero for all three. Scores for all classifiers are 
subsequently linearly scaled according to 
!"#$!! !
! ! ! !"#$%!!"#$%!"#
!!"#$%!"#
! !"!!"#$% ! !
!"#$%
!"#$%!"#!!
! !"!!"#$% ! !
! 
where !"#$%!"#! and !"#$%!"#!  are the minimum and maximum scores obtained in the 
genome-wide scan, respectively. Finally, we define the scaled summary Hb score as the 
maximum between !"#$%!"#$%&'%!!"! , !"#$%!"#$%&'"&!!"! , and !"#$%!"#"$%&!!"! .  
 
3.4.12 Association between enhancer predictions and loci 
In order to associate putative enhancers with genetic loci we defined gene loci in the 
human genome using known Gene and RefSeq annotation tracks available at the UCSC 
Genome Browser (November 2011). One or more overlapping transcripts, prohibiting 
overlap among different loci, defined each locus. Putative Hb enhancers were associated with 
loci based on genomic proximity. Therefore, our interpretation assumes that each putative Hb 
enhancer targets the nearest genetic locus. 
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3.4.13 DNase I hypersensitivity and histone modification comparisons 
We compared our putative Hb enhancers with human fetal brain, heart, and lung 
DNase I hypersensitive peaks from http://nihroadmap. nih.gov/epigenomics/. H3K4me1 and 
H3K27ac peaks were obtained from http://genome.ucsc.edu/ENCODE/ (The ENCODE 
Project Consortium 2011) and correspond to ChIP-seq from all human cell lines available at 
the time of study.  
 
3.4.14 In vivo validation 
Candidate Hb enhancers for validation were selected randomly from positively 
scoring sequences with rank less than or equal to ~40,000. Controls were selected among 
sequences that scored among the bottom 1% (i.e., rank greater than or equal to ~334,000) for 
all classifiers. Zebrafish were maintained as previously described (Kimmel et al., 1995; 
Westerfield, 2000). Predicted enhancers were amplified by PCR from human genomic DNA 
and cloned using Gateway Technology (Invitrogen). PCR fragments were TA-cloned into the 
pCR8/GW/TOPO vector (Invitrogen) then TOPO-cloned using attL1 and attL2 sites into the 
pT2cfosGWvector for injection into zebrafish embryos. Short fragment sequences for HB01 
and HB16 were synthesized as double-stranded oligos, A overhangs added, then cloned as 
predicted enhancers. At least 100 embryos were injected per construct at the two-cell stage 
with tol2 transposase as previously described (Fisher et al., 2006 a and b).  
Injected embryos were screened for GFP expression in the CNS at 24 and 48 hpf. 
Those showing CNS expression were raised to adulthood and crossed to AB zebrafish. G1 
embryos were screened for Hb expression at 24, 48, and 72 hpf. GFP positive embryos were 
live imaged at 72 hpf using a Carl Zeiss Lumar V12 Stereo microscope with AxioVision 
version 4.8 software. Embryos were fixed in 4% PFA (Sigma) overnight then post-fixed in 
! )-!
100% acetone (JT Baker) and washed in PBS with 0.5% Tween. Embryos were blocked in 
10% goat serum and 1% BSA for two hours, then incubated with chicken anti-GFP 
(Invitrogen A10262, 1:1000) overnight. After washing, Alexa Fluor 488 goat anti-chicken 
IgG (Invitrogen A11039, 1:3000) was added and incubated overnight. After washing, 





















3.5 Tables: Chapter 3 
Table 3-1. Characteristics of Hb enhancers tested in vivo. 





HB01 chr14:47542553-47542700 147 0.37 3221 
HB02 chr10:11095875-11096151 276 0.24 12498 
HB03 chr14:46003441-46003574 133 0.20 19431 
HB04 chr12:85151257-85151367 110 0.28 8718 
HB05 chr7:13451899-13452047 148 0.42 1726 
HB06 chr2:206786161-206786276 115 0.51 670 
HB07 chr10:105298975-105299102 127 0.63 188 
HB08 chr5:88758665-88758837 172 0.30 6890 
HB09 chr4:66889195-66889310 115 0.60 274 
HB10 chr13:53651033-53651240 207 0.33 5048 
HB11 chr14:27141446-27141697 251 0.25 11771 
HB12 chrX:114374399-114374510 111 0.25 11475 
HB13 chr1:206309342-206309511 169 0.27 9374 
HB14 chr13:35635698-35635867 169 0.17 25561 
HB15 chr16:13015785-13015896 111 0.31 5811 
HB16 chr14:39591833-39591950 117 0.25 12128 
HB17 chr6:2327522-2327644 122 0.24 13177 
HB18 chr2:79807546-79807739 193 0.37 3091 
HB19 chr15:62881358-62881475 117 0.33 4886 
HB20 chr15:86535910-86536025 115 0.30 6480 
HB21 chr12:6751734-6751913 179 0.32 5543 
HB22 chr20:43405575-43405696 121 0.29 7400 
HB23 chr5:139417800-139417932 132 0.22 16066 
HB24 chr20:39964905-39965010 105 0.23 14041 
HB25 chr2:117335633-117335763 130 0.27 8799 
HB26 chr3:178842751-178842854 103 0.25 11706 
HB27 chr18:48175265-48175412 147 0.15 32683 
HB28 chr3:32423887-32423998 111 0.16 29741 
HB29 chr17:35808909-35809107 198 0.15 32747 
HB30 chr14:56583170-56583278 108 0.17 26867 
HB31 chr13:52148456-52148606 150 0.15 33727 
HB32 chr5:151560335-151560535 200 0.17 26389 
HB33 chr16:84681714-84681816 102 0.15 32214 
HB34 chr7:153188989-153189115 126 0.28 8604 
HB35 chr11:102496520-102496626 106 0.23 13715 
HB36 chr10:73516897-73517093 196 0.31 6018 
! *%!
HB37 chr6:49234872-49235047 175 0.25 11954 
HB38 chr14:30318079-30318180 101 0.22 15269 
HB39 chr22:36334856-36334957 101 0.61 233 
HB40 chr2:232283281-232283418 137 0.25 11599 
HB41 chr5:67641868-67641990 122 0.33 4882 
HB42 chr10:117345190-117345362 172 0.20 18882 
HB43 chr12:90547556-90547657 101 0.32 5241 
HB44 chr22:34348464-34348585 121 0.17 26265 
HB45 chr15:66897239-66897352 113 0.29 7175 
HB46 chr16:49588251-49588360 109 0.20 20054 
HB47 chr1:104891296-104891470 174 0.20 19179 
HB48 chr3:142944914-142945039 125 0.21 18453 
HB49 chr9:137002680-137002785 105 0.33 5021 
HB50 chr17:32695070-32695176 106 0.19 22380 
HB51 chr4:21785966-21786074 108 0.18 24045 
HB52 chr2:30107189-30107302 113 0.16 29444 
HB53 chr19:34550750-34550865 115 0.16 30856 
HB54 chr15:83868753-83868853 100 0.15 34602 
HB55 chr3:82099907-82100045 138 0.17 25603 
HBN01 chr2:213474999-213475102 103 -0.82 336738 
HBN02 chr4:16218968-16219081 113 -0.84 336739 
HBN03 chr11:62420195-62420307 112 -0.69 336726 
HBN04 chr16:1429021-1429130 109 -0.71 336730 
HBN05 chr3:129750976-129751160 184 -0.55 336659 
HBN06 chr9:109890045-109890169 124 -0.57 336675 
 
Coordinates and scores of putative Hb enhancers and controls tested in vivo. Element name, 
prediction coordinates, size of prediction, scaled summary Hb score, general rank among all 


















POU 14/30 153/600 2.6 0.01 
NKX 9/30 66/600 2.4 0.005 
PAX 10/30 114/600 1.8 0.05 
LHX 9/30 39/600 4.6 0.0002 
 
Enrichment for the five most common TFs and TF families located in validated enhancer 
sequences. 20 GC matched random controls were used for each enhancer sequence. P-value 


















3.6 Figures: Chapter 3 
Figure 3-1. GC and repeat content of Hb enhancers do not differ from enhancers driving 
expression in other tissues.
 
Analysis of GC content (red) and repeat content (black) proportion of different tissue-specific 





Figure 3-2. Hindbrain classifier performs well relative to other classifiers in distinguishing 
tissue-specific enhancers from background genomic sequence. 
 
 
Area under the Receiver Operating Characteristic (ROC) curve (AUC) for 11 tissue-specific 
enhancer classifiers, each trained on at least 29 sequences extracted from the VISTA 
Enhancer Browser. All classifiers yielded reasonable performances (AUC ! 0.6, red dotted 








Figure 3-3. Weights of the top motifs for hindbrain classifier relative to weights in limb 
and heart. 
Scaled weights for the 25 most relevant motifs for the human Hb classifier trained on the 
complete Hb dataset (red). For comparison, we include the scaled weights for the same 
motifs, as determined by two additional classifiers trained on limb (dark red) and heart 
(black) human enhancers from the VISTA enhancer browser. The names of the motifs are 
listed near the baseline of the graph. Weights !! !have been linearly scaled to the intervals 
[0,1], if !! !! !, and [-1, 0], if !! ! !, according to 
!!
!!"#!
 and ! ! ! !!!!!"#
!!!"#
, respectively, 
and assuming that the range of the scores is !!!! . Motifs whose presence is relevant for 
identifying putative enhancers will have scaled weights close to 1, while motifs whose 
absence is relevant for identifying putative enhancers will have scaled weights close to -1. 
**!
Figure 3-4. Distribution of SVM scores obtained from each Hb classifier.
A, B, C) Distribution of scores for the genome-wide scans by the three human Hb classifiers, 
trained with overlapping subsets of the entire set of human Hb enhancers. A score of zero is 
used as a cut-off for putative Hb enhancers (red line). Scores of the training enhancer sets are 
indicated in red. D) Distribution of scaled summary Hb scores for the genome-wide scans 
(gray) compared to the distribution of scaled summary Hb scores for the sequences which 
were classified as putative Hb enhancers by all classifiers (red). 
! *+!
Figure 3-5. Hindbrain enhancers can be accurately predicted from DNA sequence.  
 
A) Area under the Receiver Operating Characteristic (ROC) curve (AUC) for three Hindbrain 
(Hb) enhancer classifiers trained on three highly overlapping datasets (enhancers with 
activity in the anterior Hb, posterior Hb, and whole Hb). AUC values range from 0.5 (random 
discrimination) to a theoretical maximum of 1. In a cross-validation setting our Hb classifiers 
obtained values of 0.89 (anterior Hb), 0.92 (posterior Hb), and 0.89 (combined Hb). B) 
Overlap among the top-scoring 5% Hb enhancer predictions produced by all three Hb 
classifiers. C) Fold-enrichment in 787 genes involved in Hb function in the neighborhood of 
positive predictions or putative Hb enhancers. Putative Hb enhancers were associated with 










Figure 3-6. Experimental validation of tissue-specific enhancer candidates in transgenic 
assays in mice and zebrafish. 
 
The in vivo validation rate of our computational Hb classifier, 5th column, trained on a small 
empirical dataset was comparable to those obtained with EP300 ChIP-Seq experiments in 
other brain tissues and limb (columns 3, 4 and 6) and exceeded that achieved in the heart by 










































































































Figure 3-7. Predicted enhancers display pleiotropic expression patterns in the hindbrain. 
 
 A-H) GFP reporter expression from eight stable lines corresponding to Hb predictions 
showing expression across the Hb as well as in some non-Hb domains. Dorsal view images 
of EGFP reporter expression were taken at 3dpf.  
Abbreviations: Cb – Cerebellum, CG – Cranial Ganglia, dDi – Dorsal Diencephalon, fb – Fin 
Bud, Hb – Hindbrain, L – Lens, M – Myotome, OV – Otic Vesicle, and Tm – Tegmentum. 
 
! +.!
Figure 3-8. Transcription factor motif clustering reveals functional sequence domains. 
 
A and H) UCSC Genome Browser custom track showing injected construct, classifier 
predicted HB sequence, and fragments tested for Hb expression (black bars, top to bottom). 
Colored bars mark TFBS for various factors. B-G and I-P) EGFP reporter expression 
! +%!
observed with each sequence (lateral view, top; dorsal view, bottom). All images taken at 
2dpf, anterior to the left. A) HB01 custom track with 2 subcloned fragments, B) Full length 
HB01, lateral view, C) HB01_I, lateral view, D) HB01_II, no G0 GFP reporter expression 
observed, E) Full length HB01, dorsal view, F) HB01_I, dorsal view, G) HB01_II, no G0 
GFP reporter expression observed. H) HB16 custom track with 3 subcloned fragments, I) 
Full length HB16, lateral view, J) HB16_I, lateral view, K) HB16_II, lateral view, L) 
HB16_III, lateral view, M) Full length HB16, dorsal view, N) HB16_I, dorsal view, O) 
HB16_II, dorsal view, P) HB16_III, dorsal view. Abbreviations: CG – Cranial Ganglia, Fb – 
Forebrain, Hb – Hindbrain, L – Lens, M-H – Midbrain-Hindbrain Boundary, My – Myotome, 





















 In our continuing effort to annotate the genome for transcriptional regulation and 
create the most accurate and predictive catalogs of cell-type restricted enhancers we set out to 
establish ChIP-seq as a viable technique to identify enhancers in our lab in a conservation 
independent, cell-type restricted, and genome-wide manner. For our early experiments we 
chose EP300, a transcriptional co-activator and histone acetyltransferase (Eckner et al., 1994; 
Vanden Berghe et al., 1999; Holmqvist and Mannervik, 2013), and the histone modification 
H3K4me1 as our proteins of interest. Both proteins are highly conserved, have been shown to 
be associated with enhancers in many cell types and tissues, and antibodies that have been 
used extensively for ChIP-seq are readily available (Visel et al., 2009, Blow et al., 2010).   
 We first focused on a mouse melanocyte cell line, melan-Ink4a-Arf, that was derived 
from epidermal melanocytes of an early post-natal Ink4a/Arf null pup on a C57BL/6J 
background (Bennett et al., 1987, Sviderskaya et al., 1997). Knock-out of Ink4a/Arf prevents 
senescence of the cells in culture, but has no other noticeable effects on phenotype. Melan-
Ink4a-Arf cells are darkly pigmented, genomically stable, closely resemble primary 
melanocytes and are easily expandable to the numbers needed for ChIP-seq (100-200 million 
cells per replicate). As this was largely the thesis project of a prior student, I will only briefly 
touch on the data that led to my further work.   
Using this method we identified a pattern of H3K4me1 peaks flanking EP300 peaks 
at known melanocyte enhancers. After applying this filter to the remaining data we 
! +'!
discovered 2,489 putative mouse melanocyte enhancers (Gorkin et al., 2012). This method 
achieved a high validation rate both in vitro (86%; 43/50) and in vivo (70%; 7/10). The in 
vivo validation rate was especially promising since reporter expression from the positively 
scored sequences was seen solely in melanocytes. Due to this high success rate I attempted to 
apply the same method to purified neuronal populations. 
In this chapter I will describe my early attempts at applying this ChIP-seq-based 
enhancer catalog identification strategy to a significantly smaller population (~4 million) of 
primary rat cortical neurons. Based on my work we determined that EP300 ChIP-seq fails 
with low cell number so I next investigated how well H3K4me1 identifies putative enhancers 
in the absence of EP300. I found that H3K4me1 could be used to identify enhancers in 
smaller cell populations, albeit with lower validation rates, in the absence of EP300 ChIP-seq 
data. Furthermore, this rate is increased when H3K4me1 peaks are filtered for conservation. 
   
4.2 Results 
4.2.1  H3K4me1 ChIP-seq in reduced cell numbers identifies regions of putative 
functional significance across the genome  
Establishing a large population of purified neuronal subtypes is quite difficult as 
neurons are not generally actively dividing and neuronal precursors that are dividing must be 
differentiated by the addition of chemicals such as retinoic acid (SH-SY5Y) or butyric acid 
(MN9D, Rick et al., 2006). More recently, embryonic stem cells or pluripotent stem cells 
have been differentiated by the addition of specific transgenes (Friling et al., 2009; Caiazzo et 
al., 2011; Addis et al., 2011) in an attempt to achieve a progressively more homogenous 
neuronal population. However, the resulting populations may have limited utility due to 
differences in physiological characteristics and expression profiles between in vitro derived 
! +(!
neurons and their in vivo developed counterparts and questions of lineage stability (Rick et 
al., 2006; Balasooriya and Wimalasena, 2007; Holmberg and Perlmann, 2012). Furthermore, 
the immortalized cell lines that are most easily grown and maintained in culture (SK-N-SH 
and SH-SY5Y) are derived from metastatic neuroblastomas and therefore are made up of a 
mixed population of cells that have limited utility for study of specific neuronal subtypes 
(Biedler et al., 1973; Ross et al., 1983). Unable to find an adequate transformed cell line, we 
sought to obtain the largest population of primary neurons possible to complete ChIP-seq for 
EP300 and H3K4me1.  
We collected approximately 4 million embryonic derived rat cortical neurons using 
established protocols (Gary and Mattson, 2001; Gary et al., 2003; Gary et al., 2012) and 
completed ChIP-seq as done previously in the melan-Ink4a-Arf cell line (Gorkin et al., 2012) 
for EP300 and H3K4me1 in duplicate, collecting an input sample from each experiment. 
Unexpectedly, sequencing reads from EP300 mapped to the rat genome (build Rn4) very 
poorly (~3%; Table 4-1). H3K4me1 ChIP-seq reads mapped significantly better with an 
average of 32% of reads mapping between two replicates (Table 4-1). The percentage of 
mapped reads for input samples were also relatively low, with an average of about 62% of 
reads mapping (Table 4-1). However, this result is somewhat expected due to the poor 
annotation and high proportion of gaps in the Rn4 build of the reference rat genome (Gibbs et 
al., 2004). Unfortunately, this does not explain the significant difference between the 
percentage of EP300 and H3K4me1 mapped reads and further work was required to 





4.2.2  EP300 binding is dynamic and transiently found at putative enhancers 
As previously described (chapters 1 and 2), sequence conservation can be used as an 
indication of function when looking at specific genomic loci, however it can also be 
extrapolated to the genomic context when examining ChIP-seq data. To better understand the 
sequencing results we investigated the overall sequence conservation of peaks that were 
called from our EP300 and H3K4me1 ChIP-seq (using MACS, Zhang et al., 2008 or 
CisGenome, Ji et al., 2008, respectively). We found that the H3K4me1 peaks and regions 100 
to 1500 bp that were flanked by H3K4me1 peaks are enriched for conservation while EP300 
peaks are not enriched for conservation in this dataset (Figure 4-1). This is a troubling result 
as we, and others (Gorkin et al., 2012, Rada-Iglesias et al., 2011, Visel et al., 2009, Blow et 
al., 2010), have previously shown in multiple tissue and cell types, including forebrain and 
midbrain, that EP300 peaks are associated with peaks in conservation.  
Upon further examination we found that the poor mapping success and lack of 
conservation of EP300 reads was due to insufficient ChIP enrichment and thereby sequencing 
of erroneous reads derived from sequencing adapter dimers and trimers.  These results are 
corroborated by our previous work in melanocytes that indicated that saturation of H3K4me1 
sequencing is achieved by approximately 10 million reads, while saturation for EP300 ChIP-
seq requires an excess of 30 million reads (Gorkin et al., 2012). We attempted to circumvent 
this problem in rat cortical neurons by increasing the number of reads generated for EP300 
relative to H3K4me1, however as it appears to be a problem first with the amount of ChIP 
enrichment and then with the sequencing depth this increase in read number did not help 
achieve saturation. We determined from this data that with the present technology, it is not 
possible to complete EP300 ChIP-seq in decreased cell numbers. However, the intimate 
nature with which histones interacts with DNA (Sheffield and Furey, 2012, Tsompana and 
! +*!
Buck, 2014) make ChIP-seq for histone modifications in low cell numbers an attractive 
alternative.  
 
4.2.3  H3K4me1 ChIP-seq can be used to identify putative enhancers in the absence of 
EP300 signal 
 Next, we examined the ability of H3K4me1 ChIP-seq to identify enhancers genome-
wide in the absence of EP300 data. Going back to our H3K4me1 melanocyte dataset (Gorkin 
et al. 2012), we randomly selected 10 H3K4me1 flanked regions, regardless of EP300 status. 
We then selected another 10 regions that were filtered for conservation by overlapping with 
PhastCons elements (PhastCons30way; Siepel et al., 2005). These regions were cloned into a 
luciferase reporter vector for an in vitro study of functional activity in cultured melanocytes. 
Although only a small number of sequences were successfully cloned and tested (n=7 
unfiltered, n=8 Phastcons filtered), we found that the fraction of elements showing a more 
than three fold change above the empty vector control was increased in the Phastcons filtered 
set. Only 57% of unfiltered H3K4me1 flanked regions (4/7) displayed luciferase activity 
above this threshold, while 75% of Phastcons filtered H3K4me1 flanked regions (6/8; Figure 
4-2) drove threefold higher activity. Importantly, the in vitro validation rate of regions 
selected for H3K4me1 flanked regions that overlap with EP300 peaks was still quite a bit 
higher with 86% (43/50, Gorkin et al., 2012). However, these data show that while H3K4me1 
signal alone is not as effective at identifying putative enhancer regions as EP300, when 
combined with additional data, such as conservation, it is possible to increase its predictive 





We completed ChIP-seq for the transcriptional co-activator and histone 
acetyltransferase EP300 and the histone modification H3K4me1 in a relatively small 
population (~4 million) of purified primary rat cortical neurons with the hope of combining 
these two dataset, as we had previously published in Gorkin et al., to identify putative 
regulatory elements genome-wide. However, we show here that EP300 ChIP-seq performs 
extremely poorly in low cell numbers, with a very low proportion of mapped reads and no 
enrichment for conservation (Table 4-1, Figures 4-1 and 4-2). As a member of the mediator 
complex, EP300 does not interact directly with DNA, and instead functions by acting through 
transcription factors and histones. We predict that this property makes its interaction with 
DNA less stable and highly transient. These characteristics could explain how using reduced 
cell numbers could reduce our ability to establish high ChIP enrichment at any one location 
resulting in very low amounts of DNA that becomes overwhelmed by sequencing adapter 
dimers and trimers during sequencing library preparation.  
Conversely, H3K4me1 sequencing reads mapped about 10 times better than EP300 
and peaks called from H3K4me1 reads showed a marked increase in conservation (Table 4-1, 
Figure 4-1). This unanticipated result required that we further analyze the ability of 
H3K4me1 ChIP-seq to identify enhancers in the absence EP300 signal. To this end we 
selected 10 random H3K4me1 flanked regions from our previous work in melanocytes and 
10 sequences with a Phastcons score above 0.15 for analysis of luciferase activity in vitro. 
This was based on the expectation that by filtering the H3K4me1 reads for conservation we 
would enrich for functional sequences in cases where we cannot apply an EP300 filter.  
By applying a filter for conservation we were able to increase the proportion of 
sequences driving luciferase activity at least threefold above the empty vector control by 
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approximately 25% (Figure 4-2). This is an encouraging result that implies that we may 
continue to use H3K4me1 ChIP-seq in reduced cell numbers for the genome-wide 
identification of putative enhancers even when EP300 data is not available. H3K4me1 gives a 
much broader signal and is found more extensively across the genome than EP300 (3,622 
EP300 peaks; 21,189 H3K4me1 flanked regions; >42,378 H3K4me1 peaks; Gorkin et al. 
2012) so it is expected that when used on its own it will include a higher rate of false 
positives.  
Although there continues to be a significant challenge in filtering out false positives 
from H3K4me1 ChIP-seq data, we believe that H3K4me1 ChIP-seq is an adequate predictor 
of functional activity. In combination with conservation, the predictive power H3K4me1 
ChIP-seq is magnified. We continue to investigate new methods for extracting H3K4me1 
peaks that are important for enhancer activity from background signals, including applying 
secondary and tertiary filters such as Phastcons score or ChIP-seq for additional histone 
modifications or transcription factors. Additionally, we predict that improved peak calling 
algorithms can further aid in improving our ability to extract signal from noise in H3K4me1 
ChIP-seq. Despite these issues, we believe this data has shown that H3K4me1 can effectively 
be used for ChIP-seq in reduced cell numbers and may be applied to homogenous 
populations of specialized neurons for cell-type specific enhancer discovery.  
 
4.4 Methods 
4.4.1 Culture of rat cortical neurons 
 Primary rat cortical neurons were gifted by Devin S. Gary (Kennedy Krieger 
Institute, Center for Spinal Cord Injury) and were established from embryonic day 18 
Sprague-Dawley rat cortices as described previously (Gary and Mattson, 2001; Gary et al, 
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2003, Gary et al. 2011). Pregnant females were euthanized and embryos removed. Cortices 
were dissected from pups, dissociated by trypsin treatment and tritured 15-20 times in 
Neurobasal media with B-27 supplement (Life Technologies) to break down tissue. Cell 
clumps were removed by passage through a 40-"m filter, and cells were plated on poly-D-
lysine coated plates (10"g/ml, coated overnight) at a density of 75,000 cells/cm2. Cortical 
neurons were maintained in neurobasal media and B-27 supplement for 5 days prior to ChIP.    
 
4.4.2  EP300 and H3K4me1 ChIP-seq 
ChIP for EP300 and H3K4me1 was completed as established in Gorkin et al. 2012 
with minor changes in volume to account for differences in cell number. Cells were fixed 
with 1.1% formaldehyde for 10 minutes, which was then quenched with 125mM glycine. 
Fixed cells were then lysed in lysis buffer 1 (5mM PIPES, 85mM KCl, 0.5% NP-40, and 1x 
Roche Complete, EDTA-free protease inhibitor), and lysis buffer 2 (50 mM Tris-HCl, 10 
mM EDTA, 1% SDS, and 1x Roche Complete, EDTA-free protease inhibitor). Cells were 
resuspended in 16.7mM Tris-HCl, 1.2mM EDTA, 167mM NaCl, 0.01% SDS, 1.1% Triton 
X-100, and 1x Roche Complete, EDTA-free protease inhibitor for sonication. DNA was 
sheared using a Bioruptor (Diagenode) with the following settings: high output; 30-sec 
disruption; 30-sec cooling; total sonication time of 40 min with addition of fresh ice and cold 
water to the water bath every 10 min.  
Sheared DNA was incubated overnight for chromatin immunoprecipitation with anti-
EP300 (Santa Cruz Biotechnology; sc-585) or anti-H3K4me1 (Abcam; ab8895). Antibodies 
were bound and immunoprecipitated by protein-G Dynabeads (Life Technologies) and 
collected by magnet at 4o. IPs were washed twice with low-salt wash buffer (0.1% SDS, 1% 
Triton X-100, 2mM EDTA, 20mM Tris-HCl, 150mM NaCl), twice with high-salt wash 
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buffer (0.1% SDS, 1% Triton X-100, 2mM EDTA, 20mM Tris-HCl, 500mM NaCl), and 
twice with LiCl wash buffer (250mM LiCl, 1% IGEPAL CA630, 1% deoxycholic acid 
[sodium salt], 1mM EDTA, 10mM Tris-HCl) and rinsed once with PBS (pH 7.4).  
Beads were resuspended in elution buffer (50mM Tris, 10mM EDTA, 1% SDS) and 
incubated overnight at 650C. 2 volumes of elution buffer was also added to the input fraction 
and it was incubated overnight at 650C. Samples were treated with RNase A (0.2ug/ul) for 1 
hour at 370C, and then proteinase K (0.2ug/ul) for 2 hours at 550C. DNA was purified by 
standard phenol-chloroform extraction, and resuspended in 10mM Tris-HCl. Two biological 
replicates were performed for each antibody, with each replicate consisting of a ChIP sample 
and an input (pre-IP) sample. Libraries were prepared using a standard TruSeq DNA sample 
prep kit (Illumina) and sequenced on an Illumin GA2 obtaining 100 bp reads. All four input 
samples and both H3K4me1 samples were pooled in one lane, while both EP300 samples 
were pooled in a second lane to increase read numbers.   
 
4.4.3 Mapping and peak calling 
 Reads were mapped using Bowtie2 default settings to rat genome build 4 (Gibbs et al. 
2004). EP300 peaks were called using the Model-based Analysis for ChIPseq (MACS) 
algorithm (Zhang et al. 2008). H3K4me1 peaks were called using CisGenome (Ji et al. 2008) 
because it tends to call separate peaks corresponding to each apex of the bimodal distribution 
of H3K4me1 signal flanking enhancers, whereas MACS tends to call the entire bimodal 
distribution as a single peak. The Two Sample Peak Calling option in CisGenome was used 
to call peaks from both replicates concurrently and produce a single set of output files. 
Default settings were used for both peak callers, except that ‘half window size W’ was set to 
4 for CisGenome. 
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4.4.4  PhastCons scores 
 Average PhastCons score plots (Figure 4-1) were generated with the Conservation 
Plot tool as part of the Cistrome Analysis Pipeline using interval files of H3K4me1 peaks, 
regions 100 to 1500 bp apart flanked by H3K4me1 peaks, and EP300 peaks (Liu et al. 2011).   
4.4.5  Luciferase assays 
 H3K4me1 flanked regions were selected from our previously published ChIP-seq 
dataset in the melan-a cell line (Gorkin et al. 2012) available on the NCBI Gene Expression 
Omnibus (GEO, http://www.ncbi.nlm.nih.gov/geo/) under accession number GSE38498. 
Regions flanked by H3K4me1 were further filtered by overlapping with PhastCons 
(phastCons30way) elements obtained using the UCSC Table Browser (Karolchik et al. 2004). 
Sequences were PCR amplified from mouse genomic DNA (Promega) and TA-cloned into 
pCR8/GW/TOPO (Life Technologies). Constructs were then Gateway/LR cloned (Life 
Technologies) into a luciferase reporter construct containing the firefly luciferase gene 
downstream from a minimal E1B promoter (Antonellis et al. 2006). Melan-a cells were 
plated in 24-well plates (40,000 cells/well) in biological triplicate and transfected next day 
with 400 ng of luciferase reporter and 8 ng of pCMV-RL Renilla expression vector 
(Promega) using 2 mL Lipofectamine 2000 per well (Life Technologies). Cells were lysed at 
48 hours post-transfection and assayed with the Dual-Luciferase Reporter Assay System 







4.5 Tables: Chapter 4 
Table 4-1. Fraction of mapped reads from EP300 and H3K4me1 ChIP-seq replicates. 
Sample Total reads Uniquely mapped reads Percent uniquely 
mapped reads 
Input Expt 1 18,445,970 10,969,042 59.47 
H3K4me1 Expt 1 15,489,496 4,390,210 28.34 
Input Expt 2 15,891,197 10,235,526 64.41 
H3K4me1 Expt 2 18,552,435 6,777,966 36.53 
Input Expt 3 16,337,212 10,008,333 61.62 
EP300 Expt 3 71,975,408 2,444,601 3.40 
Input Expt 4 24,077,331 14,951,967 62.10 
EP300 Expt 4 43,377,370 1,532,905  3.53 
Reads per experiment sequences on an Illumina HiSeq GA2. Sequences were mapped to the 















4.6 Figures: Chapter 4 
Figure 4-1. H3K4me1 flanked regions from rat cortical neurons are enriched for 
conservation while EP300 peaks are not. 
 
H3K4me1 peaks (red line) called by Cisgenome show slight peaks in conservation on either 
sie of the center, while regions that are flanked by H3K4me1 peaks (100-1500 bp apart; 
green line) show a spike in conservation at the center of sites implying functionality. 
However, EP300 peaks called by MACS (blue line) show no enrichment for conservation.  
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Figure 4-2. H3K4me1 flanked regions filtered for conservation show increased luciferase 
activity in vitro compared to regions not filtered for conservation.  
 
57% of regions flanked by H3K4me1 peaks (100-1500 bp apart; UF 1-7) selected at random 
drive luciferase activity at least 3 fold higher (dotted line) than an empty vector control. 
Regions filtered for overlap with PhastCons elements (Cons 1-8) drive luciferase activity 



































































ESTABLISHMENT OF SMALL-SCALE CHIP-SEQ FOR THE ANALYSIS OF 
DOPAMINERGIC NEURONAL POPULATIONS EX VIVO 
 
5.1 Introduction 
 The end goal of this thesis had always been to identify enhancers that are active in 
dopaminergic neurons and that may play a role in human variation and disease pathogenesis. 
Upon determining the value of H3K4me1 ChIP-seq in reduced cell populations we have 
shown in chapter 4 that this is a viable tool for enhancer discovery in neuronal subtypes. 
However, dopaminergic neurons are especially difficult to obtain in large numbers as they 
make up such a small proportion of the brain (Hitzemann et al., 1993).  
While trying to identify the best cell substrate to complete H3K4me1 ChIP-seq we 
became aware of the Human Epigenome Atlas, a resource produced and maintained by the 
NIH Roadmap Epigenome Consortium (Bernstein et al., 2010). The Human Epigenome Atlas 
provides a valuable tool to researchers by making publicly available hundreds of ChIP-seq, 
RNA-seq, and DNaseI-seq datasets from human embryonic stem cells, as well as fetal and 
adult human tissues. We sought to investigate the adult brain tissues profiled by H3K4me1 
from this expansive atlas. At least two replicates of H3K4me1 ChIP-seq, and an input 
sample, were available for port-mortem micro-dissected brain tissue from the anterior 
caudate, hippocampus, temporal lobe and, most significantly for my study, the substantia 
nigra. We investigated the ability of these highly biologically relevant datasets from human 
tissue to predict cell-type restricted enhancers genome-wide.  
H3K4me1 ChIP-seq in these brain sub-regions was able to detect sequences that may 
function in gene regulation, successfully identifying regions that are enriched for 
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conservation and are often located near the top 1500 most highly expressed genes in the 
substantia nigra. However, using machine learning we discovered that although significant 
k-mers with predicted biological relevance were identified, the auROC of our datasets could 
not reach higher than 0.70 irrespective of the filters that were applied. We tested a small 
number (substantia nigra unique and conserved (SN – U, Cons), n=10; substantia nigra 
unique, conserved and contains motifs for FOXA2 and NR4A2 (SN – U, Cons, FN), n=10) of 
elements in zebrafish to examine reporter expression but saw very little expression in the 
CNS in either data set, only 3/10 for SN – U, Cons and 5/10 for SN – U, Cons, FN. We 
hypothesize that the auROCs and low validation rate is due to the heterogeneity of the tissues 
in which the ChIP was completed. Micro-dissected tissues are made up of a variety of cell 
types, which introduces noise to the ChIP resulting in sub-optimal enrichment. After 
observing such low enrichment and in vivo validation we determined that these were not ideal 
substrates and we must pursue a more homogenous population of dopaminergic neurons in 
order to discover an enhancer vocabulary for dopaminergic neurons.  
To this end, we obtained a transgenic mouse line from the Gene Expression Nervous 
System Atlas (GENSAT; Gong et al., 2003; Heintz 2004) that expresses EGFP under the 
regulatory control of the human tyrosine hydroxylase locus (TH; Tg(Th-EGFP)DJ76Gsat/ 
Mmnc; from the Mutant Mouse Regional Resource Core at UNC; Khaliq and Bean, 2010; 
Ibáñez-Sandoval et al., 2010). TH catalyzes the rate-limiting step in catecholamine synthesis 
from tyrosine to dopa (Nagatsu et al., 1964) and is characteristically expressed in 
dopaminergic neurons. Mutations in the coding region of TH are linked to autosomal 
recessive forms of dopamine deficiency called Segawa syndrome (OMIM #605407; Ludecke 
et al. 1995; Brautigam et al. 1999). Mouse Th is expressed by embryonic day 11.5 (E11.5) as 
neuronal precursors are undergoing terminal differentiation to dopaminergic neurons 
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(Prakash and Wurst, 2006). Wanting to collect as many EGFP positive cells as possible, we 
dissociated the ventral midbrain at E15.5, under the assumption that the majority of 
precursors should be differentiated by then. However, especially in early experiments this 
only resulted in about 1-2% of cells sorted from the ventral midbrain being EGFP positive 
(~12,500 cells per embryo; 125,000 per litter). The low number of cells retrieved requires 
further optimization of available ChIP-seq protocols in order to obtain sufficient enrichment 
of H3K4me1 bound chromatin.  
At the time of this study, a number of low cell ChIP-seq protocols had been published 
(Goren et al., 2010; Adli et al., 2010; Adli and Bernstein, 2011; Gilfillan et al., 2012) 
presenting evidence that to accurate profiling of histone marks could be done in as few as 
10,000 cells per ChIP. We set out to optimize these protocols in our lab starting first with the 
fixed ChIP (X-ChIP) protocol from Adli and Bernstein, and later examined the utility of the 
native ChIP (N-ChIP) from Gilfillan et al. The Adli protocol was similar to the one we used 
previously for ChIP-seq in the melan-a cell line and rat cortical neurons, however due to the 
small cell numbers it employs a random amplification step after DNA isolation to increase 
the amount of library DNA. On the other hand, N-ChIP does not use formaldehyde to fix 
proteins to DNA instead employing microccal nuclease (MNase) to cut between histones and 
relying on the tight association of nucleosomes with the DNA to retain the proximity of 
histone modifications with functional sequences. Ultimately, the combination of a slightly 
altered, reduced-volume, standard ChIP protocol currently used by the Adli lab with an 
optimized sonication procedure and a ChIP specific library preparation kit proved to be 
necessary for examining H3K4me1 marks in purified dopaminergic neurons.  
Upon final optimization of ventral midbrain dissection, dissociation, and FACS we 
were able to retrieve approximately 500,000 ventral midbrain EGFP positive cells per litter of 
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Tg(Th-EGFP)DJ76Gsat embryos at E15.5. We collected 20,000 EGFP cells per sort for RNA 
isolation and qRT-PCR, showing that these cells are indeed dopaminergic. The remaining 
EGFP positive cells were split in half to complete 2 different ChIPs, one with H3K4me1 and 
one with H3K27ac. ChIP-seq for H3K27ac, a histone modification associated with active 
developmental enhancers (Creyghton et al., 2010; Rada-Iglesias et al., 2011), was completed 
to add another filter to the H3K4me1 data and aid in identification of functional sequences.  
Using these methods we identified a catalog of putative dopaminergic enhancers. 
These sequences display increased conservation at the center of sites and are enriched near 
genes associated with neuronal function and processes. Regions for in vivo validation were 
selected based on their proximity to genes involved in dopaminergic processes or association 
with Parkinson’s disease. These studies are ongoing and will be completed by another 
competent and reliable graduate student.  
 
5.2 Results 
5.2.1 H3K4me1 ChIP-seq from human brain tissue identifies putative dopaminergic 
neuron enhancers 
 Making use of publically available datasets for dopaminergic neurons we 
downloaded H3K4me1 ChIP-seq replicates for anterior caudate, hippocampus, temporal lobe 
and substantia nigra from the Human Epigenome Atlas. We re-called peaks from the mapped 
sequencing reads of each dataset and identified H3K4me1 flanked regions as described 
previously (Chapter 4; Gorkin et al., 2012; Table 5-1) to locate putative enhancer sequences 
for each brain region. To discover regions that may be necessary for specific activity in the 
substantia nigra, all H3K4me1 flanked regions identified in the other brain sub-regions that 
overlapped with substantia nigra flanked regions were removed. The remaining substantia 
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nigra sequences identified by H3K4me1 ChIP-seq were then dubbed substantia nigra unique 
dataset (Table 5-1). As a result, all sequences that were identified in at least one other brain 
sub-region studied were excluded from further analysis.  
 To better understand the characteristics of our substantia nigra H3K4me1 marked 
sequences we first examined the average conservation level of regions using the 
Conservation plot tool (Siepel et al. 2005) on the Cistrome Analysis pipeline (Liu et al. 
2011). The average PhastCons score was increased at the center of sites of the entire 
substantia nigra dataset, and conservation could be further enriched by overlapping 
substantia nigra unique H3K4me1 flanked regions with PhastCons elements (Figure 5-1). 
Next, substantia nigra U, Cons regions are enriched near genes that are highly expressed in 
human dopaminergic neurons (Marei et al. 2011; Figure 5-2; black bars), relative to those 
that are lowly expressed (Figure 5-2; light gray bars) or genes randomly selected from the 
expression range (Figure 5-2; dark gray bars). These results imply that our catalog may play a 
role in gene regulation in dopaminergic neurons. 
 
5.2.2 Microdissected brain tissue does not provide a homogenous cellular substrate for 
enhancer prediction 
 Next, we investigated the predictive power of these datasets by using machine 
learning k-mer-based SVM (Lee et al., 2011; Gorkin et al., 2012) to identify overrepresented 
k-mers. The top positively weighted k-mers identified include motifs for FOXA2 and 
NR4A2, transcription factors with known roles in dopaminergic neuron development and 
maintenance (Table 5-2; Ferri et al., 2007; Lin et al., 2009; Lee et al., 2010; Stott et al., 2013; 
Saucedo-Cardenas et al., 1998; Smits et al., 2003). Other positively weighted k-mers contain 
motifs for SOX family TFs, including SOX2 which is established as an important factor in 
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the maintenance of neural stem cells (Graham et al., 2003; Ferri et al., 2004; Liu et al., 2014). 
Factors with high negative weights include ROR$ (Table 5-2), a factor required for the 
differentiation and survival of cerebellar Purkinje neurons (Doulazmi et al., 2001; Serra et al., 
2006; Serinagaoglu et al., 2007), as well as members of the HOX and GATA families which 
are involved in hindbrain segmentation and development of numerous non-neuronal cell 
types (Tsang et al., 1997; Tennyson et al., 1998; Ohnemus et al., 2001; Huang et al., 2009; 
Miguez et al., 2012). Therefore, biologically relevant explanations for the top k-mers can be 
hypothesized, as the positively weighted k-mers have well described roles in dopaminergic 
neurons, while negatively weighted factors appear to function in the development and 
differentiation of other cell types.   
 Although the highly weighted k-mers appear biologically relevant, auROCs for each 
k-mer-SVM classifier from the substantia nigra datasets were surprisingly low. Unfiltered 
substantia nigra H3K4me1 flanked regions achieved an auROC of only 0.597 while filtering 
substantia nigra elements for unique identifcation and conservation (U, Cons) modestly 
improved the auROC to 0.650 (Figure 5-3). We sought to improve the auROC of the 
classifier by filtering the substantia nigra U, Cons set even further sequences that contained 
both FOXA2 and NR4A2 motifs.  
 Since k-mers for these factors were among the most highly weighted it seemed a 
reasonable expectation that additional selection based on these motifs would identify a more 
homogeneous catalog of putative dopaminergic enhancers, however the auROC was 
improved only slightly to 0.677. These auROCs are quite low relative to the auROC of 0.912 
achieved for EP300 and H3K4me1 overlap in melanocytes (Gorkin et al., 2012). Even when 
excluding EP300 peaks, the auROC for H3K4me1 flanked regions in melanocytes exceeded 
0.70 and H3K4me1 flanked regions filtered for conservation achieved an auROC of 0.776 
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(Figure 5-3). We expected that the auROC of a high quality classifier would reach at least 
0.70 since 0.50 describes random discrimination (Lee et al., 2012).  
 Despite the low auROCs we believed there was enough evidence, increased 
conservation (Figure 5-1), enrichment near highly expressed genes (Figure 5-2), and motifs 
for FOXA2 and NR4A2 among the top ranked k-mers (Table 5-2), to merit in vivo analysis 
of H3K4me1 flanked regions. We chose 10 regions from the collection of substantia nigra U, 
Cons as well as 10 sequences from substantia nigra U, Cons, with motifs for FOXA2 and 
NR4A2. Sequences to be tested in transgenic zebrafish were selected based on their 
proximity to loci associated with Parkinson’s disease (Table 1-1). Both sets of elements 
attained very low rates of in vivo validation (substantia nigra U, Cons = 0.35; substantia 
nigra U, Cons with motifs for FOXA2 and NR4A2 = 0.50). For most elements tested, 
although mosaic expression in the CNS was observed, multiple founders could not be 
identified in the F2 generation. One notable exception to this is seen for +10.54 ARHGEF2 
(Figure 5-4), which drives reporter expression in discrete populations of the CNS. Some of 
these populations appear to overlap with VMAT2:EGFP (a marker of monoaminergic 
neurons; Wen et al., 2007) marked cells in the diencephalon, forebrain and hindbrain (Figure 
5-4, G-I). Overall, we were unable to validate publicly available H3K4me1 datasets for the 
substantia nigra downloaded from the Human Epigenome Atlas as substrates for enhancer 
identification.  
We hypothesize that the heterogeneity of microdissected tissue obtained from this 
study introduce too many confounding signals to establish a good training set for enhancer 
identification in dopaminergic neurons. This result is in direct opposition to how the 
heterogenous training set of hindbrain elements performed in predicting hindbrain enhancers 
with high sensitivity but low specificity. In this case we had very low sensitivity and 
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specificity. Despite this failure, we still believe that the training set and classifier for 
dopaminergic neurons can be improved by using a homogeneous population of primary cells.  
 
5.2.3 Transgenic mice containing a BAC encompassing the tyrosine hydroxylase locus 
provides a homogenous population of dopaminergic neurons for ChIP-seq 
 Although the tissues collected by the Human Epigenome Atlas were extremely 
biologically relevant they was not made up of pure population of neuronal subtypes. 
Obtaining a pure population, as we previously reported with melanocytes (Gorkin et al., 
2012), will likely be the best way to remove all confounding signals and create the 
homogenous training set needed for enhancer discovery in dopaminergic neurons and 
predictions in the human genome. Towards this end, I decided to isolate a population of 
predicted dopaminergic neurons from Tg(Th-EGFP)DJ76Gsat mice.  
 Tg(Th-EGFP)DJ76Gsat mice are incompletely characterized (GENSAT; Gong et al., 
2003; Heintz, 2004) however they have been shown to express EGFP in the ventral midbrain 
(Khaliq and Bean, 2010; Ibáñez-Sandoval et al., 2010). We dissected brains from E15.5 
embryos, noting strong EGFP expression in the ventral midbrain as well as fainter expression 
in the striatum and hypothalamus of the forebrain (Figure 5-5 A). The ventral midbrain was 
removed and dissociated to a single cell suspension in preparation for FAC sorting. Dead 
cells were excluded during the sort by the addition of propidium iodide (PI) to label cells 
with damaged membranes (red). Two populations of cells were collected PI-, EFGP+ and PI-, 
EGFP- for RNA expression analysis (Figure 5-5, B).   
 We completed qRT-PCR for a number of genes that are characteristically expressed 
in neurons, Th, Slc6a3 (dopamine transporter), Pitx3, Foxa2, and Nr4a2, as well as Gad2, a 
marker of glutamatergic neurons, and Actb as a housekeeping control (Figure 5-5, C). There 
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was a marked enrichment in the PI-, EGFP+ cells for markers of dopaminergic neurons 
relative to the PI-, EGFP- population, particularly for Th, Slc6a3 and PItx3 (each showing 
>50 fold higher levels of transcript). Significantly, the non-dopaminergic transcripts did not 
show the same enrichment. This analysis shows that EGFP+ cells isolated ex vivo from the 
ventral midbrain of Tg(Th-EGFP)DJ76Gsat mice are indeed a good substrate for ChIP in 
dopaminergic neurons.  
 
5.2.5 H3K4me1 ChIP-seq in FAC sorted dopaminergic neurons identifies a catalog of 
putative enhancers 
 After extensive optimization of embryonic brain dissection and dissociation we 
completed more optimization of the standard ChIP-seq protocol. After overcoming various 
problems related to minimizing cell and DNA loss, shearing consistency, DNA isolation and 
sequencing library preparation we were finally ready to complete ChIP-seq for H3K4me1 
and H3K27ac.  Despite each ChIP sample only containing 250,000 cells and the low amount 
of DNA retrieved from each ChIP, the mappability of sequencing reads was vastly improved 
over what we had observed in H3K4me1 ChIP-seq from 4 million rat cortical neurons 
(Chapter 4; Table 5-3), with 65-75% of reads uniquely mapping for each sample. However, 
we also observed a high proportion of PCR duplicate reads (~40-60%; Table 5-3) that must 
be removed during peak calling to avoid false positives (Leleu et al., 2010). This result is 
expected given the low amount of input DNA and number of PCR cycles used for library 
prep, but reduced the number of usable reads significantly.  
 Peaks were called for each ChIP replicate using MACS (Zhang et al., 2008) to 
identify regions of enrichment because CisGenome did not perform well in this instance. We 
examined the homogeneity and predictive power of each set of peaks using the k-mer-SVM 
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classifier (Lee et al., 2011). Default MACS parameters resulted in a relatively poor classifier, 
with auROCs ranging from 0.54 to 0.71 (Table 5-4). To find the best dataset we changed 
multiple MACS parameters including P-value, m-fold, shift size, and lambda. Peak sizes 
ranged from an average of 171 to 1110 bp depending on the parameters used (Table 5-4). 
Despite the low auROCs, an increase in average PhastCons score was seen for all samples 
(Figure 5-6) implying functionality. H3K4me1 peaks consistently display higher 
conservation than H2K27ac peaks, and conservation of peaks from replicate one (Figure 5-6, 
A) was not as high as replicate two (Figure 5-6, B). This is likely due to minor differences in 
DNA input and read numbers between replicates. 
 H3K4me1 peaks were refined to exclude coding regions using the UCSC Table 
Browser (Karolichik et al., 2004) to download RefSeq exons and the subtract tool in Galaxy 
(Blankenberg et al., 2010; Goecks et al., 2010), resulting in a catalog of 6. Conservation 
peaks were reduced, but still enriched, upon the removal of regions overlapping coding 
sequences, implying that a large fraction of peaks overlap with exonic sequences (Figure 5-7, 
A). However, H3K4me1 peaks were distributed into two clusters relative to the transcription 
start site (TSS): one collection of sequences in regions close to the TSS (0-5 kb) and a second 
set between 50-500 kb away from the TSS (Figure 5-7, B). Using the Genomic Regions 
Enrichment of Annotations Tool (GREAT; McLean et al., 2010) to identify the gene closest 
to each putative enhancer we found a marked enrichment for H3K4me1 peaks near genes that 
are expressed in the midbrain and nervous system as a whole (Table 5-5). Additional 
evidence pointing to functionality in the CNS includes enrichment of H3K4me1 peaks near 
genes that involved in cell processes associated with brain development (Table 5-6). 
Although not significant in the genome-wide analysis by GREAT, many H3K4me1 peaks 
were found near genes that are associated with Parkinson’s pathogenesis in humans.  
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5.2.6 Selection of sequences for in vivo validation 
 We selected 20 regions from our catalog of 7574 putative enhancers for analysis in 
zebrafish. Regions were selected based on their proximity to genes expressed in the 
substantia nigra or linked to the development of Parkinson’s disease in humans (Table 5-7). 
Some genes important in the development and maintenance of dopaminergic neurons had 
multiple H3K4me1 peaks near their genic locus (<500kb from the TSS or located in the 
gene’s intron), such as Th, Otx2, and Park2. In these cases regions closest to the TSS were 
selected for testing in vivo. Sequences will be cloned into pTEA-cfosGW, injected into 
Tg(VMAT2:EGFP) zebrafish embryos and analyzed at the mosaic and F1 stages for 
expression in dopaminergic neurons. These studies are ongoing and progress will be reported 
as results are obtained. 
  
5.3  Conclusions 
 In an effort to obtain and validate a catalog of dopaminergic enhancers we have 
studied cells from human and mouse using H3K4me1 as a marker of putative enhancers. 
Although we observed a large peak in conservation at the center of H3K4me1 marked 
regions (Figure 5-1) as well as enrichment near genes that are highly expressed in the 
substantia nigra (Figure 5-2), the auROCs obtained by k-mer-SVM were not especially high, 
with most in the 0.60 – 0.70 range (Figure 5-3 and Table 5-4). In vivo validation for 
H3K4me1 regions derived from human brain tissue was very low, barely reaching 0.5 when 
test sequences were rigorously filtered. We hypothesize that this poor validation rate is due to 
the heterogeneity of cell types resulting from tissue microdissection and the low n (n=1) of 
brains tested.  
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 In order to obtain a more homogenous cell population we went to great care to 
dissect, dissociate to single cells, FAC sort the ventral midbrains of Tg(Th-EGFP) mice 
(Figure 5-5 A and B). The resulting purified population was greatly enriched for markers of 
dopaminergic neurons (Figure 5-5 C). We completed ChIP-seq for H3K4me1 and H3K27ac 
in these cells and obtained a catalog of putative dopaminergic neuron enhancers. These 
catalogs were enriched for conservation around the center of sites (Figures 5-6 and 5-7). 
H3K4me1 peaks were enriched near genes that were expressed in the nervous system, 
particularly in the subtantia nigra and midbrain (Table 5-5) as well as near genes involved in 
processes important for accurate brain development (Table 5-6).  
 Surprisingly, the auROCs for this pure population were not dramatically increased 
over what we had observed in the human tissue datasets. Attempts to increase the auROCs 
involved modification of a number of parameters (Table 5-4) but the maximum auROC 
reached was 0.71. This unexpected result could be explained by low sequencing coverage 
and high PCR duplicates, additionally the amount of ChIP DNA was low and difficult to 
quantitate because of the large size range of library fragments (200 – 600 bp). As a result, 
read numbers were not consistent across pooled samples, cluster generation on the Hiseq was 
not optimized out and the number of usable reads for each ChIP was lower than ENCODE 
suggested guidelines of >20 million unique reads per sample (Table 5-3; Landt et al. 2012). 
These issues would likely not be as significant in a standard ChIP-seq experiment but when 
using small cell numbers they are difficult to overcome.  
 Although we could attempt further optimization of ChIP conditions or complete more 
in silico validation of our datasets the only thing that will tell us the true value of our catalog 
is in vivo validation. Speculation about sequencing results or various computational 
predictions has its place but there is a point at which we must carry on with the analysis of 
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the data that we have acquired. The initial set of sequences chosen for validation represent a 
group that we predict to give the highest chance of driving expression in dopaminergic 
neurons, due to their location at dopaminergic and Parkinson’s loci. It is possible that we will 
not see expression in the zebrafish midbrain due to its differences in structure from 
mammals. In this case we may chose to do future reporter analyses in mice.   
 
5.4  Methods 
5.4.1 Mice and midbrain dissociation 
Hemizygous male Tg(Th-EGFP)DJ76Gsat mice were obtained from the Mutant 
Mouse Regional Resource Core (MMRRC) at the University of North Carolina, Chapel Hill. 
Transgenic mice were crossed with wild-type female Swiss Webster mice (Charles River 
Labs). Pregnant dams were euthanized by isofluorane overdose followed by cervical 
dislocation. Pups were removed from the abdomen, placed in ice cold DMEM and euthanized 
by decapitation. Brains were dissected from embryos using forceps and scalpel under a 
dissecting light microscope (Zeiss) and placed in ice cold HBSS without Mg2+ and Ca2+ 
(Quantity Biological).  
Fluorescent brains were identified using a fluorescent dissection microscope. The 
ventral midbrain was isolated by removal of the cerebellum and forebrain and tissue not 
showing EGFP expression was trimmed off. Remaining EGFP positive ventral midbrains 
were dissociated using the papain dissociation from Worthington Biochemical (Cat no. 
LK003150; Heuttner and Baughman, 1986). Briefly, tissue was minced with a scalpel, 
resuspended in papain (20 U/ml) and incubated at 37o for 30 minutes. Tissue was triturated 
with a glass pipette to break apart clumps every 10 minutes. After 30 minutes tissue was 
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triturated extensively then passed through a 40"m filter. Papain was neutralized, cells spun 
down, and then resuspended in HBSS with Mg2+ and Ca2+ for FACS. 
 
5.4.2 FACS 
Cells were stained with propidium iodide (PI) to label dead cells. The single cell 
suspension isolated from Tg(Th-EGFP)DJ76Gsat mice was FAC sorted on a Beckman 
Coulter MoFlo Cell Sorter with 3 lasers (UV 355 nm, Blue 488 nm, and Red 633 nm). 
Parameters were chosen to obtain the largest population of EGFP+, PI- cells possible, gating 
to obtain dim EGFP as well as bright in the same tube. Two populations were sorted for RNA 
analysis, 20,000 cells each for EGFP+, PI- and EGFP-, PI-. The remaining EGFP+, PI- cells 
were sorted from the suspension for ChIP.  
 
5.4.3 Chromatin immunoprecipitation and sequencing library preparation 
DNA bound to H3K4me1 and H3K27ac was immunoprecipitated using a protocol 
similar to that used in chapter 4 for rat cortical neurons and published in melanocytes (Gorkin 
et al., 2012) with some slight modifications. All ChIP steps were completed in 1.5mL 
microfuge tubes. Immediately after FACS completion cells were spun down in the HBSS 
buffer and resuspended in 1% formaldehyde (Sigma) and 10% FBS (Gibco) in PBS (Gibco). 
Cells were fixed for 10 minutes rocking at room temperature, then formaldehyde was 
quenched with the addition of glycine to a final concentration of 0.125M. Cells were spun 
down and washed twice with 10% FBS in PBS. Cells were lysed in SDS lysis buffer (50mM 
Tris-HCl (pH 8.1), 10mM EDTA, 1% w/v SDS + Roche EDTA free Complete Protease 
inhibitors).  
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Samples were diluted in ChIP Dilution Buffer (0.01% w/v SDS, 1.1% w/v Triton X-
100, 1.2mM EDTA, 16.7mM Tris-HCl (pH 8.1), 167mM NaCl + Roche EDTA free 
Complete Protease inhibitors), then sonicated using a Diagenode Bioruptor. Settings were 
high, 30-seconds disruption, 30-seconds cooling in 5 minute cycles. Every 5 minutes samples 
were vortexed and spun down to remove any foam, and the Bioruptor reservoir was refilled 
with ice-cold water. Ice was used to cool the water down, but no solid ice was allowed to 
remain in the water bath during sonication.  
After sonication like samples were pooled and 25"L was taken as input. The 
remainder was split in half for ChIP with H3K4me1 and H3K27ac. 2"g H3K4me1 (Abcam, 
ab8895) or 5"g H3K27ac (Abcam, ab4729) were added for each ChIP and samples were 
incubated rotating overnight at 4o. Protein A+G magnetic beads (Life Technologies) were 
incubated for 1 hour to bind antibodies. Complexes bound to the beads were washed twice 
with low salt wash buffer (0.1% w/v SDS, 1% w/v Triton X-100, 2mM EDTA, 20mM Tris-
HCl (pH 8.1), 150mM NaCl), twice with LiCl wash buffer (0.25M LiCl, 1% w/v NP40, 1% 
w/v deoxycholate, 1mM EDTA, 10mM Tris-HCl (pH 8.1)) and twice with TE wash buffer 
(10mM Tris-HCl (pH 8.0), 1mM EDTA). Washed beads and input samples were incubated 
overnight at 65o in elution buffer (10mM Tris-Cl, pH 8.0, 5mM EDTA, 300mM NaCl, 0.1% 
SDS). Supernatants were removed and treated with 1mg/ml RNase A (Thermo Scientific) 
followed by 2mg/ml proteinase K (Thermo Scientific). DNA was isolated using the DNA 
Clean and Concentrator kit (Zymoresearch) as instructed. Library for sequencing was created 
using the Illumina Tru-seq ChIP Library prep kit (Illumina) as instructed. Samples were 




5.4.4  RNA isolation and analysis 
RNA was isolated using an RNeasy kit (Qiagen) and cDNA was reverse transcribed 
using the Superscript III First Strand Synthesis kit (Life Technologies). Quantitative RT-PCR 
was completed using Power SYBR Green (Applied Biosystems) on a ViiA7 Real-Time PCR 
System (Applied Biosystems / Life Technologies). 
 
5.4.5  Mapping and sequencing analysis Peak Calling, k-mer-SVM, PhastCons, GREAT 
Reads were mapped to the mouse genome (UCSC mm9) using Bowtie2 (Langmead 
and Salzberg 2012) and filtered for a quality score of at least 20 to remove reads that map to 
more than one location using SAMtools (Li and Handsaker et al. 2009). Peaks were called 
with MACS (Zhang et al. 2008) testing variations in default parameters for model, shiftsize, 
lamda, and mfold. PhastCons plots for peaks were made using the Conservation Plot Tool on 
Cistrome (Siepel et al. 2005; Liu et al. 2011).  
The kmer-SVM Galaxy server was used to create classifiers, determine auROCs, and 
identify highly weighted kmers for each dataset (Fletez-Brant and Lee et al. 2013).  A five-
fold greater size null set was used for each analysis. The GREAT server (McLean et al. 2011) 
was used to associate H3K4me1 peaks with the nearest gene and identify overrepresented 
characteristics of those genes. We employed the basal plus extension setting, with proximal 
elements being 5kb upstream or downstream of the TSS, and distal being up to 1Mb away 
from the TSS.  
 
5.4.6  In vivo validation 
Sequences for in vivo validation were selected based on their proximity to genes 
expressed in dopaminergic neurons or involved in the pathogenesis of Parkinson’s disease 
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(Singleton et al., 2013; Lin and Farrer, 2014). H3K4me1 peaks overlapping conservation or 
ChIP-seq completed in other mouse brain tissues (Shen et al., 2012) were prioritized for 
analysis. Zebrafish were maintained as previously described (Kimmel et al., 1995; 
Westerfield, 2000). Sequences were cloned as described in chapter 3; predicted enhancers 
were amplified by PCR from human genomic DNA and cloned using Gateway Technology 
(Invitrogen). PCR fragments were TA-cloned into the pCR8/GW/TOPO vector (Invitrogen) 
then LR cloned into the pT2cfosGWvector, containing TdTomato instead of EGFP, for 
injection into Tg(VMAT2:EGFP) zebrafish embryos. Embryos were screening using a Zeiss 
Lumar V12 Stereo microscope with AxioVision software (version 4.5). Fish were raised to 
sexual maturity when >10% of screened embryos drove reporter expression in the CNS. 















5.5 Tables: Chapter 5 
Table 5-1. H3K4me1 ChIP-seq identifies regions with predicted enhancer function in 
neuronal subregions. 
Region Peaks Flanked Regions 
Anterior Caudate 47,206 14,384 
Hippocampus 58,204 19,146 
Temporal Lobe 44,326 12,262 
Substantia nigra 57,969 19,387 
Substantia nigra – U, Cons N/A  3596 




Number of H3K4me1 peaks and flanked regions (100-1500  bp apart) indentified in each 
brain sub-region. Abbreviations: Cons – Conserved, U – Uniquely found in the substantia 















Table 5-2. Most significant k-mers in H3K4me1 flanked regions from substantia nigra 
unique, conserved dataset. 
K-mer Weight Predicted TF P-value 
ACAAAG 2.39 Sox10 6.22E-05 
  Sox12 1.12E-04 
  Sox4 1.46E-04 
  Sox11 1.91E-04 
  Sox2 1.19E-03 
  Pou5F1 2.39E-03 
  Foxa2 5.06E-03 
AAGGCC 2.22 HNF4A 2.24E-03 
  NR4A2 2.28E-03 
  Esrrb 7.19E-03 
  PPARG::RXRA 1.11E-02 
AATAAC 2.10 Foxa2 7.28E-04 
  Tlx2 4.02E-03 
ACCTGG -2.91 ESR1 2.30E-04 
  sna 4.74E-04 
  Tcf3 1.31E-03 
  ZEB1 2.21E-03 
  ROR$ 5.85E-03 
AGGTAA -2.08 Hoxa6 9.88E-04 
  Hoxa2 2.97E-03 
  FOXF2 4.30E-03 
GCATCC -2.03 Spdef 6.75E-04 
  Gata1 1.46E-03 
  Ddit3::Cebpa 6.46E-03 
  GATA2 6.69E-03 
  ETS1 1.06E-02 
 
Kmers identified from the substantia nigra – U, Cons classifier with weights greater than |2| 




Table 5-3. Fraction of H3K4me1 and H3K27ac reads from ChIP-seq in ex vivo isolated 
DA neurons mapping to mouse genome.   






Input, R1 35,329,186 34,131,183 23,661,771 43 
H3K4me1, 
R1 
33,129,925 32,086,241 21,902,851 44 
H3K27ac, R1 13,911,455 13,499,147 9,179,551 44 
Input, R2 84,234,004 81,144,208 56,016,424 51 
H3K4me1, 
R2 
20,380,703 19,602,049 14,937,026 62 
H3K27ac, R2 10,838,276 8,404,084 7,650,174 44 
 
Sequencing completed on Illumina HiSeq GA2. Reads were mapped to the mm9 build of the 
mouse genome using Bowtie2. Percent PCR duplicates determined by MACS. 













Table 5-4. Modification of peak calling parameters changes number of peaks and kmer-
SVM auROC. 










H3K4me1 1 nomodel; 
nolambda 
n n 752 0.594 1110.1 
H3K27ac 1 nomodel; 
nolambda 
n n 839 0.543 853 
H3K4me1 1 nomodel  n y; ss=100 268 0.611 683.1 
H3K27ac 1 nomodel  n y; ss=100 455 0.540 573.4 
H3K4me1 1 nomodel, 
ss=50 
n y;  ss=50 690 0.541 310 
H3K27ac 1 nomodel, 
ss=50 










n n 839 0.543 853 
H3K4me1 2 nomodel; 
nolambda 
n n 6953 0.653 664.5 
H3K27ac 2 nomodel; 
nolambda 
n n 4521 0.711 679.3 
H3K4me1 2 nomodel  n y; ss=100 5961 0.650 646.6 
H3K27ac 2 nomodel  n y; ss=100 4014 0.711 648.7 
H3K4me1 2 nomodel, 
ss=50 
n y;  ss=50 7970 0.619 310.3 
H3K27ac 2 nomodel, 
ss=50 





n n 6953 0.651 664.5 
H3K4me1 2 mfold=10,30; 
llocal=20000 
y y; ss=100 3878 0.582 171.3 
H3K4me1 2 mfold=10,30; 
llocal=10000 
y y; ss=100 3878 0.590 171.3 
H3K4me1 2 mfold=5,30; 
llocal=10000 
y y; ss=100 6965 0.639 520 
H3K4me1 2 mfold=5,30; 
llocal=20000 






y y; ss=100 7340 0.683 376.2 
 
MACS options tested to obtain the best classifier from the mouse midbrain datasets. Further 
analysis and regions to be tested were completed on the last row.  
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Table 5-5. H3K4me1 peaks are enriched near genes expressed in the midbrain and central 
nervous system. 
Term Name   Binomial  Raw P-Value  
TS28_substantia nigra 4.546E-10 
TS28_dorsal raphe nucleus 1.319E-09 
TS28_ganglion 2.008E-08 
TS28_sympathetic ganglion 7.387E-08 
TS28_hippocampal formation 4.913E-07 
TS20_midbrain; lateral wall 6.038E-07 
TS17_peripheral nervous system; autonomic; sympathetic 6.236E-06 
TS26_brainstem 7.750E-06 
TS21_telencephalon; mantle layer 9.484E-06 
TS28_zona incerta 2.640E-05 
TS13_midbrain-hindbrain junction 4.537E-05 
TS17_rhombomere 6.550E-05 
TS28_brainstem reticular formation 1.921E-04 
TS15_future midbrain; roof plate 6.048E-04 
TS28_ventral tegmental area 1.125E-03 
TS28_pontine reticular formation 1.155E-03 
TS21_optic nerve 1.900E-03 
TS28_medial raphe nucleus 2.762E-03 
TS28_substantia nigra pars compacta 3.039E-03 
 
GREAT analysis of region-gene associations and expression locations from the MGI 
Expression database. P-Value is the Binomial Raw P-value. 
Abbreviations: TS13 – 8.0-9.5 days post coitus (dpc); TS15 – 9.0-10.25 dpc; TS17 – 10.0-




Table 5-6. GREAT region-gene associations for H3K4me1 peaks are enriched for 
pathways and processes related to the nervous system.   
Term Name  P-Value 
Dendritic spine morphogenesis 1.019E-11 
Midbrain-hindbrain boundary development 4.089E-11 
Negative regulation of transforming growth factor beta receptor signaling 
pathway 
4.933E-11 
Dendritic spine development 4.990E-10 
Negative regulation of epidermal growth factor receptor signaling pathway 9.626E-10 
Rostrocaudal neural tube patterning 2.625E-09 
Regulation of ARF protein signal transduction 2.847E-09 
Negative regulation of epidermal growth factor-activated receptor activity 1.911E-08 
Positive regulation of histone acetylation 4.620E-07 
Substrate adhesion-dependent cell spreading 7.068E-06 
Response to water 8.063E-06 
Negative regulation of protein tyrosine kinase activity 1.374E-05 
Response to food 2.742E-05 
Parasympathetic nervous system development 2.797E-05 
Preganglionic parasympathetic nervous system development 3.267E-05 
Regulation of histone acetylation 3.275E-05 
Stem cell division 1.223E-04 
Enteric nervous system development 1.923E-04 
Somatic stem cell division 2.894E-04 
Cerebellar Purkinje cell differentiation 1.353E-03 
 
Region-gene pathways and processes enriched in peaks from H3K4me1 ChIP-seq in ex vivo 
DA neurons. P-Value is the Binomial Raw P-value.  
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Table 5-7. Sequences selected from mouse VM ChIP-seq for in vivo analysis. 
Construct Coordinates of peak (mm9) Genomic features 
En1+213.76 chr1:122712847-122713355 Intergenic, En1-Celrr 
Rxrg -99.82 chr1:169430008-169430440 Intergenic, Lrrc52-Rxrg, -190kb 
from Lmx1a 
Nr4a2 prom chr2:56967450-56967659 Proximal to Nr4a2 TSS 
Sox2 -7.48 chr3:34541335-34541970 Sox-2OT, 3’ of Sox2 
Dnajc6 +0.631 chr4:101169901-101170380 Dnajc6 intron 1 
Pink1 +0.783 chr4:137881453-137881747 Pink1 intron 1 
Atp13a2 +25.96 chr4:140567690-140568369 Mfap2 intron, 25.96 to Atp13a2  
Shh +2.77 chr5:28790860-28791435 Shh intron 1 
Th- 7.70 chr7:150093577-150094369 Intergenic, Th-Ascl2 
Th -18.01 chr7:150103805-150104945 Intergenic, Th-Ascl2 
Th -18.55 chr7:150103805-150104945 Intergenic, Th-Ascl2 
Slc6a3 -0.732 chr13:73673400-73673911 Intergenic, Lpcat1-Slc6a3 
Otx2 -15.02 chr14:49293203-49293584 Otx2os1 intron 
Wnt10b -2.31 chr15:98610890-98611378 Intergenic, Wnt10b-Wnt1, 8.9kb to 
Wnt1 TSS 
Park2 +226.94 chr17:11260159-11260364 Park2 intron 2 
Park2 +514.83 chr17:11548068-11548538 Park2 intron 4 
Pax2 +51.28 chr19:44883125-44883519 Pax2 intron 6 
Gbf1 +25.07 chr19:46252062-46252521 Gbf1 intron 3, 29 kb to Pitx3 TSS 
Vax1 +40.40 chr19:59204088-59204568 Intergenic, Vax1-Slc18a2, 132kb to 
Slc18a2 TSS 
 
Name of constructs to be tested in reporter assays in vivo. Genomic location of each 
H3K4me1 peaks, and relevant proximal features. Sequences were selected based on their 





5.6 Figures: Chapter 5 
Figure 5-1. Average PhastCons score is increased at the center of H3K4me1 flanked 
regions identified from human substantia nigra 
 
Average PhastCons score around the center of H3K4me1 flanked regions from substantia 
nigra datasets; all sequences identified by H3K4me1 ChIP-seq in the substantia nigra 
(Unfiltered; red); sequences overlapping conserved regions and not identified in any of the 
other brain sub-region datasets (U, Cons; green); Unique and conserved sequences that also 
have FOXA2 and NR4A2 motifs in them (U, Cons, with FOXA2 and NR4A2 motifs; blue).  
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Figure 5-2. H3K4me1 flanked regions from substantia nigra are enriched near the top 
2500 expressed genes in dopaminergic neurons.  
 
Putative enhancers identified by H3K4me1 ChIP-seq are enriched near the 2500 most highly 
expressed genes (black bar) in the substantia nigra. Regions are depleted near the 2500 
lowest expressed genes (light gray), and equally distributed with regard to 2500 randomly 
















































Figure 5-3. Classifiers for substantia nigra datasets do not perform as well as Melan-a 
ChIP-seq sets.  
 
auROCs for classifiers from substantia nigra datasets increased with catalog refinement but 
still are significantly less than equivalent datasets from Melan-A cells. None of the substantia 








































































































































Figure 5-4. +10.54 ARHGEF2 drives expression in discrete neuronal populations 
overlapping with dopaminergic neurons.  
A representative stable line for +10.54 ARHGEF2, an element chosen based on its proximity 
(<100kb) to a SNP associated with Parkinson’s disease and overlap with  relevant TFBSs. A-
C) show reporter expression of the +10.54 ARHGEF2 construct in CNS neurons. D-F)
expression of the VMAT2:EGFP BAC marking monoaminergic neurons in the same embryo. 






































Figure 5-5. Ventral midbrain EGFP+ cells are highly enriched for expression of 
dopaminergic neuron genes. 
A) E16.5 Tg(Th-EGFP)DJ76Gsat brain, imaged ventrally with anterior to the left, posterior 
to the right. B) FACS plot of sorted neurons showing live, EGFP+ cells in R5, and EGFP-
cells in R4. C) qRT-PCR shows that EGFP+ cells collected from the VM show high 
expression of DA neuron characteristic genes relative to EGFP- cells (normalized to Actb. 
Abbreviations: Hyp – hypothalamus, VM – Ventral Midbrain. 
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Figure 5-6. Average PhastCons score is increased at the center of H3K4me1 and H3K27ac 
peaks from ex vivo dopaminergic neurons. 
The average PhastCons score is increased at the center of peaks from ChIP-seq in sorted 
mouse ventral midbrain neurons with H3K4me1 (red lines) in both replicates, and for 





















Figure 5-7. Enrichment in conservation at H3K4me1 peaks is partially due to overlap with 
coding regions. 
A) Unfiltered H3K4me1 peaks (red line) show a large peak in conservation at the center, but 
removal of all peaks overlapping with coding regions drastically reduces the conservation 
level. Sequences that only have the pieces overlapping exons (blue line) removed show a 
bimodal peak around the center. B) H3K4me1 regions show two peaks in region gene 
associations relative to the TSS with a pair of peaks between 0 and 5 kb away, as well as a 






The preponderance of GWAS signals in noncoding sequences (Maurano et al., 2012) 
has implicated common variation in enhancers as a critical determinant of human phenotypes 
and disease. In this thesis I have used a variety of methods to uncover thousands of sequences 
predicted to regulate transcription in one more neuronal subtypes. The discovery of these 
enhancer sequences will be integral to furthering our understanding of brain development and 
disease. I began by using sequence conservation across species to identify non-coding 
regulatory sequences in a locus specific manner. This approach led to the identification of 22 
new enhancers in the sequence flanking LMX1A (17) and LMX1B (5). Next, we sought to 
broaden our search space to all conserved non-coding regions throughout the genome. Using 
a machine learning approach based on a training set of 211 experimentally proven hindbrain 
enhancers we developed a primitive classifier that predicted over 40,000 sequences that may 
be active in the hindbrain. In vivo validation of this method revealed that 51/55 (93%) of 
tested elements directed CNS expression in mosaic zebrafish embryos, and 30/34 (88%) of 
these elements drove expression in the hindbrain of stable lines. The tested sequences gave 
highly pleitropic expression patterns and specificity to the hindbrain was low due to the 
heterogeneity of the training set. Despite this lack of specificity the sensitivity to detect 
sequences that will drive expression is still high, and this work has been critical in working 
towards the complete understanding of regulatory control in specific neuronal subtypes.  
 We next sought to increase the homogeneity of our training set by using a pure cell 
type rather than a tissue. This also involved the implementation of ChIP-seq to identify 
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putative enhancers. Based on previous work, we knew that ChIP-seq for EP300 and 
H3K4me1 could work well to identify enhancers genome-wide (Gorkin et al., 2012). After 
applying this same strategy to a much smaller population (4E6 vs 150E6) primary rat cortical 
neurons I found that H3K4me1 ChIP-seq still performed well, however EP300 did not. Upon 
further examination I determined that H3K4me1 ChIP-seq is an effective identifier of 
putative enhancers in the absence of EP300 data when peaks are also filtered for high 
conservation. Using luciferease assays we found that unfiltered H3K4me1 peaks drove 
luciferase activity 3 times greater than the empty vector control in 57% of constructs, while 
75% of H3K4me1 elements that were filtered for conservation level showed at least 3 times 
greater activity. This result encouraged us to continue using H3K4me1 ChIP-seq in smaller 
cell numbers where EP300 would not work for the identification of putative enhancers.  
 While working to establish a pure population of DA neurons we set out to analyze 
publically available H3K4me1 ChIP-seq data from the Human Epigenome Atlas (Bernstein 
et al., 2010).  I identified H3K4me1 flanked sequences in four human brain sub-regions: 
anterior caudate, hippocampus, temporal lobe, and the substantia nigra. With a goal of 
identifying putative enhancers specific to the substantia nigra  I filtered  this catalog to 
remove all sequences that were also found in any of the other brain sub-regions. This resulted 
in a catalog of 3,596 putative substantia nigra unique enhancers when also filtered for 
conservation status. I observed that these putative enhancers were more likely to be located 
near genes with high expression in the  substantia nigra and they were enriched for TFBSs 
for FOXA2 and NR4A2, TFs important in DA neuron development. However, the catalog 
resulted in an unexpectedly low kmer-SVM auROC, unable to reach 0.70. We hypothesize 
that the microdissected tissue substrate used in the ChIP-seq is not homogenous enough, and 
true signal is obscured by the background noise from other cell types that may have been 
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captured. I then continued my work to establish a homogeneous DA neuron population for 
ChIP-seq analysis.  
 To reach this end, we obtained a transgenic mouse line driving EGFP expression 
under the control of tyrosine hydroxylase. I optimized a protocol to dissect and dissociate 
neurons from the ventral midbrain of E15.5 embryos for FAC sorting so we could collect 
these EGFP neurons ex vivo. We showed that this population expresses DA markers in high 
levels and is therefore a good substrate for DA neuron ChIP-seq. However, these cells are 
present in very low numbers making up only about 2% of the total ventral midbrain neurons 
so further optimization of a small cell number ChIp-seq protocol was required. I finally 
completed ChIP-seq for H3K4me1 and H3K27ac on about 250,000 cells from these ex vivo 
sorted neurons to identify a catalog of putative DA enhancers. These putative enhancer show 
enrichment for conservation, are located near genes that are expressed in the substantia nigra 
and CNS as a whole, and are often located near genes associated with development of 
Parkinson’s disease. This catalog must be further validated, but offers a step in the direction 
of furthering our understanding of transcriptional regulation in DA neurons.  
 
6.2 Associating putative enhancers with their cognate genes 
 Throughout each of these chapters we have made the assumption that the putative 
enhancers identified will act to regulate the gene that is nearest to them. However, this 
assumption is not always true and further work should be done in each of these cases to 
determine which gene(s) each enhancer physically interacts with. Chromatin Conformation 
Capture (3C) has advanced significantly in recent years, allowing one to examine physical 
interactions taking place between distal regulatory elements and promoters (de Laat and 
Dekker, 2012). Characterizing the physical interactions underlying regulatory networks 
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would drastically improve our understanding of transcriptional regulation as whole, and the 
sequences necessary for the development and maintenance of our neuronal populations of 
interest.  
 For example, in the LMX1A and B study we delimited the non-coding search space 
by the genes flanking each LMX1 locus. Although this was the best method available at the 
time, it does not ensure that the non-coding sequences we studied are truly LMX1 enhancers. 
We hope to enrich for sequences that drive LMX1 expression by including the endogenous 
expression patterns of zebrafish homologs in our analysis and looking for overlapping 
patterns of expression. However, this approach is not particularly good for filtering out 
enhancers of genes that may have similar expression patterns. Specifically, the genes flanking 
LMX1A (PBX1 and RXRG) are also expressed in the CNS, thus reducing the certainty that 
the enhancers we identify truly target the LMX1A gene. 3C analysis would aid in identifying 
the true target of each enhancer and lead to a better understanding of the regulatory networks.  
 Similarly, when identifying enhancers genome-wide as in chapters 3-5 it is helpful to 
examine global expression patterns of the cells or tissues of interest (as in Gorkin et al., 
2012). We were able to examine the correlation between putative enhancers and expressed 
genes in the analysis of human substantia nigra, however RNA-seq or microarray data is not 
currently available for the human hindbrain or mouse VM. We plan to complete RNA-seq in 
the ex vivo sorted population from mouse VM. Our hypothesis is that active enhancers are 
more likely to be located near genes that are highly expressed in our cell type. This analysis 
may also aid in correlating enhancers with their cognate genes by removing genes with little 




6.3 Functional characterization of necessity and sufficiency of enhancers 
 Once we are able to determine precise transcriptional networks of enhancers and 
cognate promoters it becomes possible to start examining the necessity and sufficiency of a 
particular enhancer to the expression of its cognate gene. CRISPR-Cas9 technology is 
making it possible to edit the eukaryotic genomes easily and quickly (Mali et al., 2013). We 
can co-opt this technology in cell culture or in vivo to remove or modify specific enhancer 
sequences and characterize the changes in expression that result from these changes. This 
analysis would allow us to identify which regulatory sequences are required for the 
development and maintenance of a specific cell type and which are redundant. This 
information could then be combined with GWAS data to determine which sequences may be 
involved in the common variation that is responsible for human phenotypes (Welter et al., 
2014).  
 Increasing functional characterization of enhancers is necessary, particularly for those 
active in disease relevant cell populations, such as DA neurons. These studies may be 
difficult to interpret if physical interaction maps are not available, however expression 
profiling will aid in the identification of gene targets for the subset of enhancers that are 
required. Identifying the appropriate cellular substrate for these studies may also be difficult, 
as it has been for finding a suitable DA neuron population for ChIP-seq, however ES and iPS 
cellular differentiation is constantly improving and characterization of neuronal subtypes has 
improved drastically (Frilling et al., 2010, Holmberg and Perlmann, 2012; Mong et al., 2014). 
Additionally, large cell numbers are not necessary for expression and viability assays as they 




6.4 Translation of enhancer activity to human disease 
 The extreme end goal of my work has been to better understand the role sequence 
variation in driving common neurological diseases so that we may eventually identify 
therapies that can help protect and rehabilitate individuals with these disorders. We still have 
a long way to go for complete understanding, but I believe that the scientific community is 
making great strides towards these goals. During my thesis work hundreds of thousands of 
putative enhancers have been identified using ChIP-seq for 119 different proteins in 72 cell 
types and Dnase-seq in 125 cell types (The ENCODE Project Consortium, 2012). This 
massive amount of publically available data, along with smaller studies like mine, has proven 
that we are now capable of identifying catalogs of enhancers for cell types that are readily 
available. We can continue to identify more and more enhancer catalogs in specific cell types 
in this same way. However it is also important that future studies also focus on the functional 
aspects of identified enhancers, the impact of sequence variation within them and their role in 
human disease. Therefore, our efforts to define and catalog enhancers are not an end in 
themselves. 
 Despite this, my work in identifying neuronally expressed enhancers has contributed 
to an improved understanding of regulatory vocabularies and lays a framework for future 
studies. Although my early efforts to characterize Hb vocabularies may now appear 
rudimentary, they were among the first to comprehensively define regulatory encryption in 
specific tissues. They also pointed the way to my subsequenct efforts to identify cell-type 
dependent (DA neuron) regulatory vocabularies. These and related efforts continue to present 
technical challenges, but those too will be overcome. The results will be to illuminate the 
sequence basis of cell-dependent transcriptional control and facilitate prediction of the impact 
and phenotypic consequences of variation in regulatory noncoding sequences.     
! %&&!
REFERENCES 
Adams KA, Maida JM, Golden JA, Riddle RD. The transcription factor Lmx1b maintains 
 Wnt1 expression within the isthmic organizer. Development. 2000 May;127(9):1857-
 67. 
Addis RC, Hsu FC, Wright RL, Dichter MA, Coulter DA, Gearhart JD. Efficient conversion 
 of astrocytes to functional midbrain dopaminergic neurons using a single 
 polycistronic vector. PLoS One. 2011;6(12):e28719. 
Adli M, Zhu J, Bernstein BE. Genome-wide chromatin maps derived from limited numbers 
 of hematopoietic progenitors. Nat Methods. 2010 Aug;7(8):615-8. 
Adli M, Bernstein BE. Whole-genome chromatin profiling from limited numbers of cells 
 using nano-ChIP-seq. Nat Protoc. 2011 Sep 29;6(10):1656-68. Ahn KJ, Passero F Jr, 
 Crenshaw EB 3rd. Otic mesenchyme expression of Cre recombinase directed by the 
 inner ear enhancer of the Brn4/Pou3f4 gene. Genesis. 2009 Mar;47(3):137-41. 
 doi: 10.1002/dvg.20454. 
Aizawa H, Amo R, Okamoto H. Phylogeny and ontogeny of the habenular structure. Front
 Neurosci. 2011 Dec 21;5:138. 
Amberger J, Bocchini CA, Scott AF, Hamosh A. McKusick's Online Mendelian Inheritance 
 in Man (OMIM). Nucleic Acids Res. 2009 Jan;37 (Database issue): D793-6. 
Amores A, Force A, Yan YL, Joly L, Amemiya C, Fritz A, Ho RK, Langeland J, Prince V, 
Wang  YL, Westerfield M, Ekker M, Postlethwait JH. Zebrafish hox clusters and vertebrate 
 genome evolution. Science. 1998 Nov 27;282(5394):1711-4. 
Andreasen NC, Pierson R. The role of the cerebellum in schizophrenia. Biol Psychiatry. 2008 
 Jul 15;64(2):81-8. 
Antonellis A, Huynh JL, Lee-Lin SQ, Vinton RM, Renaud G, Loftus SK, Elliot G, Wolfsberg 
 TG, Green ED, McCallion AS, Pavan WJ. Identification of neural crest and glial 
 enhancers at the mouse Sox10 locus through transgenesis in zebrafish. PLoS Genet. 
 2008 Sep 5;4(9):e1000174. 
Aston-Jones G. Brain structures and receptors involved in alertness. Sleep Med. 2005 Jun;6 
 Suppl 1:S3-7.  
Avila RL, Tevlin BR, Lees JP, Inouye H, Kirschner DA. Myelin structure and composition in 
 zebrafish. Neurochem Res. 2007;32:197–209. 
Bailey TL, Elkan C. Fitting a mixture model by expectation maximization to discover motifs 
 in biopolymers. Proc Int Conf Intell Syst Mol Biol. 1994;2:28-36. 
Bailey TL, Gribskov M. Methods and statistics for combining motif match scores. J Comput 
 Biol. 1998 Summer;5(2):211-21. 
Banerji J, Rusconi S, Schaffner W. Expression of a beta-globin gene is enhanced by remote 
 SV40 DNA sequences. Cell. 1981 Dec;27(2 Pt 1):299-308. 
Barbazuk WB, Korf I, Kadavi C, Heyen J, Tate S, Wun E, Bedell JA, McPherson JD, 
 Johnson SL. The syntenic relationship of the zebrafish and human genomes. Genome 
 Res. 2000 Sep;10(9):1351-8. 
! %&'!
Bardet PL, Schubert M, Horard B, Holland LZ, Laudet V, Holland ND, Vanacker JM.
 Expression of estrogen-receptor related receptors in amphioxus and zebrafish: 
 implications for the evolution of posterior brain segmentation at the invertebrate-
 to-vertebrate transition. Evol Dev. 2005 May-Jun;7(3):223-33. 
Barski A, Zhao K. Genomic location analysis by ChIP-Seq. J Cell Biochem. 2009 May 
 1;107(1):11-8.  
Benjamini Y, Hochberg Y. Controlling the false discovery rate: A practical and powerful 
 approach to multiple testing. J R Stat Soc Ser B Methodol 1995 57: 289–300. 
Benko S, Fantes JA, Amiel J, Kleinjan DJ, Thomas S, Ramsay J, Jamshidi N, Essafi A, 
 Heaney S, Gordon CT, McBride D, Golzio C, Fisher M, Perry P, Abadie V, Ayuso C, 
 Holder- Espinasse M, Kilpatrick N, Lees MM, Picard A, Temple IK, Thomas P, 
 Vazquez MP, Vekemans M, Roest Crollius H, Hastie ND, Munnich A, Etchevers 
 HC, Pelet A, Farlie PG, Fitzpatrick DR, Lyonnet S. Highly conserved non-coding 
 elements on either side of SOX9 associated with Pierre Robin sequence. Nat Genet. 
 2009 Mar;41(3):359-64. 
Bernstein BE, Stamatoyannopoulos JA, Costello JF, Ren B, Milosavljevic A, Meissner A, 
 Kellis  M, Marra MA, Beaudet AL, Ecker JR, Farnham PJ, Hirst M, Lander ES, 
 Mikkelsen TS, Thomson JA. The NIH Roadmap Epigenomics Mapping Consortium. 
 Nat Biotechnol. 2010 Oct;28(10):1045-8.  
Berquin PC, Giedd JN, Jacobsen LK, Hamburger SD, Krain AL, Rapoport JL, Castellanos 
 FX. Cerebellum in attention-deficit hyperactivity disorder: a morphometric MRI 
 study. Neurology. 1998 Apr;50(4):1087-93. 
Bhatia S, Bengani H, Fish M, Brown A, Divizia MT, de Marco R, Damante G, Grainger R, 
 van Heyningen V, Kleinjan DA. Disruption of autoregulatory feedback by a mutation 
 in a remote, ultraconserved PAX6 enhancer causes aniridia. Am J Hum Genet. 2013 
 Dec 5;93(6):1126-34. 
Biedler JL, Helson L, Spengler BA. Morphology and growth, tumorigenicity, and 
 cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res. 1973 
 Nov; 33(11):2643-52. 
Binot AC, Manfroid I, Flasse L, Winandy M, Motte P, Martial JA, Peers B, Voz ML. Nkx6.1
 and nkx6.2 regulate alpha- and beta-cell formation in zebrafish by acting on 
 pancreatic endocrine progenitor cells. Dev Biol. 2010 Apr 15;340(2):397-407. 
Blankenberg D, Von Kuster G, Coraor N, Ananda G, Lazarus R, Mangan M, Nekrutenko A, 
 Taylor J. Galaxy: a web-based genome analysis tool for experimentalists. Curr Protoc 
 Mol Biol. 2010 Jan;Chapter 19:Unit 19.10.1-21. 
Blow MJ, McCulley DJ, Li Z, Zhang T, Akiyama JA, Holt A, Plajzer-Frick I, Shoukry M, 
 Wright C, Chen F, Afzal V, Bristow J, Ren B, Black BL, Rubin EM, Visel A, 
 Pennacchio LA. ChIP-Seq identification of weakly conserved heart enhancers. Nat 
 Genet. 2010 Sep;42(9): 806-10. 
Bonn S, Zinzen RP, Perez-Gonzalez A, Riddell A, Gavin AC, Furlong EE. Cell type-specific 
 chromatin immunoprecipitation from multicellular complex samples using BiTS-
 ChIP. Nat Protoc. 2012 Apr 26;7(5):978-94. 
! %&(!
Bryne JC, Valen E, Tang MH, Marstrand T, Winther O, da Piedade I, Krogh A, Lenhard B, 
 Sandelin A. JASPAR, the open access database of transcription factor-binding 
 profiles: new content and tools in the 2008 update. Nucleic Acids Res. 2008 Jan; 
 36(Database issue):D102-6.  
Budick SA, O'Malley DM. Locomotor repertoire of the larval zebrafish: swimming, turning 
 and prey capture. J Exp Biol. 2000 Sep;203(Pt 17):2565-79.  
Bulger M, Groudine M. Functional and mechanistic diversity of distal transcription 
 enhancers. Cell. 2011 Feb 4;144(3):327-39. 
Burke TW, Kadonaga JT. Drosophila TFIID binds to a conserved downstream basal  
 promoter element that is present in many TATA-box-deficient promoters. Genes 
 Dev 1996;10:711–724. 
Burke TW, Kadonaga JT. The downstream core promoter element, DPE, is conserved from 
 Drosophila to humans and is recognized by TAFII60 of Drosophila. Genes Dev 1997; 
 11:3020–3031. 
Buratowski S, Hahn S, Guarente L, Sharp PA. Five intermediate complexes in transcription 
 initiation by RNA polymerase II. Cell. 1989 Feb 24;56(4):549-61. 
Burzynski GM, Reed X, Taher L, Stine ZE, Matsui T, Ovcharenko I, McCallion AS. 
 Systematic elucidation and in vivo validation of sequences enriched in hindbrain 
 transcriptional  control. Genome Res. 2012 Nov;22(11):2278-89. 
Burzynski GM, Reed X, Maragh S, Matsui T, McCallion AS. Integration of genomic and 
 functional approaches reveals enhancers at LMX1A and LMX1B. Mol Genet 
 Genomics. 2013 Nov;288(11):579-89. 
Caiazzo M, Dell'Anno MT, Dvoretskova E, Lazarevic D, Taverna S, Leo D, Sotnikova TD, 
 Menegon A, Roncaglia P, Colciago G, Russo G, Carninci P, Pezzoli G, Gainetdinov 
 RR, Gustincich S, Dityatev A, Broccoli V. Direct generation of functional 
 dopaminergic neurons from mouse and human fibroblasts. Nature. 2011 Jul 3; 
 476(7359):224-7. 
Carninci P, Sandelin A, Lenhard B, Katayama S, Shimokawa K, Ponjavic J, Semple CA,  
 Taylor MS,Engström PG, Frith MC, Forrest AR, Alkema WB, Tan SL, Plessy C, 
 Kodzius R, Ravasi T, KasukawaT, Fukuda S, Kanamori-Katayama M, Kitazume 
 Y, Kawaji H, Kai C, Nakamura M, Konno H, NakanoK, Mottagui-Tabar S, Arner P, 
 Chesi A, Gustincich S, Persichetti F, Suzuki H, Grimmond SM, WellsCA, Orlando 
 V, Wahlestedt C, Liu ET, Harbers M, Kawai J, Bajic VB, Hume DA, Hayashizaki Y. 
 Genome-wide analysis of mammalian promoter architecture and evolution. Nat.
 Genet 2006;38:626–635. 
Cepeda-Nieto AC, Pfaff SL, Varela-Echavarría A. Homeodomain transcription factors in the 
 development of subsets of hindbrain reticulospinal neurons. Mol Cell Neurosci. 2005 
 Jan;28(1):30-41. 
Chang CC, Lin CJ. LIBSVM: A library for support vector machines. ACM Trans Intell Syst 
 Technol 2011 2: article 27. 
! %&)!
Cheng CW, Yan CH, Choy SW, Hui MN, Hui CC, Cheng SH. Zebrafish homologue irx1a is 
 required for the differentiation of serotonergic neurons. Dev Dyn. 2007 Sep;236(9): 
 2661-7. 
Chepelev I, Wei G, Wangsa D, Tang Q, Zhao K. Characterization of genome-wide enhancer-  
 promoter interactions reveals co-expression of interacting genes and modes of 
 higher order chromatin organization. Cell Res. 2012 Mar; 22(3):490-  503.  
Chizhikov VV, Lindgren AG, Mishima Y, Roberts RW, Aldinger KA, Miesegaes GR, Currle 
DS,  Monuki ES, Millen KJ. Lmx1a regulates fates and location of cells originating from 
 the cerebellar rhombic lip and telencephalic cortical hem. Proc Natl Acad Sci USA. 
 2010 Jun 8;107(23):10725-30. 
Cooper GM, Stone EA, Asimenos G; NISC Comparative Sequencing Program, Green ED, 
 Batzoglou S, Sidow A. Distribution and intensity of constraint in mammalian 
 genomic sequence. Genome Res. 2005 Jul;15(7):901-13. 
Cooper GM, Shendure J. Needles in stacks of needles: finding disease-causal variants in a 
 wealth of genomic data. Nat Rev Genet. 2011 Aug 18;12(9):628-40. 
Cooper SJ, Trinklein ND, Anton ED, Nguyen L, Myers RM. Comprehensive analysis of 
 transcriptional promoter structure and function in 1% of the human genome.
 Genome Res 2006;16:1–10. 
Creyghton MP, Cheng AW, Welstead GG, Kooistra T, Carey BW, Steine EJ, Hanna J, 
 Lodato  MA, Frampton GM, Sharp PA, Boyer LA, Young RA, Jaenisch R. Histone 
 H3K27ac separates active from poised enhancers and predicts developmental state. 
 Proc Natl Acad Sci USA. 2010 Dec 14;107(50):21931-6.  
Dai JX, Johnson RL, Ding YQ. Manifold functions of the Nail-Patella Syndrome gene 
 Lmx1b in vertebrate development. Dev Growth Differ. 2009 Apr;51(3):241-50. 
de Kok YJ, Merkx GF, van der Maarel SM, Huber I, Malcolm S, Ropers HH, Cremers FP. A 
 duplication/paracentric inversion associated with familial X-linked deafness (DFN3) 
 suggests the presence of a regulatory element more than 400 kb upstream of the 
 POU3F4 gene. Hum Mol Genet. 1995 Nov;4(11):2145-50. 
de Laat W, Dekker J. 3C-based technologies to study the shape of the genome. Methods. 
 2012 Nov;58(3):189-91. 
Ding YQ, Marklund U, Yuan W, Yin J, Wegman L, Ericson J, Deneris E, Johnson RL, Chen 
 ZF. Lmx1b is essential for the development of serotonergic neurons. Nat Neurosci. 
 2003 Sep;6(9):933-8. 
Doulazmi M, Frédéric F, Capone F, Becker-André M, Delhaye-Bouchaud N, Mariani J. A 
 comparative study of Purkinje cells in two RORalpha gene mutant mice: 
 staggerer and RORalpha(-/-).Brain Res Dev Brain Res. 2001 Apr 30;127(2):165-74. 
Eckner R, Arany Z, Ewen M, Sellers W, Livingston DM. The adenovirus E1A-associated 
 300-kD protein exhibits properties of a transcriptional coactivator and belongs to an 
 evolutionarily conserved family. Cold Spring Harb Symp Quant Biol. 1994; 59: 85-
 95. 
Elia J, Gai X, Xie HM, Perin JC, Geiger E, Glessner JT, D'arcy M, deBerardinis R, 
 Frackelton E, Kim C, Lantieri F, Muganga BM, Wang L, Takeda T, Rappaport EF, 
! %&*!
 Grant SF, Berrettini W, Devoto M, Shaikh TH, Hakonarson H, White PS. Rare 
 structural variants found in attention-deficit hyperactivity disorder are preferentially 
 associated with neurodevelopmental genes. Mol Psychiatry. 2010 Jun;15(6):637-46. 
Elsen GE, Choi LY, Millen KJ, Grinblat Y, Prince VE. Zic1 and Zic4 regulate zebrafish roof 
 plate specification and hindbrain ventricle morphogenesis. Dev Biol. 2008 Feb 
 15;314(2):376-92. 
Emison ES, McCallion AS, Kashuk CS, Bush RT, Grice E, Lin S, Portnoy ME, Cutler DJ, 
 Green ED, Chakravarti A. A common sex-dependent mutation in a RET enhancer 
 underlies Hirschsprung disease risk. Nature. 2005 Apr 14;434 (7035):857-63. 
ENCODE Project Consortium. Identification and analysis of functional elements in 1% of the 
 human genome by the ENCODE pilot project. Nature. 2007 Jun14;447(7146):799-
 816.  
ENCODE Project Consortium. A user's guide to the encyclopedia of DNA elements 
 (ENCODE). PLoS Biol. 2011 Apr;9(4):e1001046. 
Ernst J, Kheradpour P, Mikkelsen TS, Shoresh N, Ward LD, Epstein CB, Zhang X, Wang 
 L, Issner R, Coyne M, Ku M, Durham T, Kellis M, Bernstein BE. Mapping and 
 analysis of chromatin state dynamics in nine human cell types. Nature. 2011 May
 5;473(7345):43-9. 
Failli V, Bachy I, Rétaux S. Expression of the LIM-homeodomain gene Lmx1a (dreher) 
 during development of the mouse nervous system. Mech Dev. 2002 Oct;118(1-2): 
 225-8. 
Fantes J, Redeker B, Breen M, Boyle S, Brown J, Fletcher J, Jones S, Bickmore W, 
 Fukushima Y, Mannens M, et al. Aniridia-associated cytogenetic rearrangements 
 suggest that a position effect may cause the mutant phenotype. Hum Mol Genet. 1995 
 Mar;4(3): 415-22. 
Ferri AL, Cavallaro M, Braida D, Di Cristofano A, Canta A, Vezzani A, Ottolenghi S, 
 Pandolfi PP, Sala M, DeBiasi S, Nicolis SK. Sox2 deficiency causes 
 neurodegeneration and impaired neurogenesis in the adult mouse brain. 
 Development. 2004 Aug;131(15): 3805-19. 
Ferri AL, Lin W, Mavromatakis YE, Wang JC, Sasaki H, Whitsett JA, Ang SL. Foxa1 and 
 Foxa2  regulate multiple phases of midbrain dopaminergic neuron development in a 
 dosage-dependent manner. Development. 2007 Aug;134(15): 2761-9. 
Filippi A, Mahler J, Schweitzer J, Driever W. Expression of the paralogous tyrosine  
 hydroxylase encoding genes th1 and th2 reveals the full complement of  
 dopaminergic and noradrenergic neurons in zebrafish larval and juvenile brain. J 
 Comp Neurol. 2010 Feb 15;518(4):423-38. 
Filippi A, Mueller T, Driever W. vglut2 and gad expression reveal distinct patterns of dual 
 GABAergic versus glutamatergic cotransmitter phenotypes of dopaminergic and 
 noradrenergic neurons in the zebrafish brain. J Comp Neurol. 2014 Jun 15; 
 522(9):2019-37. 
! %&+!
Fisher S, Grice EA, Vinton RM, Bessling SL, McCallion AS. Conservation of RET 
 regulatory function from human to zebrafish without sequence similarity. 
 Science. 2006 Apr 14;312(5771):276-9.  
Fisher S, Grice EA, Vinton RM, Bessling SL, Urasaki A, Kawakami K, McCallion AS. 
 Evaluating the biological relevance of putative enhancers using Tol2 transposon- 
 mediated transgenesis in zebrafish. Nat Protoc. 2006;1(3):1297-305. 
FitzGerald PC, Sturgill D, Shyakhtenko A, Oliver B, Vinson C. Comparative genomics of 
 Drosophila and human core promoters. Genome Biol 2006;7:R53. 
Fletez-Brant C, Lee D, McCallion AS, Beer MA. kmer-SVM: a web server for identifying 
 predictive regulatory sequence features in genomic data sets. Nucleic Acids Res.
 2013 Jul;41(Web Server issue):W544-56. doi: 10.1093/nar/gkt519. 
Friling S, Andersson E, Thompson LH, Jönsson ME, Hebsgaard JB, Nanou E, Alekseenko 
 Z, Marklund U, Kjellander S, Volakakis N, Hovatta O, El Manira A, Björklund A,
 Perlmann T, Ericson J. Efficient production of mesencephalic dopamine 
 neurons by Lmx1a expression in embryonic stem cells. Proc Natl Acad Sci USA.
 2009 May 5;106 (18):7613-8. 
Gadd MS, Bhati M, Jeffries CM, Langley DB, Trewhella J, Guss JM, Matthews JM. 
 Structural basis for partial redundancy in a class of transcription factors, the LIM 
 homeodomain proteins, in neural cell type specification. J Biol Chem. 2011 Dec
 16;286(50):42971-80. 
Gary DS, Mattson MP. Integrin signaling via the PI3-kinase-Akt pathway increases  neuronal 
 resistance to glutamate-induced apoptosis. J Neurochem. 2001 Mar;76(5): 1485-96. 
Gary DS, Milhavet O, Camandola S, Mattson MP. Essential role for integrin linked kinase in 
 Akt-mediated integrin survival signaling in hippocampal neurons. J Neurochem. 
 2003 Feb;84(4):878-90. 
Gary DS, Malone M, Capestany P, Houdayer T, McDonald JW. Electrical stimulation 
 promotes the survival of oligodendrocytes in mixed cortical cultures. J Neurosci Res. 
 2012 Jan;90(1):72-83. 
Gates MA, Kim L, Egan ES, Cardozo T, Sirotkin HI, Dougan ST, Lashkari D, Abagyan R, 
 Schier AF, Talbot WS. A genetic linkage map for zebrafish: comparative analysis 
 and localization of genes and expressed sequences. Genome Res. 1999 Apr;9(4):334-
 47. 
Gershenzon NI, Trifonov EN, Ioshikhes IP. The features of Drosophila core promoters 
 revealed by statistical analysis. BMC Genomics 2006;7:161. 
Ghysen A. The origin and evolution of the nervous system. Int J Dev Biol. 2003;47(7-8):555-
 62. 
Gibbs RA, Weinstock GM, Metzker ML, Muzny DM, Sodergren EJ, Scherer S, Scott G, 
 Steffen D, Worley KC, Burch PE et al. Genome sequence of the Brown Norway rat 
 yields insights into mammalian evolution. Nature. 2004 Apr 1;428(6982):493-521. 
Giguère V. To ERR in the estrogen pathway. Trends Endocrinol Metab. 2002 Jul;3(5):220-
 225.  
! %&,!
Gilfillan GD, Hughes T, Sheng Y, Hjorthaug HS, Straub T, Gervin K, Harris JR, Undlien 
 DE, Lyle R. Limitations and possibilities of low cell number ChIP-seq. BMC 
 Genomics. 2012 Nov 21;13:645. 
Goecks J, Nekrutenko A, Taylor J; Galaxy Team. Galaxy: a comprehensive approach for 
 supporting accessible, reproducible, and transparent computational research in the 
 life sciences. Genome Biol. 2010;11(8):R86. 
Goldberg, ML. Ph.D. Thesis.  Stanford University; Stanford, CA, U.S.A.: 1979.  
Gompel N, Prud'homme B, Wittkopp PJ, Kassner VA, Carroll SB. Chance caught on the 
 wing: cis-regulatory evolution and the origin of pigment patterns in Drosophila. 
 Nature. 2005 Feb 3;433(7025):481-7. 
Gong S, Zheng C, Doughty ML, Losos K, Didkovsky N, Schambra UB, Nowak NJ, Joyner 
 A, Leblanc G, Hatten ME, Heintz N. A gene expression atlas of the central nervous 
 system based on bacterial artificial chromosomes. Nature. 2003 Oct 30; 425(6961): 
 917-25. 
Gorkin DU, Lee D, Reed X, Fletez-Brant C, Bessling SL, Loftus SK, Beer MA, Pavan WJ, 
 McCallion AS. Integration of ChIP-seq and machine learning reveals enhancers and a 
 predictive regulatory sequence vocabulary in melanocytes. Genome Res. 2012 
 Nov;22(11):2290-301. 
Gorkin, DU. Ph.D. Thesis.  Johns Hopkins University; Baltimore, MD, U.S.A.: 2013. 
Graham V, Khudyakov J, Ellis P, Pevny L. SOX2 functions to maintain neural progenitor 
 identity. Neuron. 2003 Aug 28;39(5):749-65. 
Grice EA, Rochelle ES, Green ED, Chakravarti A, McCallion AS. Evaluation of the RET 
 regulatory landscape reveals the biological relevance of a HSCR-implicated 
 enhancer. Hum Mol Genet. 2005 Dec 15;14(24):3837-45. 
Guo C, Qiu HY, Huang Y, Chen H, Yang RQ, Chen SD, Johnson RL, Chen ZF, Ding YQ. 
 Lmx1b is essential for Fgf8 and Wnt1 expression in the isthmic organizer during 
 tectum and cerebellum development in mice. Development. 2007 Jan;134(2):317-25. 
Guo S. Linking genes to brain, behavior and neurological diseases: what can we learn from 
 zebrafish? Genes Brain Behav. 2004 Apr;3(2):63-74. 
Guyon I, Weston J, Barnhill S, Vapnik V. Gene selection for cancer classification using 
 support vector machines. Mach Learn 2002 46: 389–422. 
Hawkins RD, Hon GC, Yang C, Antosiewicz-Bourget JE, Lee LK, Ngo QM, Klugman S, 
 Ching KA, Edsall LE, Ye Z, Kuan S, Yu P, Liu H, Zhang X, Green RD, Lobanenkov 
 VV, Stewart R, Thomson JA, Ren B. Dynamic chromatin states in human ES cells 
 reveal potential regulatory sequences and genes involved in pluripotency. Cell Res. 
 2011 Oct;21(10):1393-409. 
He A, Kong SW, Ma Q, Pu WT. Co-occupancy by multiple cardiac transcription factors 
 identifies transcriptional enhancers active in heart. Proc Natl Acad Sci USA. 2011 
 Apr 5;108(14):5632-7. 
Heintz N. Gene expression nervous system atlas (GENSAT). Nat Neurosci. 2004 May;7(5): 
 483. 
Heintzman ND, Stuart RK, Hon G, Fu Y, Ching CW, Hawkins RD, Barrera LO, Van Calcar 
 S, Qu C, Ching KA, Wang W, Weng Z, Green RD, Crawford GE, Ren B. Distinct 
! %&-!
 and predictive chromatin signatures of transcriptional promoters and enhancers in the 
 human genome. Nat Genet. 2007 Mar;39(3):311-8. 
Heintzman ND, Hon GC, Hawkins RD, Kheradpour P, Stark A, Harp LF, Ye Z, Lee LK, 
 Stuart RK, Ching CW, Ching KA, Antosiewicz-Bourget JE, Liu H, Zhang X, Green 
 RD, Lobanenkov V, Stewart R, Thomson JA, Crawford GE, Kellis M, Ren B. 
 Histone modifications at human enhancers reflect global cell-type-specific gene 
 expression. Nature. 2009 May 7; 459(7243):108-12.  
Hitzemann R, Qian Y, Hitzemann B. Dopamine and acetylcholine cell density in the 
 neuroleptic responsive (NR) and neuroleptic nonresponsive (NNR) lines of mice. J 
 Pharmacol Exp Ther. 1993 Jul;266(1):431-8. 
Hobert O, Westphal H. Functions of LIM-homeobox genes. Trends Genet. 2000 Feb;16(2): 
 75-83. 
Holmberg J, Perlmann T. Maintaining differentiated cellular identity. Nat Rev Genet. 2012 
 May 18;13(6):429-39. 
Holmqvist PH, Mannervik M. Genomic occupancy of the transcriptional co-activators p300 
 and CBP. Transcription. 2013 Jan-Feb;4(1):18-23. 
Holzschuh J, Barrallo-Gimeno A, Ettl AK, Durr K, Knapik EW, Driever W. Noradrenergic  
 neurons in the zebrafish hindbrain are induced by retinoic acid and require tfap2a 
 for expression of the neurotransmitter phenotype. Development. 2003 Dec;130(23): 
 5741-54. 
Horak CE, Mahajan MC, Luscombe NM, Gerstein M, Weissman SM, Snyder M. GATA-1  
 binding sites mapped in the beta-globin locus by using mammalian chIp-chip  
 analysis. Proc Natl Acad Sci USA. 2002 Mar 5;99(5):2924-9. 
Hsu F, Kent WJ, Clawson H, Kuhn RM, Diekhans M, Haussler D. The UCSC Known Genes. 
 Bioinformatics. 2006 May 1;22(9):1036-46. 
Huang M, Sage C, Li H, Xiang M, Heller S, Chen ZY. Diverse expression patterns of LIM-
 homeodomain transcription factors (LIM-HDs) in mammalian inner ear 
 development. Dev Dyn. 2008 Nov;237(11):3305-12. 
Huang Z, Dore LC, Li Z, Orkin SH, Feng G, Lin S, Crispino JD. GATA-2 reinforces 
 megakaryocyte development in the absence of GATA-1. Mol Cell Biol. 2009 
 Sep;29(18):5168-80. 
Huettner JE, Baughman RW. Primary culture of identified neurons from the visual cortex of 
 postnatal rats. J Neurosci. 1986 Oct;6(10):3044-60. 
Ibáñez-Sandoval O, Tecuapetla F, Unal B, Shah F, Koós T, Tepper JM. Electrophysiological 
 and morphological characteristics and synaptic connectivity of tyrosine 
 hydroxylase-expressing neurons in adult mouse striatum. J Neurosci. 2010 May 
 19;30(20):6999-7016.  
Inoka S. Balasooriya and K. Wimalasena. Are SH-SY5Y and MN9D cell lines truly 
 dopaminergic? FASEB J. April 2007. 21 (Meeting Abstract Supplement) A1274. 
Ji H, Jiang H, Ma W, Johnson DS, Myers RM, Wong WH. An integrated software system for 
 analyzing ChIP-chip and ChIP-seq data. Nat Biotechnol. 2008 Nov;26(11):1293-300. 
! %'.!
Juven-Gershon T1, Kadonaga JT. Regulation of gene expression via the core promoter and 
 the basal transcriptional machinery. Dev Biol. 2010 Mar 15;339(2):225-9. 
Karolchik D, Hinrichs AS, Furey TS, Roskin KM, Sugnet CW, Haussler D, Kent WJ. The 
 UCSC Table Browser data retrieval tool. Nucleic Acids Res. 2004 Jan1;32 (Database
 issue):D493-6. 
Karolchik D, Kuhn RM, Baertsch R, Barber GP, Clawson H, Diekhans M, Giardine B, Harte
 RA, Hinrichs AS, Hsu F, Kober KM, Miller W, Pedersen JS, Pohl A, Raney BJ, 
Rhead  B, Rosenbloom KR, Smith KE, Stanke M, Thakkapallayil A, Trumbower H, Wang T, 
 Zweig AS, Haussler D, Kent WJ. The UCSC Genome Browser Database: 2008 
 update. Nucleic Acids Res. 2008 Jan;36(Database issue):D773-9.  
Kawai H, Arata N, Nakayasu H. Three-dimensional distribution of astrocytes in zebrafish 
 spinal cord. Glia. 2001;36:406–413. 
Kelberman D, de Castro SC, Huang S, Crolla JA, Palmer R, Gregory JW, Taylor D, Cavallo 
 L, Faienza MF, Fischetto R, Achermann JC, Martinez-Barbera JP, Rizzoti K, Lovell-
 Badge  R, Robinson IC, Gerrelli D, Dattani MT. SOX2 plays a critical role in the 
 pituitary, forebrain, and eye during human embryonic development. J Clin 
 Endocrinol Metab. 2008 May;93(5):1865-73.  
Khaliq ZM, Bean BP. Pacemaking in dopaminergic ventral tegmental area neurons: 
 depolarizing drive from background and voltage-dependent sodium conductances. J 
 Neurosci. 2010 May 26;30(21):7401-13 
Kim TH, Barrera LO, Zheng M, Qu C, Singer MA, Richmond TA, Wu Y, Green RD, Ren B. 
 A high resolution map of active promoters in the human genome. Nature 
 2005;436:876– 880. 
Kimmel CB, Ballard WW, Kimmel SR, Ullmann B, Schilling TF. Stages of embryonic 
 development of the zebrafish. Dev Dyn. 1995 Jul;203(3):253-310. 
Kittler J, Hatef M, Duin RPW, Matas J. On combining classifiers. IEEE Trans Pattern Anal 
 Mach Intell 1998 20: 226–239. 
Kiyota T, Kato A, Altmann CR, Kato Y. The POU homeobox protein Oct-1 regulates radial 
 glia formation downstream of Notch signaling. Dev Biol. 2008 Mar15;315(2):579-92. 
Kleinjan DJ1, Coutinho P. Cis-ruption mechanisms: disruption of cis-regulatory control as a 
 cause of human genetic disease. Brief Funct Genomic Proteomic. 2009 Jul;8(4):317-
 32. 
Koo SK, Hill JK, Hwang CH, Lin ZS, Millen KJ, Wu DK. Lmx1a maintains proper 
 neurogenic, sensory, and non-sensory domains in the mammalian inner ear. Dev Biol. 
 2009 Sep 1;333(1):14-25. 
Koulen P, Janowitz T, Johnston LD, Ehrlich BE. Conservation of localization patterns of IP 
 (3) receptor type 1 in cerebellar Purkinje cells across vertebrate species. J Neurosci 
 Res. 2000;61:493–499. 
Kuwada JY. Development of the zebrafish nervous system: genetic analysis and 
 manipulation. Curr Opin Neurobiol. 1995 Feb;5(1):50-4. 
! %'%!
Lagrange T, Kapanidis AN, Tang H, Reinberg D, Ebright RH. New core promoter element in 
 RNA polymerase II-dependent transcription: sequence-specific DNA binding by 
 transcription factor IIB. Genes Dev 1998;12:34–44. 
Landt SG, Marinov GK, Kundaje A, Kheradpour P, Pauli F, Batzoglou S, Bernstein BE, 
 Bickel P, Brown JB, Cayting P, Chen Y, DeSalvo G, Epstein C, Fisher-Aylor KI, 
 Euskirchen G, Gerstein M, Gertz J, Hartemink AJ, Hoffman MM, Iyer VR, Jung YL, 
 Karmakar S, Kellis M, Kharchenko PV, Li Q, Liu T, Liu XS, Ma L, Milosavljevic A, 
 Myers RM, Park PJ, Pazin MJ, Perry MD, Raha D, Reddy TE, Rozowsky J, Shoresh 
 N, Sidow A, Slattery M, Stamatoyannopoulos JA, Tolstorukov MY, White KP, Xi S, 
 Farnham PJ, Lieb JD, Wold BJ, Snyder M. ChIP-seq guidelines and practices of the 
 ENCODE and mod ENCODE consortia. Genome Res. 2012 Sep;22(9):1813-31. 
Langmead B, Salzberg S. Fast gapped-read alignment with Bowtie 2. Nature Methods. 2012, 
 9:357-359. 
Lee D, Karchin R, Beer MA. Discriminative prediction of mammalian enhancers from DNA 
 sequence. Genome Res. 2011 Dec;21(12):2167-80. 
Lee HS, Bae EJ, Yi SH, Shim JW, Jo AY, Kang JS, Yoon EH, Rhee YH, Park CH, Koh HC, 
 Kim HJ, Choi HS, Han JW, Lee YS, Kim J, Li JY, Brundin P, Lee SH. Foxa2 and 
 Nurr1 synergistically yield A9 nigral dopamine neurons exhibiting improved 
 differentiation, function, and cell survival. Stem Cells. 2010 Mar 31;28(3):501-12. 
Leleu M, Lefebvre G, Rougemont J. Processing and analyzing ChIP-seq data: from short 
 reads to regulatory interactions. Brief Funct Genomics. 2010 Dec;9(5-6):466-76. 
Lettice LA, Horikoshi T, Heaney SJ, van Baren MJ, van der Linde HC, Breedveld GJ, Joosse 
 M, Akarsu N, Oostra BA, Endo N, Shibata M, Suzuki M, Takahashi E, Shinka T, 
 Nakahori Y, Ayusawa D, Nakabayashi K, Scherer SW, Heutink P, Hill RE, Noji S. 
 Disruption of a long-range cis-acting regulator for Shh causes preaxial polydactyly. 
 Proc Natl Acad Sci USA. 2002 May 28;99(11):7548-53. 
Lettice LA, Heaney SJ, Purdie LA, Li L, de Beer P, Oostra BA, Goode D, Elgar G, Hill RE, 
 de Graaff E. A long-range Shh enhancer regulates expression in the developing limb 
 and fin and is associated with preaxial polydactyly. Hum Mol Genet. 2003 Jul 
 15;12(14): 1725-35. 
Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, Marth G, Abecasis G, Durbin 
 R; 1000 Genome Project Data Processing Subgroup. The Sequence Alignment/Map 
 format and SAMtools. Bioinformatics. 2009 Aug 15;25(16): 2078-9. 
Lim CY, Santoso B, Boulay T, Dong E, Ohler U, Kadonaga JT. The MTE, a new core 
 promoter element for transcription by RNA polymerase II. Genes Dev 2004;18:1606-
 1617. 
Lin MK, Farrer MJ. Genetics and genomics of Parkinson's disease. Genome Med. 2014 Jun 
 30; 6(6):48. 
Lin W, Metzakopian E, Mavromatakis YE, Gao N, Balaskas N, Sasaki H, Briscoe J, Whitsett 
 JA, Goulding M, Kaestner KH, Ang SL. Foxa1 and Foxa2 function both upstream of 
 and cooperatively with Lmx1a and Lmx1b in a feed forward loop promoting 
! %'&!
 mesodiencephalic dopaminergic neuron development. Dev Biol. 2009 Sep 15; 
 333(2):386-96. 
Liu T, Ortiz JA, Taing L, Meyer CA, Lee B, Zhang Y, Shin H, Wong SS, Ma J, Lei Y, Pape 
 UJ, Poidinger M, Chen Y, Yeung K, Brown M, Turpaz Y, Liu XS. Cistrome: an 
 integrative platform for transcriptional regulation studies. Genome Biol. 2011 Aug 
 22; 12(8):R83. 
Liu YR, Laghari ZA, Novoa CA, Hughes J, Webster JR, Goodwin PE, Wheatley SP, Scotting 
 PJ. Sox2 acts as a transcriptional repressor in neural stem cells. BMC Neurosci. 2014 
 Aug 8;15:95. 
Mahony S, Benos PV. STAMP: a web tool for exploring DNA-binding motif similarities. 
 Nucleic Acids Res. 2007 Jul;35(Web Server issue):W253-8. 
Mali P, Yang L, Esvelt KM, Aach J, Guell M, DiCarlo JE, Norville JE, Church GM. RNA-
 guided  human genome engineering via Cas9. Science. 2013 Feb 15;339(6121):823-6. 
Marei HE, Althani A, Afifi N, Michetti F, Pescatori M, Pallini R, Casalbore P, Cenciarelli C, 
 Schwartz P, Ahmed AE. Gene expression profiling of embryonic human neural stem 
 cells and dopaminergic neurons from adult human substantia nigra. PLoS One. 
 2011;6(12):e28420. 
Matys V, Fricke E, Geffers R, Gössling E, Haubrock M, Hehl R, Hornischer K, Karas D, Kel 
 AE, Kel-Margoulis OV, Kloos DU, Land S, Lewicki-Potapov B, Michael H, Münch 
 R, Reuter I, Rotert S, Saxel H, Scheer M, Thiele S, Wingender E. TRANSFAC: 
 transcriptional  regulation, from patterns to profiles. Nucleic Acids Res. 2003 Jan 
 1;31(1):374-8. 
Matys V, Kel-Margoulis OV, Fricke E, Liebich I, Land S, Barre-Dirrie A, Reuter I, 
 Chekmenev D, Krull M, Hornischer K, Voss N, Stegmaier P, Lewicki-Potapov B, 
 Saxel H, Kel AE, Wingender E. TRANSFAC and its module TRANSCompel: 
 transcriptional gene regulation in eukaryotes. Nucleic Acids Res. 2006 Jan 1; 
 34(Database issue):D108-10. 
Maurano MT, Humbert R, Rynes E, Thurman RE, Haugen E, Wang H, Reynolds AP, 
 Sandstrom R, Qu H, Brody J, Shafer A, Neri F, Lee K, Kutyavin T, Stehling-Sun S, 
 Johnson AK, Canfield TK, Giste E, Diegel M, Bates D, Hansen RS, Neph S, Sabo PJ, 
 Heimfeld S, Raubitschek A, Ziegler S, Cotsapas C, Sotoodehnia N, Glass I, Sunyaev 
 SR, Kaul R, Stamatoyannopoulos JA. Systematic localization of common disease-
 associated variation in regulatory DNA. Science. 2012 Sep 7;337(6099):1190-5. 
McGaughey DM, Stine ZE, Huynh JL, Vinton RM, McCallion AS. Asymmetrical 
 distribution of  non-conserved regulatory sequences at PHOX2B is reflected at the 
 ENCODE loci and illuminates a possible genome-wide trend. BMC Genomics. 2009 
 Jan 7;10:8. McGaughey DM, Vinton RM, Huynh J, Al-Saif A, Beer MA, McCallion 
 AS. Metrics of  sequence constraint overlook regulatory sequences in an exhaustive 
 analysis at phox2b. Genome Res. 2008 Feb;18(2):252-60. 
McLean CY, Bristor D, Hiller M, Clarke SL, Schaar BT, Lowe CB, Wenger AM, Bejerano 
 G. GREAT improves functional interpretation of cis-regulatory regions. Nat 
 Biotechnol. 2010 May;28(5):495-501.  
! %''!
McMahon C, Gestri G, Wilson SW, Link BA. Lmx1b is essential for survival of periocular 
 mesenchymal cells and influences Fgf-mediated retinal patterning in zebrafish. 
 Dev Biol. 2009 Aug 15;332(2):287-98. 
Mercer TR, Edwards SL, Clark MB, Neph SJ, Wang H, Stergachis AB, John S, Sandstrom  
 R, Li G, Sandhu KS, Ruan Y, Nielsen LK, Mattick JS, Stamatoyannopoulos JA. 
 DNaseI-hypersensitive exons colocalize with promoters and distal regulatory  
 elements. Nat Genet. 2013 Aug;45(8):852-9.  
Meyer-Lindenberg A, Miletich RS, Kohn PD, Esposito G, Carson RE, Quarantelli M, 
 Weinberger DR, Berman KF. Reduced prefrontal activity predicts exaggerated 
 striatal dopaminergic function in schizophrenia. Nat Neurosci. 2002 Mar;5(3):267-
 71. 
Miguez A, Ducret S, Di Meglio T, Parras C, Hmidan H, Haton C, Sekizar S, Mannioui A, 
 Vidal M, Kerever A, Nyabi O, Haigh J, Zalc B, Rijli FM, Thomas JL. Opposing roles 
 for Hoxa2 and Hoxb2 in hindbrain oligodendrocyte patterning. J Neurosci. 2012 Nov 
 28; 32(48):17172-85.  
Miller W, Makova KD, Nekrutenko A, Hardison RC. Comparative genomics. Annu Rev 
 Genomics Hum Genet. 2004;5:15-56. 
Millonig JH, Millen KJ, Hatten ME. The mouse Dreher gene Lmx1a controls formation of 
 the roof plate in the vertebrate CNS. Nature. 2000 Feb 17;403(6771):764-9. 
Mishima Y1, Lindgren AG, Chizhikov VV, Johnson RL, Millen KJ. Overlapping function of 
 Lmx1a and Lmx1b in anterior hindbrain roof plate formation and cerebellar growth. J 
 Neurosci. 2009 Sep 9;29(36):11377-84. 
Mong J, Panman L, Alekseenko Z, Kee N, Stanton LW, Ericson J, Perlmann T. Transcription 
 factor-induced lineage programming of noradrenaline and motor neurons from 
 embryonic stem cells. Stem Cells. 2014 Mar;32(3):609-22. 
Mueller T, Wullimann MF. Anatomy of neurogenesis in the early zebrafish brain. Brain  
 Res Dev Brain Res. 2003 Jan 10;140(1):137-55. 
Mueller T, Vernier P, Wullimann MF. A phylotypic stage in vertebrate brain development: 
 GABA cell patterns in zebrafish compared with mouse. J Comp Neurol. 2006 Feb 
 1;494(4):620-34. 
Nagatsu T, Levitt M, Udenfriend S. Tyrosine hydroxylase: the initial step in norepinephrine 
 biosynthesis. J Biol Chem. 1964 Sep;239:2910-7. 
Nakatani T, Kumai M, Mizuhara E, Minaki Y, Ono Y. Lmx1a and Lmx1b cooperate with 
 Foxa2 to coordinate the specification of dopaminergic neurons and control of floor 
 plate cell differentiation in the developing mesencephalon. Dev Biol. 2010 Mar 
 1;339(1): 101-13. 
Naranjo S, Voesenek K, de la Calle-Mustienes E, Robert-Moreno A, Kokotas H,  
 Grigoriadou M, Economides J, Van Camp G, Hilgert N, Moreno F, Alsina B,  
 Petersen MB, Kremer H, Gómez-Skarmeta JL. Multiple enhancers located in a 1- 
 Mb region upstream of POU3F4 promote expression during inner ear  
 development and may be required for hearing. Hum Genet. 2010 Oct; 128(4):411-9. 
! %'(!
Narlikar L, Gordân R, Hartemink AJ. A nucleosome-guided map of transcription factor 
 binding sites in yeast. PLoS Comput Biol. 2007 Nov;3(11):e215. 
Narlikar L, Sakabe NJ, Blanski AA, Arimura FE, Westlund JM, Nobrega MA, Ovcharenko I. 
 Genome-wide discovery of human heart enhancers. Genome Res. 2010 Mar;20(3): 
 381-92.  
Nelson SB, Janiesch C, Sander M. Expression of Nkx6 genes in the hindbrain and gut of the 
 developing mouse. J Histochem Cytochem. 2005 Jun;53(6):787-90. 
Nichols DH, Pauley S, Jahan I, Beisel KW, Millen KJ, Fritzsch B. Lmx1a is required for 
 segregation of sensory epithelia and normal ear histogenesis and morphogenesis. 
 Cell Tissue Res. 2008 Dec;334(3):339-58. 
Nolis IK, McKay DJ, Mantouvalou E, Lomvardas S, Merika M, Thanos D. Transcription 
 factors  mediate long-range enhancer-promoter interactions. Proc Natl Acad Sci USA. 
 2009 Dec 1;106(48):20222-7.  
Noonan JP, McCallion AS. Genomics of long-range regulatory elements. Annu Rev  
 Genomics Hum Genet. 2010;11:1-23.  
O'Hara FP, Beck E, Barr LK, Wong LL, Kessler DS, Riddle RD. Zebrafish Lmx1b.1 and 
 Lmx1b.2 are required for maintenance of the isthmic organizer. Development. 2005 
 Jul;132(14):3163-73. 
Ohler U, Liao GC, Niemann H, Rubin GM. Computational analysis of core promoters in  
 the Drosophila genome. Genome Biol 2002;3:RESEARCH0087. 
Ohnemus S, Bobola N, Kanzler B, Mallo M. Different levels of Hoxa2 are required for 
 particular developmental processes. Mech Dev. 2001 Oct;108(1-2):135-47. 
O'Neill LP, Turner BM. Histone H4 acetylation distinguishes coding regions of the human 
 genome from heterochromatin in a differentiation-dependent but transcription-
 independent manner. EMBO J. 1995 Aug 15;14(16):3946-57. 
O'Neill LP, Turner BM. Immunoprecipitation of chromatin. Methods Enzymol. 1996;274: 
 189-97. 
Ong CT, Corces VG. Enhancer function: new insights into the regulation of tissue-specific 
 gene expression. Nat Rev Genet. 2011 Apr;12(4):283-93. 
Panne D, Maniatis T, Harrison SC. An atomic model of the interferon-beta enhanceosome. 
 Cell. 2007 Jun 15;129(6):1111-23. 
Pattyn A, Vallstedt A, Dias JM, Sander M, Ericson J. Complementary roles for Nkx6 and 
 Nkx2 class proteins in the establishment of motoneuron identity in the hindbrain. 
 Development. 2003 Sep;130(17):4149-59. 
Pennacchio LA, Ahituv N, Moses AM, Prabhakar S, Nobrega MA, Shoukry M, Minovitsky 
 S, Dubchak I, Holt A, Lewis KD, Plajzer-Frick I, Akiyama J, De Val S, Afzal V, 
 Black BL, Couronne O, Eisen MB, Visel A, Rubin EM. In vivo enhancer analysis of 
 human  conserved non-coding sequences. Nature. 2006 Nov 23;444(7118):499-502. 
Peri F, Nusslein-Volhard C. Live imaging of neuronal degradation by microglia reveals 
 a role for v0-ATPase a1 in phagosomal fusion in vivo. Cell. 2008;133:916–927. 
! %')!
Plaza S, Dozier C, Langlois MC, Saule S. Identification and characterization of a 
 neuroretina-specific enhancer element in the quail Pax-6 (Pax-QNR) gene. Mol Cell 
 Biol. 1995 Feb;15(2):892-903.  
Prakash N, Wurst W. Development of dopaminergic neurons in the mammalian brain. Cell 
 Mol Life Sci. 2006 Jan;63(2):187-206. 
Pruitt KD, Tatusova T, Klimke W, Maglott DR. NCBI Reference Sequences: current status, 
 policy and new initiatives. Nucleic Acids Res. 2009 Jan;37(Database issue):D32-6.  
Rada-Iglesias A, Bajpai R, Swigut T, Brugmann SA, Flynn RA, Wysocka J. A unique 
 chromatin signature uncovers early developmental enhancers in humans. Nature. 
 2011 Feb 10;470(7333):279-83. 
Rick CE, Ebert A, Virag T, Bohn MC, Surmeier DJ. Differentiated dopaminergic MN9D 
 cells only partially recapitulate the electrophysiological properties of midbrain 
 dopaminergic neurons. Dev Neurosci. 2006;28(6):528-37. 
Rink E, Wullimann MF. Connections of the ventral telencephalon and tyrosine  
 hydroxylase distribution in the zebrafish brain (Danio rerio) lead to identification 
 of an ascending dopaminergic system in a teleost. Brain Res Bull.  2002 Feb-Mar 1; 
 57(3-4):385-7. 
Robertson G, Hirst M, Bainbridge M, Bilenky M, Zhao Y, Zeng T, Euskirchen G, Bernier B, 
 Varhol R, Delaney A, Thiessen N, Griffith OL, He A, Marra M, Snyder M, Jones S. 
 Genome-wide profiles of STAT1 DNA association using chromatin 
 immunoprecipitation and massively parallel sequencing. Nat Methods. 2007 Aug; 
 4(8):651-7. 
Robinson TE, Berridge KC. The neural basis of drug craving: an incentive-sensitization 
 theory of addiction. Brain Res Brain Res Rev. 1993 Sep-Dec;18(3):247-91. 
Ross RA, Spengler BA, Biedler JL. Coordinate morphological and biochemical 
 interconversion of human neuroblastoma cells. J Natl Cancer Inst. 1983 Oct;71(4): 
 741-7. 
Saucedo-Cardenas O, Quintana-Hau JD, Le WD, Smidt MP, Cox JJ, De Mayo F, Burbach 
 JP, Conneely OM. Nurr1 is essential for the induction of the dopaminergic phenotype 
 and the survival of ventral mesencephalic late dopaminergic precursor neurons. 
 Proc Natl Acad Sci USA. 1998 Mar 31;95(7):4013-8. 
Savitt JM, Dawson VL, Dawson TM. Diagnosis and treatment of Parkinson disease:  
 molecules to medicine. J Clin Invest. 2006 Jul;116(7):1744-54. 
Schneider-Maunoury S1, Gilardi-Hebenstreit P, Charnay P. How to build a vertebrate 
 hindbrain. Lessons from genetics. C R Acad Sci III. 1998 Oct;321(10):819-34. 
Serinagaoglu Y, Zhang R, Zhang Y, Zhang L, Hartt G, Young AP, Oberdick J. A promoter 
 element with enhancer properties, and the orphan nuclear receptor RORalpha, are 
 required for Purkinje cell-specific expression of a Gi/o modulator. Mol Cell Neurosci. 
 2007 Mar;34(3):324-42. 
Serra HG, Duvick L, Zu T, Carlson K, Stevens S, Jorgensen N, Lysholm A, Burright E, 
 Zoghbi HY, Clark HB, Andresen JM, Orr HT. RORalpha-mediated Purkinje cell 
! %'*!
 development determines disease severity in adult SCA1 mice. Cell. 2006 Nov 
 17;127(4):697-708. 
Shaw MW, Falls HF, Neel JV. Congenital Aniridia. Am J Hum Genet. 1960 
 Dec;12(4Pt1):389- 415. 
Shawe-Taylor J, Cristianini N. On the generalisation of soft margin algorithms. IEEE Trans 
 Inf Theory 2002 48: 2721–2735.  
Sheffield NC, Furey TS. Identifying and characterizing regulatory sequences in the human 
 genome with chromatin accessibility assays. Genes (Basel). 2012 Oct15;3(4):651-
 70. 
Shen Y, Yue F, McCleary DF, Ye Z, Edsall L, Kuan S, Wagner U, Dixon J, Lee L, 
 Lobanenkov VV, Ren B. A map of the cis-regulatory sequences in the mouse 
 genome. Nature. 2012  Aug 2;488(7409):116-20. 
Shirasaki R, Pfaff SL. Transcriptional codes and the control of neuronal identity. Annu Rev 
 Neurosci. 2002;25:251-81. 
Siepel A, Bejerano G, Pedersen JS, Hinrichs AS, Hou M, Rosenbloom K, Clawson H, Spieth 
 J, Hillier LW, Richards S, Weinstock GM, Wilson RK, Gibbs RA, Kent WJ, Miller 
 W, Haussler D. Evolutionarily conserved elements in vertebrate, insect, worm, and 
 yeast genomes. Genome Res. 2005 Aug;15(8):1034-50. 
Singleton AB, Farrer MJ, Bonifati V. The genetics of Parkinson's disease: progress and 
 therapeutic implications. Mov Disord. 2013 Jan;28(1):14. 
Smale ST, Baltimore D. The “initiator” as a transcription control element. Cell. 1989;57:103–
 113. 
Smits SM, Ponnio T, Conneely OM, Burbach JP, Smidt MP. Involvement of Nurr1 in 
 specifying the neurotransmitter identity of ventral midbrain dopaminergic neurons. 
 Eur J Neurosci. 2003 Oct;18(7):1731- 8. 
Song L, Crawford GE. DNase-seq: a high-resolution technique for mapping active gene  
 regulatory elements across the genome from mammalian cells. Cold Spring Harb 
 Protoc. 2010 Feb;2010(2):pdb.prot5384. 
Spaniol P, Bornmann C, Hauptmann G, Gerster T. Class III POU genes of zebrafish are 
 predominantly expressed in the central nervous system. Nucleic Acids Res. 1996 
 Dec 15;24(24):4874-81. 
Stott SR, Metzakopian E, Lin W, Kaestner KH, Hen R, Ang SL. Foxa1 and foxa2 are  
 required for the maintenance of dopaminergic properties in ventral midbrain  
 neurons at late embryonic stages. J Neurosci. 2013 May 1;33(18):8022-34. 
Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, 
 Pomeroy SL, Golub TR, Lander ES, Mesirov JP. Gene set enrichment analysis: a 
 knowledge-based approach for interpreting genome-wide expression profiles. Proc 
 Natl Acad Sci USA. 2005 Oct 25;102(43):15545-50. 
Tennyson VM, Gershon MD, Wade PR, Crotty DA, Wolgemuth DJ. Fetal development of 
 the enteric nervous system of transgenic mice that overexpress the Hoxa-4 gene. Dev 
 Dyn. 1998 Mar;211(3):269-91. 
! %'+!
Thisse C, Thisse B, Schilling TF, Postlethwait JH.Structure of the zebrafish snail1 gene and 
 its expression in wild-type, spadetail and no tail mutant embryos. Development. 1993 
 Dec;119(4):1203-15. 
Thisse C, Degrave A, Kryukov GV, Gladyshev VN, Obrecht-Pflumio S, Krol A, Thisse B, 
 Lescure A. Spatial and temporal expression patterns of selenoprotein genes during 
 embryogenesis in zebrafish. Gene Expr Patterns. 2003 Aug;3(4):525-32. 
Thisse B, Heyer V, Lux A, Alunni V, Degrave A, Seiliez I, Kirchner J, Parkhill JP, Thisse C. 
 Spatial and temporal expression of the zebrafish genome by large-scale in situ 
 hybridization screening. Methods Cell Biol. 2004;77:505-19. 
Thisse B, Thisse C. Fast release clones: A high throughput expression analysis. In ZFIN 
 Direct Data Submission (http://zfin.org) 2004. 
Thomas MC, Chiang CM. The general transcription machinery and general cofactors. Crit 
 Rev Biochem Mol Biol. 2006 May-Jun;41(3):105-78. 
Thompson JA, Ziman M. Pax genes during neural development and their potential role in 
 neuroregeneration. Prog Neurobiol. 2011 Nov;95(3):334-51.  
Trinklein ND, Aldred SF, Hartman SJ, Schroeder DI, Otillar RP, Myers RM. An abundance 
 of bidirectional promoters in the human genome. Genome Res. 2004 Jan;14(1):62-6. 
Tsang AP, Visvader JE, Turner CA, Fujiwara Y, Yu C, Weiss MJ, Crossley M, Orkin SH. 
 FOG, a multitype zinc finger protein, acts as a cofactor for transcription factor 
 GATA-1 in erythroid and megakaryocytic differentiation. Cell. 1997 Jul 11; 
 90(1):109-19. 
Tsompana M, Buck MJ. Chromatin accessibility: a window into the genome. Epigenetics 
 Chromatin. 2014 Nov 20;7(1):33. doi: 10.1186/1756-8935-7-33. 
Tzschentke TM, Schmidt WJ. Functional relationship among medial prefrontal cortex,
 nucleus accumbens, and ventral tegmental area in locomotion and reward. Crit Rev 
 Neurobiol. 2000;14(2):131-42. Review. 
Vanacker JM, Pettersson K, Gustafsson JA, Laudet V. Transcriptional targets shared by 
 estrogen receptor- related receptors (ERRs) and estrogen receptor (ER) alpha, but 
 not by ERbeta. EMBO J. 1999 Aug 2;18(15):4270-9. 
Vanden Berghe W, De Bosscher K, Boone E, Plaisance S, Haegeman G. The nuclear factor-
 kappaB engages CBP/p300 and histone acetyltransferase activity for  transcriptional 
 activation of the interleukin-6 gene promoter. J Biol Chem. 1999 Nov 5;274(45): 
 32091-8. 
Verrijzer CP, Van der Vliet PC. POU domain transcription factors. Biochim Biophys Acta. 
 1993 Apr 29;1173(1):1-21.  
Visel A, Minovitsky S, Dubchak I, Pennacchio LA. VISTA Enhancer Browser--a database of 
 tissue-specific human enhancers. Nucleic Acids Res. 2007 Jan;35(Database issue): 
 D88-92. 
Visel A, Blow MJ, Li Z, Zhang T, Akiyama JA, Holt A, Plajzer-Frick I, Shoukry M, Wright  
 C, Chen F, Afzal V, Ren B, Rubin EM, Pennacchio LA. ChIP-seq accurately  
 predicts tissue-specific activity of enhancers. Nature. 2009 Feb 2;457 (7231): 854-8. 
! %',!
Visel A, Rubin EM, Pennacchio LA. Genomic views of distant-acting enhancers. Nature. 
 2009 Sep 10;461(7261):199-205. 
Vollrath D, Jaramillo-Babb VL, Clough MV, McIntosh I, Scott KM, Lichter PR, Richards 
 JE. Loss-of-function mutations in the LIM-homeodomain gene, LMX1B, in nail-
 patella  syndrome. Hum Mol Genet. 1998 Jul;7(7):1091-8. 
Wang W, Zhong J, Wang YQ. Comparative genomic analysis reveals the evolutionary 
 conservation of Pax gene family. Genes Genet Syst. 2010;85(3):193-206. 
Waskiewicz AJ, Rikhof HA, Hernandez RE, Moens CB. Zebrafish Meis functions to stabilize 
 Pbx proteins and regulate hindbrain patterning. Development. 2001 Nov; 128(21): 
 4139-51. 
Welter D, MacArthur J, Morales J, Burdett T, Hall P, Junkins H, Klemm A, Flicek P, 
 Manolio T, Hindorff L, Parkinson H. The NHGRI GWAS Catalog, a curated resource 
 of SNP-trait associations. Nucleic Acids Res. 2014 Jan;42 (Database issue): D1001-6. 
Wen L, Wei W, Gu W, Huang P, Ren X, Zhang Z, Zhu Z, Lin S, Zhang B. Visualization of 
 monoaminergic neurons and neurotoxicity of MPTP in live transgenic zebrafish. Dev 
 Biol. 2008 Feb 1;314(1):84-92. 
Westerfield M, McMurray JV, Eisen JS. Identified motoneurons and their innervation of 
 axial muscles in the zebrafish. J Neurosci. 1986;6:2267–2277. 
Westerfield M. The zebrafish book: a guide for the laboratory use of zebrafish (Danio rerio). 
 University of Oregon Press, Eugene. 2000. 
Yan CH, Levesque M, Claxton S, Johnson RL, Ang SL. Lmx1a and lmx1b function 
 cooperatively to regulate proliferation, specification, and differentiation of midbrain 
 dopaminergic progenitors. J Neurosci. 2011 Aug 31;31(35):12413-25. 
Yoshida M, Macklin WB. Oligodendrocyte development and myelination in GFP-transgenic 
 zebrafish. J Neurosci Res. 2005;81:1–8. 
Zhang Y, Liu T, Meyer CA, Eeckhoute J, Johnson DS, Bernstein BE, Nusbaum C, Myers 
 RM, Brown M, Li W, Liu XS. Model-based analysis of ChIP-Seq (MACS). Genome 
















Appendix 1: Primers used for cloning  
Enhancer Build Forward primer Reverse primer 








LMX1A -8.19 Hg19 TGCAAGAAGAAGTTTGGT
GACT 
CCAATGGCTGTGCTCCTC 




































































LMX1A Hg19 CAAACTGAGGCCCAAGAA TGGACGTCTGAGCTGAAG
! %(.!












































































































































































































































































































































































































































PBX1 +78.50 Hg19 CAGTGGATTCTTCAGAGGT CTATGGCTAGGGCAGAG
! %()!
ATGG AGC 




















































Nr4a2 prom Mm9 CCGCGCTCGCTTTGGT GCCTGACCTCTCATCCTT
CG 




























Pax2 +51.28 Mm9 TGTTTGCTAGCCATGTTTT CTGGAAAATCCCCGCCAG
! %(*!
CCTT AC 







































Appendix 2: Representative EGFP expression patterns driven by all elements with 
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